Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,retinoid binding (GO:0005501),-0.8271720825745689,-2.6532849652239974,0.0,0.0,0.0,8/22,7.46%,NR2F2;ALDH1A2;PTGDS;RBP4;CYP26B1;RBP1;CRABP2;ABCA4
prerank,retinoic acid binding (GO:0001972),-0.7528991148501416,-1.9976759485287299,0.0,0.063081464932578,0.104,2/12,3.87%,NR2F2;CYP26B1
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.7719299042871584,-1.9804132181439256,0.0033003300330033004,0.04882576664272987,0.121,4/11,11.15%,ITPR1;RASA3;ITPR3;RYR2
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.6921866883233795,-1.9564044540916306,0.0,0.039345727279980855,0.157,9/16,11.04%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.6921866883233795,-1.9564044540916306,0.0,0.039345727279980855,0.157,9/16,11.04%,PTPRK;PTPRG;PTPRB;PTPRD;PTPRM;PTPRN2;PTPRZ1;PTPRO;PTPRT
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.5844318131170062,-1.927279047274544,0.0,0.043479879784036814,0.203,9/26,7.81%,SLC6A13;SLC16A12;SLC16A2;ABCG2;SLC16A6;SLC6A12;SLC6A1;SLC16A11;SLC16A4
prerank,monocarboxylic acid binding (GO:0033293),-0.6369220383811586,-1.9160217499491923,0.010101010101010102,0.04093421937513536,0.218,3/18,6.33%,NR2F2;CYP26B1;NAPEPLD
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",0.8723643099251446,1.8813563880677364,0.0,0.04923365212933335,0.046,3/14,0.87%,NOX4;DUOX1;NCF4
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.723368485770419,-1.8593459175411833,0.0036363636363636364,0.06187864038937206,0.336,7/11,14.13%,ITPR1;TRPC5;ITPR3;TRPC6;TRPC4;TRPC7;TRPC3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),0.9199474702531701,1.8442748630855441,0.0,0.0689271129810667,0.113,3/10,0.87%,NOX4;DUOX1;NCF4
prerank,store-operated calcium channel activity (GO:0015279),-0.7182390059985213,-1.8429992679204914,0.012987012987012988,0.06438823727581407,0.389,6/10,14.13%,TRPC5;TRPC6;TRPC4;ORAI2;TRPC7;TRPC3
prerank,CoA-ligase activity (GO:0016405),-0.6678652294062531,-1.8231323588364965,0.004132231404958678,0.06949652916300966,0.442,5/14,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,semaphorin receptor activity (GO:0017154),-0.7224497885948472,-1.7868318674744739,0.011029411764705883,0.0875753465396807,0.549,6/11,8.64%,PLXNA2;NRP2;PLXNA4;PLXND1;NRP1;PLXNB1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),-0.46142034498433226,-1.7756219249376728,0.0,0.08829623128274688,0.589,12/55,4.70%,SLC7A2;SLC6A13;SLC16A12;SLC13A3;SLC16A2;SLC16A6;SLC6A12;PDPN;SLC38A11;SLC7A5;SLC16A11;SLC22A4
prerank,amino acid:sodium symporter activity (GO:0005283),-0.6997422653194942,-1.7626990253220634,0.020905923344947737,0.09038661011851788,0.622,4/11,3.01%,SLC6A13;SLC1A3;SLC6A12;SLC6A1
prerank,acid-thiol ligase activity (GO:0016878),-0.6753451803945459,-1.7590187167127016,0.008,0.08637425767402628,0.637,5/13,12.68%,ACSL1;ACSS3;AACS;ACSS1;ACSS2
prerank,poly(A)-specific ribonuclease activity (GO:0004535),-0.6954562095527785,-1.7587922845969386,0.0034602076124567475,0.08075853081198968,0.637,8/12,19.35%,CNOT2;PAN3;CNOT7;NOCT;CNOT6L;TOE1;PNLDC1;CNOT1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.8212788068735773,1.7355714004275251,0.0013568521031207597,0.372534634445289,0.59,5/12,7.27%,ARSA;SULF2;ARSJ;ARSI;SULF1
prerank,serine-type peptidase activity (GO:0008236),0.6202835526234093,1.7307075309451905,0.0,0.2998329414676401,0.623,23/96,16.64%,HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;GZMK;PRSS12;PCSK4;RHBDF1;TPP1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;PRSS8;HGF;HTRA2
prerank,platelet-derived growth factor binding (GO:0048407),0.8163067194485473,1.70362398782658,0.0040650406504065045,0.36314741810596285,0.763,6/11,10.14%,COL3A1;COL1A2;COL1A1;COL5A1;COL6A1;COL2A1
prerank,protease binding (GO:0002020),0.6085967593273898,1.6911331978786495,0.0,0.36597014749471124,0.827,24/99,10.48%,COMP;COL3A1;COL1A2;TIMP2;COL1A1;CCBE1;DPP4;FAP;CD177;ITGB3;ANXA2;ECM1;SRI;BIN1;SPATA2;SYVN1;ADAMTSL4;ATP9A;CARD16;TRIP4;CLTC;ADRM1;ITGAV;CSTB
prerank,serine-type endopeptidase activity (GO:0004252),0.606142570152528,1.682322334224638,0.0,0.3533569547111011,0.859,19/80,16.64%,PCSK6;KLK9;PRSS48;DPP4;HPN;FAP;PCSK5;MMP2;PRSS12;PCSK4;RHBDF1;MASP2;GZMM;PIK3IP1;KLK1;KLK6;CLPP;HGF;HTRA2
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),-0.6668738513171271,-1.6753598616438385,0.02564102564102564,0.1496848320434054,0.878,4/11,14.90%,PPP1R1A;PPP1R8;PPP1R14A;PABIR1
prerank,fibroblast growth factor receptor binding (GO:0005104),0.7402282672953255,1.6736830952609971,0.0037546933667083854,0.3461125744692135,0.893,4/21,2.88%,FGF18;FGF7;NPTN;FGF2
prerank,low-density lipoprotein particle binding (GO:0030169),-0.5611429489882584,-1.6313341727153179,0.02608695652173913,0.18955885873059827,0.929,6/16,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.6518076715183432,-1.612238592016623,0.026022304832713755,0.20272790943021535,0.947,6/10,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,microtubule plus-end binding (GO:0051010),0.700613101528976,1.611087675334845,0.0129366106080207,0.6560110625944063,0.987,13/20,22.51%,DCTN1;CLIP1;DST;MAPRE3;CLIP2;MAPRE1;CLIP4;PAFAH1B1;STIM1;CLIP3;CLASP2;NUMA1;FBXW11
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),-0.6100053852804186,-1.6079132417303654,0.040740740740740744,0.19672863639990426,0.948,4/13,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",-0.5551039208764517,-1.5781645246660125,0.03862660944206009,0.22399265937923885,0.967,10/16,33.13%,ETHE1;CDO1;ALOX12;ADI1;PIR;BCO2;HGD;ALOXE3;HAAO;ALOX5
prerank,filamin binding (GO:0031005),-0.6146851990346214,-1.5731080645401154,0.04332129963898917,0.22060693103539988,0.969,6/11,15.73%,NEBL;SYNPO2;TMEM67;CEACAM1;FBLIM1;MICALL2
prerank,BMP receptor binding (GO:0070700),-0.6100066068068829,-1.5654516766954016,0.05415162454873646,0.22005614269238302,0.973,4/12,1.98%,BMP6;CDH5;BMP5;BMP7
prerank,protein tyrosine kinase activator activity (GO:0030296),0.6863660039000523,1.5584409532072372,0.02644836272040302,1.0,1.0,7/19,12.38%,EFNA5;ANGPT4;DGKQ;GAS6;ABI1;NRG3;EGF
prerank,protein kinase C binding (GO:0005080),0.5910863704585811,1.545282415199225,0.0194954128440367,1.0,1.0,15/43,10.45%,AVPR1A;NELL2;IRS1;DACT3;ADAM9;HDAC9;HDAC7;DACT1;DACT2;YWHAG;PRKD2;PARD6A;TIRAP;ITGAV;SQSTM1
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.714617895038812,1.5398372979131971,0.034346103038309116,1.0,1.0,4/14,10.96%,CAPN5;CAPN2;CAPN1;CAPN11
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.727487808203977,1.5358046655549922,0.020435967302452316,0.9933836118095493,1.0,2/13,3.53%,EHHADH;MIF
prerank,phospholipase binding (GO:0043274),0.7116998493163625,1.5113592857224367,0.05242463958060288,1.0,1.0,4/13,6.81%,SYK;FYN;DGKQ;SRC
prerank,calcium-release channel activity (GO:0015278),-0.5289594536507081,-1.5053993776473964,0.055299539170506916,0.29704536545259647,0.998,3/17,5.14%,ITPR1;RASA3;ITPR3
prerank,frizzled binding (GO:0005109),0.5994187231332401,1.5006213563857933,0.03202846975088968,1.0,1.0,6/34,2.82%,MYOC;LRP6;WNT10B;WNT2;CCDC88C;WNT9A
prerank,clathrin adaptor activity (GO:0035615),0.692689718423016,1.498131440596894,0.034528552456839307,1.0,1.0,4/15,6.08%,STON2;AP1G2;AP1M1;AP2A2
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.5895141839213384,-1.4975774358850413,0.07457627118644068,0.29785499614351446,0.998,3/10,3.01%,SLC6A13;SLC6A12;SLC6A1
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.5387122752119086,-1.488013157698739,0.06493506493506493,0.3012086491662012,0.999,5/15,9.80%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,C-C chemokine binding (GO:0019957),0.6252065381589383,1.4817813179197803,0.050188205771643665,1.0,1.0,6/22,17.61%,ACKR3;ACKR4;ACKR1;ZFP36;CXCR4;CXCR2
prerank,bHLH transcription factor binding (GO:0043425),-0.48844554652989663,-1.4735022444072563,0.07239819004524888,0.3125287702005168,0.999,8/19,12.63%,FHL2;SMAD3;CREBBP;SP1;TCF12;SIRT1;LMO2;USF1
prerank,phospholipase inhibitor activity (GO:0004859),0.718641283199007,1.4705506468207947,0.058823529411764705,1.0,1.0,3/10,2.53%,SNCB;ANXA1;ANXA2
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.5502384113868483,-1.4702769167636913,0.060836501901140684,0.3062599182602374,0.999,5/13,9.80%,ALDH1A1;ALDH1A2;ALDH7A1;ALDH4A1;ALDH1L1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),0.6601102615439596,1.4625617387246201,0.06957708049113233,1.0,1.0,3/15,4.54%,SLC1A5;SLC1A7;SLC1A6
prerank,3'-5' DNA helicase activity (GO:0043138),0.6546684874664079,1.4620651050121982,0.06521739130434782,1.0,1.0,6/16,18.32%,NAV2;HELQ;ASCC3;ERCC3;RECQL;BLM
prerank,amino acid transmembrane transporter activity (GO:0015171),-0.37903107007246756,-1.4434727764300908,0.030927835051546393,0.3377073098448667,0.999,15/47,13.35%,SLC7A11;SLC7A2;SLC6A13;SLC16A2;PDPN;SLC6A1;SLC38A11;SLC7A5;SLC22A4;SLC3A2;SLC38A5;SLC25A44;SLC6A6;SLC43A1;SLC7A14
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5554564515233841,-1.4390392824302485,0.07518796992481203,0.335058067391741,1.0,6/11,15.93%,CASP4;CASP3;CASP7;CFLAR;CASP9;CASP6
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7166934739732621,1.4383882777203092,0.06629055007052186,1.0,1.0,3/10,6.11%,DPP4;FAP;PRCP
prerank,ligand-gated calcium channel activity (GO:0099604),-0.4771144371479263,-1.4347103057931403,0.05286343612334802,0.33048272560440434,1.0,3/19,5.14%,ITPR1;RASA3;ITPR3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.6545154117479807,1.4313844969330916,0.08075370121130551,1.0,1.0,1/14,0.74%,DHRS9
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.6856376614885694,1.4293990850894231,0.0850480109739369,1.0,1.0,3/11,14.45%,AKR1B1;RDH14;RDH13
prerank,growth factor receptor binding (GO:0070851),0.5177661579336893,1.4288672152840292,0.018711018711018712,1.0,1.0,27/95,16.68%,AREG;FGF18;FGF7;TIMM50;GLMN;BTC;FYN;ITGB3;VEGFA;FGF2;ITGA5;PTPRJ;ARF4;SRC;TLR5;SNX1;ESM1;ATXN2;PSEN1;ERN1;PIBF1;EGF;PDGFRA;FER;IL4;IL6;EFEMP1
prerank,acylglycerol lipase activity (GO:0047372),0.6978479236546511,1.4271183529937297,0.07945205479452055,1.0,1.0,1/11,0.62%,MGLL
prerank,chemokine binding (GO:0019956),0.5694976644972004,1.416316269954603,0.06345475910693302,1.0,1.0,9/30,17.61%,ACKR3;ITGB3;FGF2;ACKR4;ITGAV;ACKR1;ZFP36;CXCR4;CXCR2
prerank,lipoprotein particle binding (GO:0071813),-0.45663752267441593,-1.4161843852067721,0.07471264367816093,0.3504142611891703,1.0,6/20,10.51%,PLTP;SCARB1;THBS1;STAB1;CDH13;SORL1
prerank,carbohydrate:cation symporter activity (GO:0005402),0.683571072622528,1.4090377821510682,0.08458390177353342,1.0,1.0,5/11,13.02%,SLC5A9;SLC17A5;SLC2A10;SLC23A1;SLC23A2
prerank,UDP-glycosyltransferase activity (GO:0008194),0.5196194236538633,1.4056669301265667,0.03194888178913738,1.0,1.0,13/70,10.59%,HAS2;HAS1;B4GALT1;B3GALNT1;CSGALNACT2;EXT1;B4GALNT4;POMGNT2;CHSY3;B3GAT3;RFNG;LARGE1;B3GNT8
prerank,ubiquitin-specific protease binding (GO:1990381),0.6105151795118665,1.398042675283871,0.08084577114427861,1.0,1.0,9/19,24.40%,SPATA2;SYVN1;CLTC;AMFR;SELENOS;PTEN;DERL1;RHBDD2;LCOR
prerank,ferrous iron binding (GO:0008198),-0.46614532326411406,-1.3969321664061212,0.09574468085106383,0.3734101970797096,1.0,17/21,35.25%,SNCA;FTH1;PHYH;EGLN3;FECH;EGLN1;ISCU;CDO1;FTL;FTO;ALKBH2;TET2;ACP5;ALKBH3;HAAO;HIF1AN;HEPH
prerank,receptor antagonist activity (GO:0048019),0.6247826889555412,1.3944120448814785,0.08072916666666667,1.0,1.0,4/17,17.99%,DKK2;IGSF1;DKK3;PXDN
prerank,phospholipase activator activity (GO:0016004),0.6907802140484282,1.3917368274155104,0.10955056179775281,1.0,1.0,4/10,9.18%,CCL8;FYN;SRC;STX4
prerank,glucuronosyltransferase activity (GO:0015020),0.6102443560839996,1.3911920182466633,0.09278350515463918,1.0,1.0,5/19,21.55%,EXT1;B3GAT3;LARGE1;CHPF;B3GAT2
prerank,solute:sodium symporter activity (GO:0015370),0.5719338816942913,1.3876008181140829,0.08653846153846154,1.0,1.0,3/27,2.11%,SLC5A9;SLC4A10;SLC4A8
prerank,LRR domain binding (GO:0030275),-0.48594402374538737,-1.3831672371158419,0.09836065573770492,0.3872042051408524,1.0,2/14,0.31%,PAWR;ROBO1
prerank,ATPase binding (GO:0051117),0.5064560083476579,1.3829472899876352,0.047619047619047616,1.0,1.0,22/71,17.23%,AR;ESR1;EGFR;ANK2;ATP6V0A2;TOR1AIP2;SYVN1;ZNHIT6;SRC;ABCA1;PKD2;PSEN1;ATP6V1E1;PDE4D;BBC3;SNU13;PPP3CA;CLPP;ATP6V0A1;SELENOS;ANK1;NUFIP1
prerank,growth factor activity (GO:0008083),0.5062686699516598,1.3818206691456045,0.05190677966101695,1.0,1.0,17/74,16.31%,LIF;AREG;FGF18;FGF7;BTC;VEGFA;FGF2;CLCF1;INHA;JAG1;NRG3;EGF;GDNF;ARTN;IL4;IL6;HGF
prerank,water transmembrane transporter activity (GO:0005372),-0.5464877146057769,-1.3815462835872236,0.10931174089068826,0.3788032535283322,1.0,2/11,8.86%,PDPN;AQP11
prerank,tropomyosin binding (GO:0005523),-0.48808110804563243,-1.3792264511289338,0.1095890410958904,0.3721653691397568,1.0,3/16,6.57%,NEBL;CALD1;TMOD3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.6338486317134429,1.3743021228274444,0.11263736263736264,1.0,1.0,3/13,10.25%,GPSM2;GPSM1;GDI1
prerank,chemoattractant activity (GO:0042056),0.5642524624081466,1.3702538301818523,0.10952380952380952,1.0,1.0,8/26,16.31%,FGF7;VEGFA;FGF2;MIF;CXCL10;GPNMB;GDNF;HGF
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.5495851148809451,1.3698135556447408,0.09451575262543757,1.0,1.0,8/35,7.45%,SYK;SRMS;TNK1;FYN;CLK1;CSK;SRC;ABL2
prerank,cardiolipin binding (GO:1901612),0.6830370646395972,1.3673084854003985,0.1017191977077364,1.0,1.0,1/10,0.56%,UCP1
prerank,thiol-dependent deubiquitinase (GO:0004843),0.4971698896815491,1.3671949219914985,0.03761755485893417,1.0,1.0,25/83,16.14%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,C-C chemokine receptor activity (GO:0016493),0.5802349429773824,1.364703359365996,0.10375,1.0,1.0,4/21,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,cytokine activity (GO:0005125),0.4795269937549551,1.3612706175751272,0.030895983522142123,1.0,1.0,18/131,6.75%,LIF;CCL8;WNT10B;WNT2;TGFB3;IL16;CTF1;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;CLCF1;IL33;CXCL10;TNFRSF11B;INHA
prerank,lipase activator activity (GO:0060229),0.6776017554911659,1.3598721253658772,0.1172316384180791,1.0,1.0,3/10,6.81%,CCL8;FYN;SRC
prerank,cytokine receptor binding (GO:0005126),0.4911461317072231,1.3594274306383254,0.039832285115303984,1.0,1.0,10/83,6.97%,TNFSF9;SYK;LIF;TIMM50;VEGFA;TGFB2;MIF;CLCF1;SOCS2;TLR5
prerank,metalloendopeptidase activity (GO:0004222),0.5019185583407012,1.3582348211263935,0.04375,1.0,1.0,23/76,18.46%,ADAMTS5;ADAMTS2;MMP2;ADAM9;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;ECE2;EEF1AKMT4-ECE2;PAPLN;THOP1;RCE1;IDE;SPG7;MMP16;ADAMTS6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",0.6690108285146041,1.358105839164882,0.13352272727272727,1.0,1.0,2/10,7.88%,AMDHD1;DPEP1
prerank,lipase activity (GO:0016298),0.5341028145489718,1.3533279635127413,0.08626560726447219,1.0,1.0,10/43,19.37%,MGLL;SMPD3;CEL;LCAT;SEC23IP;PNPLA8;DAGLB;LIPC;LIPH;DDHD1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),0.5614133256232372,1.3511791816021002,0.13116726835138387,1.0,1.0,7/25,11.05%,PARP3;ART4;PARP11;PARP6;SIRT2;ZC3HAV1;PARP14
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),0.5425833722078517,1.3476981746386114,0.11044417767106843,1.0,1.0,4/29,4.54%,SLC1A5;SLC25A21;SLC26A5;SLC1A6
prerank,anion transmembrane transporter activity (GO:0008509),-0.5142305481259941,-1.3471484880636335,0.14339622641509434,0.41953332092165574,1.0,4/12,4.48%,ABCG2;SLCO2B1;SLC39A8;SLC22A6
prerank,galactosyltransferase activity (GO:0008378),0.6562884049862563,1.3387916974860044,0.13229018492176386,1.0,1.0,2/11,2.22%,B4GALT3;B4GALT1
prerank,metallopeptidase activity (GO:0008237),0.4760420907162116,1.334456065584978,0.05188199389623601,1.0,1.0,32/113,18.46%,ADAMTS5;BMP1;ADAMTS2;ANPEP;MMP2;ADAM9;ADAMTS3;COPS5;ADAMTSL1;ADAM19;ADAM33;ADAMTSL4;LNPEP;DPEP1;MMP11;ADAMTSL5;ECE1;ADAMTSL3;ADAMTS18;ECE2;EEF1AKMT4-ECE2;NUDT16;PAPLN;THOP1;ADAM15;RCE1;IDE;SPG7;LAP3;MMP16;METAP2;ADAMTS6
prerank,O-acyltransferase activity (GO:0008374),0.5418671700776255,1.3287874894023497,0.1191588785046729,1.0,1.0,11/30,21.00%,GPAT4;MOGAT1;PLAAT1;LCAT;LPCAT1;MBOAT7;MOGAT2;PIGW;GPAT3;GPAM;SOAT1
prerank,hormone activity (GO:0005179),0.5025239177480475,1.32468834985764,0.0967391304347826,1.0,1.0,9/54,13.43%,AMH;METRNL;INHA;GRP;ADCYAP1;SPX;CCL25;HCRT;TRH
prerank,deubiquitinase activity (GO:0101005),0.4766902664156593,1.3206608610440762,0.06735751295336788,1.0,1.0,25/88,16.14%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;STAMBPL1;USP7;MINDY3;USP22
prerank,omega peptidase activity (GO:0008242),0.4751674408176078,1.3175873870015864,0.06950207468879668,1.0,1.0,26/89,16.14%,UCHL1;DESI2;JOSD2;USP36;COPS5;OTUD3;ZRANB1;USP32;USP10;USP29;USP4;OTUD1;UCHL5;USP39;USP26;USP33;OTUD7B;USP48;USP50;USP5;ZC3H12A;GGT7;STAMBPL1;USP7;MINDY3;USP22
prerank,inorganic cation transmembrane transporter activity (GO:0022890),-0.3445352737356388,-1.316077959129037,0.06315789473684211,0.4698023164790897,1.0,9/48,8.81%,TRPM3;TRPM6;SLC12A7;NALCN;SLC41A1;SLC12A2;ABCC9;TRPC6;CALHM5
prerank,metallocarboxypeptidase activity (GO:0004181),-0.41008197077230757,-1.3158534727839377,0.125,0.45794555006362153,1.0,4/26,5.65%,AEBP1;CPE;CPM;AGBL3
prerank,hexosyltransferase activity (GO:0016758),0.471681860224277,1.3117996471485347,0.07312049433573635,1.0,1.0,20/101,11.50%,HAS2;HAS1;B4GALT3;B4GALT1;B3GALNT1;CSGALNACT2;FUT2;DPY19L2;EXT1;B4GALNT4;POMGNT2;PIGZ;CHSY3;B3GAT3;RFNG;ALG1;LARGE1;FUT9;B3GNT8;GBA2
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",0.5441817775401321,1.3056637587268718,0.13608748481166463,1.0,1.0,6/25,11.99%,FMO4;FMO2;FMO1;CYP27B1;MICAL2;POR
prerank,adrenergic receptor binding (GO:0031690),0.5873233749544063,1.304413162602939,0.15616797900262466,1.0,1.0,6/16,11.84%,GNAS;UCHL1;DLG4;C1QBP;MAGI2;PDE4D
prerank,peptidoglycan binding (GO:0042834),-0.536070237457975,-1.3037059366973327,0.2014388489208633,0.4702461399341636,1.0,7/10,35.82%,RNASE7;NOD1;NOD2;PGLYRP1;JCHAIN;NLRP3;TLR2
prerank,microtubule binding (GO:0008017),0.4530462837318234,1.3009664227765598,0.01805416248746239,1.0,1.0,75/222,22.88%,MID1;NME8;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;CEP295NL;FGF13;S100A9;S100A8;HOOK2;CLIP1;MID2;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;POLB;ALMS1;MAPRE1;CLIP4;CAMSAP1;MAPT;KIF20B;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;UXT;NAV3;PAFAH1B1;STIM1;CLIP3;MDM1;RMDN2;KIF26B;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;FBXW11;MAP1S;CCDC88A;RMDN1
prerank,calcium-activated potassium channel activity (GO:0015269),0.6302166974064862,1.3004367651350244,0.16115702479338842,1.0,1.0,2/11,5.97%,KCNMA1;KCNU1
prerank,pre-mRNA binding (GO:0036002),0.5432991960903264,1.298406889986907,0.14303329223181258,1.0,1.0,11/28,19.99%,TARBP2;HNRNPA1;SRSF6;RBM4;U2AF1;RBM22;CELF2;DDX5;SLBP;U2AF2;PTBP1
prerank,1-phosphatidylinositol binding (GO:0005545),0.5812740593370819,1.2966370434470214,0.16062176165803108,1.0,1.0,4/15,11.34%,SESTD1;SCIN;FRMPD2;WDFY1
prerank,protein tyrosine phosphatase activity (GO:0004725),-0.31111177028234815,-1.2924564526929443,0.0196078431372549,0.48177132370541775,1.0,22/71,13.45%,PTPRK;PTPN14;EYA1;PTPRG;PTPRB;PTPRD;PTPN9;PTPRM;PTPRN2;PALD1;PTPRZ1;PTPRO;PTPN1;CDC25A;PTPRT;PTPN2;HACD2;PTPN4;PTPN21;PTP4A2;PTPRN;UBASH3B
prerank,myosin II binding (GO:0045159),0.6322113950046963,1.2876291216908904,0.1853932584269663,1.0,1.0,2/10,3.65%,GSN;LLGL1
prerank,single-stranded telomeric DNA binding (GO:0043047),0.6252160345474082,1.2864333415870646,0.16983695652173914,1.0,1.0,5/11,22.09%,HNRNPA1;CTC1;TERF1;RAD50;TERF2IP
prerank,endopeptidase activity (GO:0004175),0.4458658349094934,1.28608987278378,0.02004008016032064,1.0,1.0,54/257,16.91%,ADAMTS5;HTRA3;PCSK6;KLK9;PRSS48;DPP4;HPN;UCHL1;FAP;PCSK5;ADAMTS2;MMP2;ADAM9;PRSS12;USP36;ADAMTS3;ADAMTSL1;ADAM19;ADAM33;PCSK4;ADAMTSL4;RHBDF1;USP10;USP29;TPP1;MMP11;ADAMTSL5;PSEN1;ECE1;MASP2;ADAMTSL3;ADAMTS18;USP26;USP33;GZMM;ECE2;EEF1AKMT4-ECE2;USP48;NAPSA;PAPLN;PIK3IP1;USP5;THOP1;KLK1;KLK6;RCE1;TASP1;USP7;CLPP;PDIA3;HGF;HTRA2;IDE;SPG7
prerank,ribonuclease P activity (GO:0004526),0.6046763885711026,1.2859073672208596,0.20868347338935575,1.0,1.0,3/11,5.84%,RPP25;RPP21;PRORP
prerank,calcium:sodium antiporter activity (GO:0005432),-0.5129426254162295,-1.284582203877861,0.1773049645390071,0.485562991750559,1.0,4/10,12.85%,SLC24A3;SLC8A3;SLC3A2;SLC24A5
prerank,transcription coactivator binding (GO:0001223),0.5641647220414456,1.2841572473777922,0.18159203980099503,1.0,1.0,4/20,8.96%,AR;ESR1;SMAD4;CDK9
prerank,protein phosphatase inhibitor activity (GO:0004864),-0.39425594370662703,-1.2832344799456028,0.13095238095238096,0.47670036817088596,1.0,8/26,14.90%,PTN;PPP1R1A;LMTK2;BOD1L1;PPP1R8;PPME1;PPP1R14A;PABIR1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.5636972212995708,1.283195579263549,0.17916137229987295,1.0,1.0,3/18,2.53%,ANXA1;PKP3;ANXA2
prerank,kinase inhibitor activity (GO:0019210),0.5132318737210799,1.274243136237906,0.160188457008245,1.0,1.0,14/33,25.03%,LRP6;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;DUS2;YWHAB;HEXIM1;DNAJC3
prerank,ribosome binding (GO:0043022),0.4890872023009256,1.2695746979706777,0.14893617021276595,1.0,1.0,14/46,18.03%,RPSA;IGHMBP2;C1QBP;SRP19;GTPBP6;MRPS27;EIF6;SBDS;EIF2S1;ZC3H12A;SEC61A1;CPEB1;YTHDF1;NAA15
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.5238212493016049,-1.2667017877729254,0.20363636363636364,0.4989825929314053,1.0,3/10,5.56%,PRKAG2;PKIG;PRKAR1B
prerank,myosin V binding (GO:0031489),0.576519009565376,1.2662411203810648,0.19490445859872613,1.0,1.0,7/15,26.10%,RAB6A;RAB6B;RAB3D;RAB27B;RAB10;RAB39B;RAB3C
prerank,chemokine receptor activity (GO:0004950),0.527526050776744,1.2658220280578758,0.18450184501845018,1.0,1.0,4/24,17.61%,ACKR3;ACKR4;CXCR4;CXCR2
prerank,gap junction channel activity (GO:0005243),-0.4120960266853416,-1.2641902712402548,0.12041884816753927,0.4933281591144832,1.0,10/22,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.5356182177867936,1.2622342912946696,0.195,1.0,1.0,4/24,5.66%,CAMKK1;EEF2K;CAMK2D;PHKA2
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.5531940258110565,1.2617718139145637,0.185785536159601,1.0,1.0,3/18,15.11%,DHRS9;HSD3B7;HSD17B8
prerank,neuropeptide hormone activity (GO:0005184),0.535993737016479,1.2606776153146362,0.19877300613496932,1.0,1.0,4/22,12.24%,GRP;ADCYAP1;SPX;HCRT
prerank,wide pore channel activity (GO:0022829),-0.40452465560787115,-1.260480649374382,0.11702127659574468,0.48996835022208035,1.0,10/23,30.55%,GJB6;GJB2;GJA1;GJC1;GJD3;GJA4;PANX2;GJA5;GJD2;GJA3
prerank,receptor ligand activity (GO:0048018),0.4353547187362718,1.2581657796408967,0.03907815631262525,1.0,1.0,32/245,9.60%,LIF;SEMA3C;AREG;AMH;FGF18;WNT10B;FGF7;DPP4;WNT2;TGFB3;IL16;CTF1;BTC;VEGFA;WNT9A;FGF2;TGFB2;MIF;BMP15;METRNL;CLCF1;IL33;CXCL10;TNFRSF11B;INHA;GAS6;SEMA3A;JAG1;TNFSF13B;CCL25;NRG3;BMP8A
prerank,Lys63-specific deubiquitinase activity (GO:0061578),0.6167506476794874,1.2581263508356415,0.23087818696883852,1.0,1.0,4/10,25.79%,DESI2;STAMBPL1;CYLD;OTUD4
prerank,calcium ion binding (GO:0005509),0.4355790333099131,1.2574954529066997,0.019,1.0,1.0,40/323,8.22%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;SYT2;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A9;S100A8;SMOC2;SLIT1;SYT12;SYT11;CALU;DSC3;DSC2;COLEC11;SYT13;RCN3;THBS4;RET;PKD2;S100A6;CAPN1
prerank,nuclear import signal receptor activity (GO:0061608),0.5720727904047959,1.255681424678178,0.20889487870619947,1.0,1.0,9/15,26.59%,KPNA2;IPO9;TNPO2;IPO5;KPNA1;RANBP6;TNPO1;KPNA6;KPNB1
prerank,ionotropic glutamate receptor binding (GO:0035255),0.6299680661751944,1.2545512703086812,0.2099125364431487,1.0,1.0,5/10,21.47%,GNAS;DLG4;SQSTM1;NSF;SHISA6
prerank,dynactin binding (GO:0034452),0.5953370836490844,1.2544992135196278,0.18963165075034105,1.0,1.0,5/12,18.97%,BICD1;MAPT;BBS4;SNX6;PAFAH1B1
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.5401855742508683,1.2544613106187996,0.20127388535031848,1.0,1.0,9/21,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,carboxypeptidase activity (GO:0004180),-0.35586884378573863,-1.2535702726011628,0.1450381679389313,0.4942156185930015,1.0,5/35,5.65%,AEBP1;CPE;CPM;MINDY2;AGBL3
prerank,enoyl-CoA hydratase activity (GO:0004300),0.6153968903783367,1.2534050857950743,0.20903954802259886,1.0,1.0,2/10,7.65%,EHHADH;AUH
prerank,pentosyltransferase activity (GO:0016763),0.49874871383388064,1.2530245909145576,0.16743119266055045,1.0,1.0,9/36,11.05%,PARP3;UMPS;ART4;PARP11;PARP6;SIRT2;LARGE1;ZC3HAV1;PARP14
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.506423424215527,1.2526853672006755,0.18032786885245902,1.0,1.0,10/33,17.52%,AR;SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;LLPH;UVSSA;ERCC5
prerank,G protein-coupled receptor binding (GO:0001664),0.44135357204889836,1.2523845585349047,0.09146341463414634,1.0,1.0,18/132,10.17%,MYOC;LRP6;WNT10B;GNAS;WNT2;GNAI3;CCDC88C;WNT9A;USP4;C1QBP;BICD1;S1PR2;STUB1;FZD7;CCL25;GNAZ;USP33;CALCA
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.45619545124871846,1.251470607424483,0.14105263157894737,1.0,1.0,17/72,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;TIRAP;TWF1;PLEKHA4;SNX21;AVIL;SLC9A1
prerank,general transcription initiation factor binding (GO:0140296),0.5259771832985174,1.2445404650599439,0.20217917675544794,1.0,1.0,6/25,15.52%,AR;ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,ligand-gated channel activity (GO:0022834),0.5065586358807653,1.2360712612507077,0.1850989522700815,1.0,1.0,13/29,27.39%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,ligand-gated ion channel activity (GO:0015276),0.5027269727904364,1.2345010812214525,0.1853997682502897,1.0,1.0,13/30,27.39%,GRIN3A;GRIN2D;GRIA2;CNGB1;GRID1;GRIN2A;CHRNA5;GRIA3;GRIK5;GRIK2;GRIK4;ANXA6;GRID2
prerank,chloride transmembrane transporter activity (GO:0015108),0.5474250137563893,1.230818428603768,0.21912350597609562,1.0,1.0,5/16,17.09%,SLC26A5;SLC4A8;SLC26A6;SLC12A5;SLC26A1
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),-0.3853780372959476,-1.2302972026025805,0.14705882352941177,0.5332692754956702,1.0,11/22,29.40%,DUSP10;PPM1F;DUSP7;MTMR3;DUSP6;DUSP19;DUSP15;MTMR2;DUSP4;CDKN3;DUSP18
prerank,glucose transmembrane transporter activity (GO:0005355),0.5459586772962519,1.2302518086230798,0.22625,1.0,1.0,4/17,14.47%,SLC5A9;MFSD4A;SLC2A10;SLC2A3
prerank,heme binding (GO:0020037),0.45940917469515663,1.2299382273492727,0.17270788912579957,1.0,1.0,5/65,6.81%,NOX4;CYP2S1;NR1D1;DGCR8;SRC
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),0.4743353057605237,1.229567310017275,0.20518602029312288,1.0,1.0,11/38,15.34%,NCF4;SESTD1;PLEKHF1;ATG2B;WIPI2;PLEKHA4;WDR45B;SNX21;ATG2A;DENND1A;PLA2G4E
prerank,O-methyltransferase activity (GO:0008171),0.6106783166814325,1.229345630700953,0.21664275466284075,1.0,1.0,7/10,29.90%,MEPCE;COQ3;COMT;CMTR2;FTSJ3;ASMT;LRTOMT
prerank,gated channel activity (GO:0022836),0.5666569454480307,1.2280428435567667,0.24360699865410498,1.0,1.0,3/14,7.22%,PIEZO2;TMEM63A;TMEM266
prerank,tubulin binding (GO:0015631),0.4231796430383142,1.2239318858238888,0.047,1.0,1.0,103/295,25.85%,MID1;NME8;RAB11FIP5;MAP1B;SAXO1;DNM1;DCTN1;CCDC88C;FYN;CEP295NL;FGF13;S100A9;S100A8;HOOK2;ATF5;CLIP1;MID2;GPAA1;DLEC1;CEP44;NDEL1;REEP3;FHDC1;DST;PSRC1;KIFC2;KIF21B;MAPRE3;FSD1;STARD9;HDAC6;GAS2L1;TOGARAM1;CLIP2;SYBU;DYNC1I1;KIF2A;NCALD;POLB;ALMS1;CAMSAP1;MAPT;TBCEL;KIF20B;SETD2;TPPP3;CCSAP;SBDS;KIF3A;KIF21A;CFAP157;MAP6;ABRAXAS1;CRIPT;TERF1;KIF3B;BBS4;INO80;BCAS3;BLOC1S2;CHP1;MAP4;CDK5RAP2;MAP7D3;SNPH;RCC2;CKAP5;CENPE;EML1;ALDOA;UXT;NAV3;PAFAH1B1;CLIP3;MDM1;RMDN2;STMN4;KIF26B;TTLL11;CLASP2;NUMA1;TUBGCP5;MAP1A;DCX;MAP1S;DNAL1;CCDC88A;TPR;RMDN1;TRIM36;NLRP5;KATNA1;EMD;RMDN3;ARL8A;MTCL1;VBP1;AGBL1;PHF6;KIF13B;EML6;CCDC88B;TPGS1
prerank,chemokine receptor binding (GO:0042379),0.4834448923015011,1.223414448189183,0.2066974595842956,1.0,1.0,5/35,12.91%,CCL8;ITCH;CXCL10;CCL25;CCL13
prerank,protein tyrosine kinase activity (GO:0004713),0.4355007012344686,1.222573302292205,0.12,1.0,1.0,28/108,14.53%,SYK;DDR2;EPHB2;AXL;SRMS;EGFR;TNK1;FGFR1;EPHA3;FYN;MST1R;CLK1;CSK;RET;SRC;ABL2;TWF1;EPHB3;DYRK2;MUSK;CAMKK2;EPHA10;SCYL1;FLT3;HIPK4;PDGFRA;FER;DDR1
prerank,platelet-derived growth factor receptor binding (GO:0005161),0.570144028092501,1.2209351003514073,0.21921515561569688,1.0,1.0,6/13,14.13%,ITGB3;VEGFA;ITGA5;PTPRJ;ERN1;PDGFRA
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4783471718153131,1.2185005251671601,0.21694915254237288,1.0,1.0,11/42,13.54%,ANXA1;PKP3;NPTN;ANXA2;JAM3;CD47;SIRPA;DSCAM;PDLIM1;IGSF9;PALLD
prerank,translation initiation factor activity (GO:0003743),0.48618311295619865,1.2169300859841055,0.19791666666666666,1.0,1.0,19/36,27.14%,EIF3B;COPS5;EIF4A1;EIF3K;AGO2;EIF1;EIF3A;EIF2S1;EIF3E;EIF3D;EIF2S2;EIF2B1;EIF2A;EIF4G3;EIF3L;EIF2B2;EIF4G1;EIF4E2;EIF3M
prerank,anion:anion antiporter activity (GO:0015301),0.5358375135608314,1.2161525882110735,0.23237597911227154,1.0,1.0,5/17,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC25A4;SLC26A6
prerank,cAMP response element binding (GO:0035497),0.595715249096094,1.2147078180908197,0.2402315484804631,1.0,1.0,5/10,21.89%,CREB5;CREB3L1;ATF7;E4F1;JUN
prerank,exopeptidase activity (GO:0008238),0.458416561820651,1.214627183419122,0.20773480662983426,1.0,1.0,22/50,26.90%,DPP4;FAP;ANPEP;PRCP;LNPEP;DPEP1;CNDP2;XPNPEP3;NUDT16;NPEPPS;RCE1;LAP3;METAP2;DPP9;METAP1;METAP1D;JMJD7;ZMPSTE24;DPEP2;DPP10;CTSA;DPP7
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.4354037157975682,1.210975109585604,0.15113871635610765,1.0,1.0,21/91,12.04%,GSN;SESTD1;SCIN;ANXA2;AMER3;SVIL;KCNJ2;CGAS;OSBPL2;PFN2;FZD7;CLVS2;TIRAP;WIPI2;TWF1;PLEKHA4;WDR45B;SNX21;AVIL;MAPT;SLC9A1
prerank,phospholipase activity (GO:0004620),0.4502736271071714,1.207548769001479,0.18471337579617833,1.0,1.0,15/67,20.38%,MGLL;SMPD3;PLCE1;PLCB4;PLAAT1;SEC23IP;PNPLA8;PLA2G4E;PDIA3;SMPD1;LIPC;LIPH;DDHD1;GPLD1;GDPD3
prerank,ionotropic glutamate receptor activity (GO:0004970),0.5424735246904631,1.2075027102712348,0.22727272727272727,1.0,1.0,8/17,24.46%,GRIN3A;GRIN2D;GRIA2;GRIN2A;GRIA3;GRIK5;GRIK2;GRIK4
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.43988953183735613,1.2041296627093325,0.1806853582554517,1.0,1.0,14/73,18.00%,AVPR1A;VIPR2;F2R;GLP2R;S1PR2;CRHR1;LTB4R2;INPP5K;GPR37L1;TSHR;GPR37;LHCGR;SORCS1;RXFP1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.439387721473344,-1.2019524246804318,0.23076923076923078,0.5872233968988537,1.0,2/14,0.45%,SLC7A11;SLC1A3
prerank,androgen receptor binding (GO:0050681),0.4998454539379187,1.2001992337418945,0.22867737948084055,1.0,1.0,15/25,30.27%,FOXP1;PRMT2;SMARCA4;RNF14;TRIM68;DDX5;NSD1;TMF1;RNF6;KDM4C;CALR;KDM3A;PRPF6;ZBTB7A;WIPI1
prerank,alkali metal ion binding (GO:0031420),-0.4450581346946027,-1.1992267910577181,0.20161290322580644,0.5816979500648899,1.0,2/13,3.29%,ATP1A2;PDXK
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.46310177675071806,-1.1973776863727876,0.2446043165467626,0.5746614537620681,1.0,3/11,4.38%,SGMS1;PIGN;SAMD8
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),-0.4514444466955938,-1.19344341932059,0.2260536398467433,0.572156643715493,1.0,5/12,19.64%,H3-3A;POU2F1;STAT1;GTF2B;TAF1
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5103756850870179,1.192992246894976,0.264669163545568,1.0,1.0,8/20,18.85%,MAGI3;DLG2;AK2;MPP1;CMPK2;AK8;AK9;CARD11
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.5422129809374702,1.1922036712565238,0.2744310575635877,1.0,1.0,5/15,17.09%,SLC26A5;SLC4A8;SLC4A3;SLC26A6;SLC26A1
prerank,cAMP binding (GO:0030552),-0.4752085367958227,-1.1905091023793328,0.22456140350877193,0.5682472119757686,1.0,2/11,0.58%,RAPGEF4;RAPGEF2
prerank,ribosomal large subunit binding (GO:0043023),0.5751430165470921,1.1894346386367687,0.2803738317757009,1.0,1.0,6/11,14.09%,DHX33;CPSF6;NPM1;EIF6;LTN1;RBM3
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.5422024246342063,1.188079028548487,0.28746594005449594,1.0,1.0,3/14,5.84%,RPP25;RPP21;PRORP
prerank,calcium-dependent phospholipid binding (GO:0005544),0.4562863003630324,1.187941882695059,0.24751381215469614,1.0,1.0,7/49,5.22%,ANXA1;SYT2;ANXA2;CPNE8;SYT12;SYT11;SYT13
prerank,snoRNA binding (GO:0030515),0.475259747599503,1.1867622826956854,0.2576312576312576,1.0,1.0,16/30,29.13%,NUDT1;NUDT7;NUDT16L1;GAR1;DDX21;NUDT16;XRCC5;SNU13;NUDT5;NUFIP1;TBL3;PRKDC;NOP56;TSR1;NHP2;NOP58
prerank,cytokine receptor activity (GO:0004896),0.43006971514524117,1.1860168657036128,0.20526315789473684,1.0,1.0,11/83,15.34%,IL4R;GHR;IL1RL1;CD44;IL17RA;IL10RA;ACKR4;CSF2RA;FLT3;CNTFR;FZD4
prerank,glutamate receptor binding (GO:0035254),0.5327273206355505,1.184686270126462,0.27440633245382584,1.0,1.0,5/17,15.87%,GNAS;DLG4;SQSTM1;SYNDIG1;NSF
prerank,mechanosensitive ion channel activity (GO:0008381),0.5619932283153974,1.1814392062819405,0.2717241379310345,1.0,1.0,2/12,5.17%,PIEZO2;TMEM63A
prerank,insulin-like growth factor I binding (GO:0031994),0.554439863262219,1.179597791265975,0.29010695187165775,1.0,1.0,4/13,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.4457687497577504,-1.1791276173111795,0.29577464788732394,0.5837708449692811,1.0,2/11,3.60%,SASH1;DAB2IP
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.48254766896145296,1.1785656753416518,0.24794359576968272,1.0,1.0,12/31,22.49%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,alanine transmembrane transporter activity (GO:0022858),-0.45656506195591084,-1.1782876916341092,0.23426573426573427,0.5749996306048328,1.0,3/12,12.51%,SLC3A2;SLC38A5;SLC6A6
prerank,myosin binding (GO:0017022),0.4411915528629534,1.178229214439483,0.24167561761546724,1.0,1.0,17/55,20.96%,MYOC;GSN;RAB6A;LLGL1;RAB6B;TRAK2;RAB3D;MOBP;RHOA;TRIOBP;RAB27B;GIPC1;CXCR4;ARFGEF1;RALA;RAB10;PYCARD
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),0.556686687919321,1.178165116424795,0.2845528455284553,1.0,1.0,2/12,6.28%,IRS1;SH2B1
prerank,DNA polymerase activity (GO:0034061),0.5029310395895146,1.176122453398308,0.26548672566371684,1.0,1.0,9/22,28.08%,REV3L;POLB;POLE3;POLI;POLD1;REV1;POLH;POLE2;CHRAC1
prerank,CoA hydrolase activity (GO:0016289),0.5362785964436756,1.1754830678173314,0.2756324900133156,1.0,1.0,4/16,14.26%,ACOT6;NUDT7;ACOT9;ACOT1
prerank,peptidase inhibitor activity (GO:0030414),0.4737343431493145,1.1733346824034052,0.26173708920187794,1.0,1.0,7/33,12.41%,TIMP2;GPC3;UCHL5;CAST;CSTB;SLPI;RECK
prerank,RNA polymerase binding (GO:0070063),0.510141503865676,1.1699619627175313,0.27261146496815286,1.0,1.0,5/18,12.64%,BIN1;SCAF8;TCERG1;ANP32B;ZFP36
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),0.5266504894522327,1.1675467081178965,0.2838196286472148,1.0,1.0,2/16,4.54%,SLC1A5;SLC1A6
prerank,syntaxin-1 binding (GO:0017075),-0.37733502297943333,-1.1671082687436674,0.26288659793814434,0.5905163822055228,1.0,5/22,8.74%,UNC13B;UNC13C;SYNPR;STXBP5;DAPK1
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.5736707448890643,1.1670609082424892,0.29178885630498536,1.0,1.0,4/10,12.09%,DSC2;CD47;SIRPA;JUP
prerank,ribonuclease P RNA binding (GO:0033204),0.5609465183708708,1.1668584193108866,0.30626780626780625,1.0,1.0,5/10,26.60%,RPP25;RPP21;POP4;RPP30;RPP14
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),-0.45203083398116906,-1.16617059710037,0.2638888888888889,0.5820907090994062,1.0,2/11,8.69%,SLC22A4;SLC25A20
prerank,protein tyrosine kinase binding (GO:1990782),0.43013211425461867,1.1648510774304959,0.25477707006369427,1.0,1.0,10/71,10.45%,NOX4;ANGPT4;PIK3R2;ACVR1;BANK1;GAS6;FLT3LG;NRG3;SIRPA;SQSTM1
prerank,chemorepellent activity (GO:0045499),0.486941026847562,1.1644560143183789,0.2893772893772894,1.0,1.0,5/25,12.28%,SEMA3C;DPP4;SEMA3A;NRG3;SEMA3D
prerank,insulin-like growth factor binding (GO:0005520),0.5281142092180311,1.1630266395784028,0.3011734028683181,1.0,1.0,4/15,4.58%,IGFBP5;ITGB3;IGFBP6;IGFBP4
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.4712315021735774,1.1629150336237826,0.2688296639629201,1.0,1.0,13/34,22.49%,UBE2B;UBE2J2;UBE2N;UBE2W;UBE2G2;UBE2A;CDC34;UFC1;UBE2G1;UBE2R2;UBE2D3;UBE2Q2;UBE2Z
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.568227972616175,1.1618599155336027,0.29790209790209793,1.0,1.0,4/10,24.78%,KAT2B;CDKN1A;CDKN2C;HEXIM1
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4625189585642179,1.1613194065669286,0.2756183745583039,1.0,1.0,12/33,21.45%,MAF1;SCAF8;RTRAF;NCOA3;SPTY2D1;AGO2;ELP4;URI1;UVSSA;ERCC5;RRN3;PAF1
prerank,leucine zipper domain binding (GO:0043522),-0.45641636131086283,-1.1606199388674965,0.30128205128205127,0.5843523273995249,1.0,1/10,0.28%,PAWR
prerank,ion gated channel activity (GO:0022839),0.48433419468470335,1.1600562018274767,0.29674306393244876,1.0,1.0,3/24,5.17%,KCNT2;ANO3;TMEM63A
prerank,peptidase activator activity (GO:0016504),0.49767523848659606,1.1567065591880041,0.2933832709113608,1.0,1.0,4/22,8.52%,PCOLCE2;PCOLCE;ADRM1;CLPX
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5150500103649918,1.1550295058466924,0.3096129837702871,1.0,1.0,7/20,15.12%,GPAT4;MOGAT1;AGPAT3;LPCAT1;MOGAT2;AGPAT5;GPAT3
prerank,R-SMAD binding (GO:0070412),0.5140925680125288,1.1536972655217372,0.3090676883780332,1.0,1.0,8/18,22.03%,LDLRAD4;PMEPA1;SMAD4;SMAD6;DDX5;PPM1A;JUN;SMURF1
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.47345786339922363,1.1532679798588736,0.2962515114873035,1.0,1.0,10/28,23.63%,RPP25;RPP21;PRORP;AGO2;NUDT16L1;NUDT16;POP4;AGO3;RPP30;EDC3
prerank,poly-purine tract binding (GO:0070717),-0.354638805589521,-1.1527040310044698,0.23780487804878048,0.5924164344062709,1.0,11/27,19.34%,RBPMS;ATXN1;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3;PNPT1
prerank,regulatory RNA binding (GO:0061980),0.45157334414267625,1.1520750480628814,0.26406429391504016,1.0,1.0,11/38,19.45%,TARBP2;HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,nucleotidyltransferase activity (GO:0016779),0.4938847290235101,1.1518943580437047,0.27892030848329047,1.0,1.0,9/19,23.90%,PAPSS2;TENT4A;CGAS;YRDC;NUDT5;TENT2;TENT4B;CRPPA;REV1
prerank,ribonuclease activity (GO:0004540),0.43362524124297847,1.15171629361292,0.2754098360655738,1.0,1.0,13/56,15.17%,DIS3L2;ANG;RNASE4;NYNRIN;AGO2;EXOSC7;SAMHD1;ERN1;RNASE6;RCL1;ZC3H12A;EXOSC1;SMG6
prerank,insulin-like growth factor receptor binding (GO:0005159),0.5465448144078368,1.1510315855380422,0.3282336578581363,1.0,1.0,4/12,7.00%,GNAS;IRS1;SOCS2;YWHAG
prerank,nucleotide diphosphatase activity (GO:0004551),-0.42610576919230336,-1.150746438100398,0.2974910394265233,0.5863259976712326,1.0,6/14,15.83%,ENPP1;NUDT4;ENPP4;NUDT3;NUDT12;NUDT13
prerank,manganese ion binding (GO:0030145),0.4413284320601865,1.1506123121774567,0.27827050997782704,1.0,1.0,18/48,26.91%,B4GALT1;MGAT1;ABL2;XPNPEP3;DYRK2;LARGE1;GALNT1;NUDT16;MPPE1;MGAT5;MGAT2;NEK4;XYLT2;MGAT5B;ADCY2;GALNT4;XXYLT1;ADPRM
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),-0.46290588872337063,-1.1503517396765712,0.2895622895622896,0.5773557807388494,1.0,2/10,2.52%,KDM7A;KDM4A
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.5545989572447375,1.1498178780011086,0.3157181571815718,1.0,1.0,5/13,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,polynucleotide adenylyltransferase activity (GO:0004652),0.5514497339035704,1.1487154784169935,0.3050139275766017,1.0,1.0,5/12,18.37%,TENT5B;TENT4A;PAPOLB;TENT2;TENT4B
prerank,lipid phosphatase activity (GO:0042577),0.5189695019707214,1.1483196381535044,0.293888166449935,1.0,1.0,6/14,17.79%,PLPP3;PLPP1;PLPP7;INPP5K;PLPPR3;PLPP2
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.49634234228336194,1.146915449644523,0.3099121706398996,1.0,1.0,10/21,21.50%,ACBD3;WASF1;GSKIP;AKAP14;AKAP8;AKAP9;AKAP1;ARFGEF1;PRRC1;AKAP8L
prerank,protein heterodimerization activity (GO:0046982),-0.24002029383537507,-1.1457104159645528,0.0,0.5779166606715648,1.0,29/178,9.11%,TCF4;ATP1A2;BMP6;TPM1;TENM4;BCL2L1;MEF2C;EPAS1;BCL2;ARNT2;YWHAH;ADRA1B;RALGAPA1;ZHX3;ITGA3;KCNB1;KCNB2;AHR;ABCG1;IRAK2;AGTR1;PSMF1;MICU2;IKBKG;MIGA2;ZHX1;ADRA2A;ERBB2;SMC3
prerank,inorganic anion transmembrane transporter activity (GO:0015103),-0.3363657840502621,-1.145305784061741,0.24516129032258063,0.5695783775992669,1.0,7/27,5.75%,SLC22A8;SLC26A7;ANO1;ANKH;SLC39A8;SLC22A6;SLC5A5
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4934402995115477,1.1451038574551249,0.3128834355828221,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4934402995115477,1.1451038574551249,0.3128834355828221,1.0,1.0,5/21,9.15%,CDKL2;CDK14;CDK4;CDK9;CDK20
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",0.5110874466091965,1.1442267057064202,0.2948557089084065,1.0,1.0,4/18,6.87%,AKR1B1;ALDH18A1;ALDH3A2;FAR1
prerank,FAD binding (GO:0071949),-0.3439321381320088,-1.1419978616246267,0.2603550295857988,0.5678010686707726,1.0,5/24,7.86%,MICAL3;DDO;PRODH;CRY1;AGPS
prerank,phosphatidate phosphatase activity (GO:0008195),0.5302930773349287,1.1382454366339314,0.327445652173913,1.0,1.0,6/13,20.28%,PLPP3;PLPP5;PLPP1;PLPPR3;PLPP2;LPIN3
prerank,protein phosphorylated amino acid binding (GO:0045309),0.4464974270705465,1.1361251552619673,0.3087248322147651,1.0,1.0,14/42,24.09%,SYK;IRS1;PIK3R2;ABL2;YWHAE;PIN1;PTPN5;RASA1;PTPN3;YES1;YWHAB;VAV2;SH3BP2;NCK2
prerank,death domain binding (GO:0070513),-0.4438794333013721,-1.1360949519725478,0.2971014492753623,0.5722938941195245,1.0,4/11,11.69%,BCL2L1;BCL2;DAPL1;RIPK1
prerank,hormone receptor binding (GO:0051427),0.5233590250111965,1.1359961283254905,0.3153034300791557,1.0,1.0,5/14,28.28%,SOCS2;ADCYAP1;NCOA6;NPPC;JAK2
prerank,telomeric DNA binding (GO:0042162),0.45646546302225216,1.1354254460648416,0.31139835487661577,1.0,1.0,15/32,28.52%,CTC1;ACD;HNRNPD;XRCC5;TERF1;SMG7;SMG6;RAD50;BLM;TINF2;TERF2IP;UPF1;SMG5;STN1;XRCC6
prerank,epidermal growth factor receptor binding (GO:0005154),0.4777612317904587,1.134528977363469,0.32324455205811137,1.0,1.0,8/25,16.68%,AREG;BTC;ARF4;SNX1;ATXN2;EGF;FER;EFEMP1
prerank,GDP binding (GO:0019003),0.4224688556633233,1.133581615131951,0.29882604055496265,1.0,1.0,26/63,27.93%,GNAI3;RAP1B;RIT2;DYNC1LI1;RAB2A;NRAS;KRAS;RRAGD;NME2;ARF6;GEM;RAB27B;RAB35;RAB5B;RAB5C;RRAS2;RALA;RAB10;RAB18;RAB12;RAB29;RAP1A;DIRAS2;RHEBL1;RAB8B;RAP2B
prerank,BMP binding (GO:0036122),-0.44686360139790277,-1.1326163125394582,0.3007518796992481,0.5708091254472807,1.0,3/11,7.95%,ENG;GREM2;BMPR2
prerank,transmembrane receptor protein kinase activity (GO:0019199),0.4226984492253288,1.1325514851252805,0.314192849404117,1.0,1.0,16/60,14.53%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;TGFBR2;ACVR1;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1
prerank,transcription coregulator binding (GO:0001221),0.43265980924440867,1.1306687624512581,0.3257328990228013,1.0,1.0,20/50,25.29%,AR;ESR1;SMAD4;NR1D1;HDAC6;PHF1;CDK9;HDAC3;EHMT2;PER1;CTCF;CIT;RPL23;CTBP1;EZH2;RORA;PER3;RELA;LCOR;CHD6
prerank,flavin adenine dinucleotide binding (GO:0050660),0.4289455444344539,1.1298980833530337,0.3005405405405405,1.0,1.0,11/53,15.89%,NOX4;ETFA;AIFM2;ACADVL;MICAL2;NQO2;POR;PPOX;AOX1;ACOX1;ETFDH
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.43990941168022785,1.1288911677882627,0.3204104903078677,1.0,1.0,7/38,12.90%,SERPINB8;ANXA2;SERPINE3;SERPINF1;SERPINH1;SLPI;SERPING1
prerank,triglyceride lipase activity (GO:0004806),0.49528741892249706,1.1285640222757412,0.33207070707070707,1.0,1.0,5/20,18.64%,CEL;LCAT;DAGLB;LIPC;LIPH
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.5442384192932497,1.1280870171929618,0.3353028064992615,1.0,1.0,5/11,16.05%,NUDT1;NUDT7;NUDT16L1;NUDT16;NUDT5
prerank,metal ion binding (GO:0046872),0.3880966886996529,1.127498877983074,0.105,1.0,1.0,93/477,19.25%,ASPN;COMP;FBN1;GSN;CDH26;THBS3;GCLC;LOXL2;CDHR5;SNCB;SCIN;ANXA1;LRP1;MAPK12;DIS3L2;SYT2;POSTN;CLEC3B;ARSA;SPARC;ANXA2;EFHD1;IRAK3;SLIT3;SLIT2;S100A10;PLSCR4;SRI;S100A9;S100A8;SMOC2;SLIT1;SYT12;SYT11;CALU;FOXK2;DSC3;DSC2;COLEC11;SYT13;MVK;RCN3;THBS4;RET;IDH1;EYA2;ABL2;UBA2;PKD2;S100A6;CAPN1;IQGAP1;NDUFAB1;CDH22;ERN1;DYRK2;CAMKK2;CALML4;MAP3K6;NUDT16;CERK;FAN1;GLCE;CALM2;ATP2A2;S100G;CASQ1;STK3;PPP3CA;TUBB4A;GEM;DNASE1L2;CHP1;PLA2G4E;NUDT5;ANXA4;NME1;CANT1;PADI2;SYT1;ANXA8;ANXA8L1;TPM4;ADPRH;NCS1;STK38;EFCAB9;RP2;EML1;IDH3G;PPP3CB;STIM1;TNNC2
prerank,sodium channel regulator activity (GO:0017080),0.44890513380314917,1.1249813049276989,0.3070776255707763,1.0,1.0,11/37,20.23%,FGF13;SGK3;SGK2;ATP2B4;CAMK2D;FXYD5;SCN4B;PRSS8;FGF14;GPLD1;PTPN3
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.4695021662408888,1.1231259600965429,0.3369434416365824,1.0,1.0,8/26,22.44%,B3GALNT1;CSGALNACT2;B4GALNT4;CHSY3;B3GNT8;B3GALNT2;CHPF;CHPF2
prerank,CXCR chemokine receptor binding (GO:0045236),0.5436305561022398,1.1221502242471106,0.338865836791148,1.0,1.0,2/11,6.22%,ITCH;CXCL10
prerank,transcription corepressor binding (GO:0001222),0.4622564246364361,1.120416981108008,0.3285198555956679,1.0,1.0,12/27,24.40%,ESR1;NR1D1;HDAC6;PHF1;HDAC3;EHMT2;PER1;CTBP1;EZH2;RORA;PER3;LCOR
prerank,histone deacetylase activity (GO:0004407),0.48314752030930974,1.1203198361084241,0.3272010512483574,1.0,1.0,7/19,20.08%,HDAC9;HDAC6;SIRT2;HDAC3;HDAC4;SUDS3;MIER1
prerank,MHC class II protein complex binding (GO:0023026),0.5437641143624321,1.1200765153979155,0.3475783475783476,1.0,1.0,4/11,15.67%,CD81;YWHAE;HSP90AA1;PKM
prerank,chemokine activity (GO:0008009),0.4468177730276749,1.1153527614858658,0.31934731934731936,1.0,1.0,4/31,12.91%,CCL8;CXCL10;CCL25;CCL13
prerank,snRNA binding (GO:0017069),0.43004697824359633,1.1121010670365354,0.3321917808219178,1.0,1.0,15/42,24.78%,MEPCE;LSM4;PRPF4;CDK9;RBM22;SNRPB2;DDX21;SNU13;SNRPA;SNRPD3;LSM7;LARP7;SNRPA1;COIL;HEXIM1
prerank,protein kinase inhibitor activity (GO:0004860),0.42699834117942664,1.111786306201896,0.3352534562211982,1.0,1.0,16/42,25.03%,CAMK2N1;TAOK3;PPP1R1B;GSKIP;NPM1;SMCR8;CDKN1A;NCK1;QARS1;GMFB;IBTK;DUS2;CIT;YWHAB;HEXIM1;DNAJC3
prerank,AMP binding (GO:0016208),-0.43324456983402093,-1.1112052873434322,0.32452830188679244,0.6118934497774361,1.0,5/11,13.12%,PRKAG2;PFKM;PRKAG3;ACSS2;PFKL
prerank,double-stranded DNA binding (GO:0003690),0.38006436589827447,1.1092314504479375,0.126,1.0,1.0,80/531,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;NFIX;IRF4;EGFR;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;KLF2;RAD51B;JUND;ZBTB12;NFATC4;MAFF;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;MND1;TARDBP;DPF1;CGAS;SMAD5;MTF1;HOXA4;GLI2;TBX6;ETV3;SOX8;NR6A1;MYBL2;FOXC2;ONECUT1;POLG2;MBNL2;CPSF4;ATF7;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;DDX11;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,RNA binding (GO:0003723),0.37609326908426294,1.1075258693247634,0.042,1.0,1.0,496/1321,29.16%,COL14A1;DCN;RPSA;AHNAK;DDX18;SRSF2;LRP1;C1D;AFF2;ZC3H8;MBNL1;DNM1;PKP3;RPP25;EIF3B;FNDC3B;TARBP2;ADARB1;MTHFSD;HNRNPA1;MRPS11;ANG;ANXA2;ALDH18A1;SRSF6;DIMT1;NXF1;HDLBP;NYNRIN;RFTN1;RRBP1;DDX19B;ABT1;RBMS3;USP36;URB1;DDX49;DHX16;ZFP36L1;TNS1;DAZL;TRMT6;NUDT1;RBM4;CLUH;GTPBP4;KRI1;EIF4A1;RPP21;GNL3L;ZCRB1;ERI3;SUGP2;DDX42;SCAF8;USP10;SAMD4B;NUDT7;KCTD12;KPNA2;DDX51;CFAP65;RBBP6;RTRAF;RCAN3;TRMT2A;UBAP2L;TARDBP;DGCR8;IGHMBP2;C1QBP;MEPCE;SYNE1;FSCN1;YWHAG;DNAJC2;RC3H1;UCHL5;SRP19;LSM4;FNDC3A;CLTC;TDRD3;MYO5A;FCF1;NOC2L;DHX33;U2AF1;SPATS2;POLR1G;CAST;SRSF3;UBE2N;ZFP36L2;ATXN2;NSRP1;USO1;YWHAE;DYNC1LI1;LARP4;CHCHD1;PRPF3;GPATCH1;MRPL13;NUP98;CPSF6;AGO2;DUSP11;DALRD3;ESF1;HNRNPD;RBM22;NOP9;TDRD7;NUDT16L1;GAR1;KHDC4;EXOSC7;SAMHD1;LGALS1;SIDT2;EIF1;SRP9;ARF1;SELENOH;MEX3A;MRPS27;HELZ2;MBNL2;SON;CSTB;CPSF4;CHD2;SMC1A;GSPT2;HNRNPH1;YRDC;RRP36;NPM1;MAPRE1;RPL10A;WDR46;TCERG1;ZC3HAV1;SERPINH1;DDX56;DDX21;DHX8;ASCC3;SEC23IP;MRPL10;HNRNPUL2;GFM1;CELF2;DAP3;PEG10;UBTF;MAPT;SARS2;RBFOX2;GTPBP10;NUDT16;SLPI;PUM1;PRPF40A;IGF2BP1;UNK;PSTK;SRSF11;EIF3A;FLNB;XRCC5;LARP1;SBDS;ZFP36;RPP25L;POLR2D;RPS27L;POLR2G;MPHOSPH10;DDX17;RPS5;RPGR;ZCCHC24;SNU13;DNA2;AKAP8;EIF2S1;ATXN2L;NOLC1;ELP1;DDX11;HNRNPA3;DCAF13;DDX4;LLPH;TRMT10B;AQR;POLDIP3;ZC3H12A;RBM3;RRP7A;NUFIP2;EXOSC1;PNISR;MRM3;SMG7;CISD2;THOC2;PTCD2;HSP90AA1;MRPL3;SEC63;DDX50;EIF3E;SF3B4;GSPT1;ZC3H11A;DIAPH1;TRMT1;GTF2F1;BTF3;SMG6;FYTTD1;MRPL21;DYNC1H1;DDX20;ZCCHC8;MDH2;MANF;RSL1D1;RPL6;NOP53;BAG4;DDX52;MAP4;PKM;PRPF38B;PPIL4;HMGB3;SNTB2;PDIA3;CCDC124;GRWD1;POP4;SF3A1;NUDT5;PSIP1;SPTBN1;RBM33;CPSF2;RTCA;PHF5A;EIF3D;PPP1CC;DDX5;SNRPA;CHD3;SNRPG;FXR2;SNRPD3;SAP18;AGO4;NME1;PNN;ABCF1;PPIA;NUFIP1;ILF2;RCC2;PWP2;YTHDF1;SNIP1;YTHDF2;LUC7L3;DDX31;RCC1L;DDX39A;IPO5;SRRM1;EPRS1;FKBP4;RPF2;RBM6;NAA15;ARCN1;AKAP1;EIF2S2;EBNA1BP2;RBM39;PUF60;ZBED4;TENT4B;METAP2;NCBP3;SUPV3L1;SLBP;SRFBP1;STRAP;TCF20;ALDOA;TYW5;AIMP1;NOC3L;DDX24;ARL6IP4;HNRNPUL1;SRRM3;UBFD1;U2AF2;DUS2;PTCD1;MEX3C;MCAT;AGO3;TBL3;LUC7L2;RPL22L1;RPL23;RPL17;NOL10;KMT2C;ELAVL2;PDCD11;NOVA1;LSM7;XPOT;PTBP1;GTF2E2;FLNA;ANXA7;KRR1;REPIN1;RBM28;GANAB;SF3B2;SF3B1;RPS25;ZCCHC17;RBM45;MTIF2;SRPK1;TEP1;MAK16;PRR3;NEMF;AKAP8L;THRAP3;RC3H2;KIN;IMMT;EIF2A;JUN;RPP30;LARP7;PTBP2;PRPF38A;GPKOW;DUSP14;PLEC;NOP2;RSL24D1;YTHDF3;RBM5;RNMT;TPR;NOC4L;BAZ2A;SNRPA1;ZC3H4;PURG;MRPL54;EDC3;CSTF2T;RRP1B;TRAP1;CCT4;TNRC6A;EIF4G3;DAZAP1;EIF3L;RTF1;BRIX1;DIDO1;EIF4H;RALY;AGFG1;CPSF7;SCAF4;NOA1;MKRN2;G3BP1;WDR33;RTN4;PSMD4;API5;PABPN1;SEC61B;KHNYN;MARK2;PPIG;HEXIM1;CALR;MTCL1;LARP6;RPL22;CELF3;EWSR1;PARP12;RAMAC;EXOSC10;S100A16;PHF6;HSP90B1;TNPO1;APEH;ERAL1;UBAP2;DHX32;FBRSL1;ALYREF;UPF3B;CEBPZ;H1-0;OTUD4;CSNK1E;ZNF638;R3HDM1;DCP1A;LRRC59;MRPL14;DCP1B;RBMX;EIF4G1;NOP16;CRNKL1;FTSJ3;PRPF6;TASOR;KPNB1;RPP14;SAFB;EIF4E2;DHX29;GDI2;CCDC9;BZW1;CMSS1;RSRC2;UPF1;DDX1;MRPL12;LSM5;SMG5;PRKDC;CDC40;RPL34;HTATSF1;THOC5;ZFR;AGO1;NOP56;AATF;TSR1;DUT;CCT6A;NHP2;CELF1;YARS1;TBL2;CPSF3;ZRANB2;SARS1;RPS26;GOT2;CCDC86;LSM1;MRPS23;RBM15;MYH10;MSI1;XRCC6;HNRNPC;SNRPC;CNBP;WBP11;ATP5F1A;SRSF5;WDR43;PDIA4;PEBP1;UTP18;IGF2BP3;DHFR;NOP58;SUMO1
prerank,potassium ion leak channel activity (GO:0022841),0.5068066908350553,1.1068402807632445,0.35006605019815057,1.0,1.0,3/15,9.45%,KCNK5;KCNK13;KCNK9
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.43706607983829915,1.1043127346759385,0.33294117647058824,1.0,1.0,17/37,31.04%,MARS2;TARS1;SARS2;VARS1;HARS1;GARS1;VARS2;QARS1;EPRS1;EARS2;NARS1;YARS1;SARS1;DARS1;WARS2;AARS1;LARS2
prerank,protein-arginine N-methyltransferase activity (GO:0016274),0.5341470440241413,1.1024564560744377,0.3638814016172507,1.0,1.0,5/11,31.65%,PRMT2;FBXO11;CARM1;PRMT8;PRMT7
prerank,ligand-gated cation channel activity (GO:0099094),0.4041916271374347,1.1018229760146903,0.32142857142857145,1.0,1.0,18/75,24.46%,SCNN1B;P2RX3;GRIN3A;KCNJ2;GRIN2D;GRIA2;KCNJ3;ASIC2;GRIN2A;CHRNA7;CHRNA5;KCNH2;GRIA3;ASIC1;GRIK5;GRIK2;KCNJ11;GRIK4
prerank,protein serine/threonine kinase activator activity (GO:0043539),0.4407919451562546,1.1016830098158914,0.34959349593495936,1.0,1.0,14/34,28.59%,CKS1B;ETAA1;STRADA;IQGAP1;CALM2;DBF4;STK3;MAP2K2;CAB39;ALS2;PARP16;CKS2;FAM20A;INCENP
prerank,endopeptidase inhibitor activity (GO:0004866),0.4006782270755788,1.1007606117506152,0.3229166666666667,1.0,1.0,14/82,12.90%,TIMP2;SERPINB8;ANXA2;BIN1;SERPINE3;CARD16;UCHL5;CAST;SERPINF1;CSTB;SERPINH1;SLPI;RECK;SERPING1
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),-0.32213736234909235,-1.0998790761711563,0.2898550724637681,0.6291550307189021,1.0,8/32,10.95%,KDM7A;KDM4A;TET1;PHYH;EGLN3;BBOX1;TMLHE;EGLN1
prerank,carboxy-lyase activity (GO:0016831),0.474183983267705,1.0986803093581872,0.36049382716049383,1.0,1.0,9/23,25.38%,UMPS;GGCX;ODC1;BCKDHA;UXS1;AZIN2;AMD1;UROD;MVD
prerank,double-stranded RNA binding (GO:0003725),0.4046298234090477,1.0985487470060142,0.33689839572192515,1.0,1.0,11/70,9.74%,MBNL1;TARBP2;ADARB1;RFTN1;EIF4A1;DGCR8;RC3H1;CLTC;DHX33;AGO2;SIDT2
prerank,sequence-specific DNA binding (GO:0043565),0.37724251986768303,1.0984745636179531,0.148,1.0,1.0,90/590,14.75%,LMX1A;LHX8;ESR1;PAX9;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;CTC1;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;CXXC1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;FOXL1;ACD;ETV3;SOX8;WDR77;NR6A1;MYBL2;FOXC2;HNRNPD;ONECUT1;MBNL2;CPSF4;ATF7;CSRNP3;BCL6;CEBPB;MAPT;GLI3;XRCC5;BACH2;KDM5B;TERF1;SIX1;HDAC4;RFX5;SMG7;PLAGL2;KLF4;HOXA7;HOXC4;HOXA9;POU3F2
prerank,transferrin receptor binding (GO:1990459),0.5456395873020103,1.0979013379365001,0.3744619799139168,1.0,1.0,3/10,8.19%,SNX1;CD81;CHUK
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.5340386467268317,1.0967061157704021,0.3844049247606019,1.0,1.0,3/11,19.06%,CNGB1;HCN4;HCN1
prerank,palmitoyltransferase activity (GO:0016409),0.45103969059905785,1.0953801403013115,0.35595238095238096,1.0,1.0,11/28,23.21%,ZDHHC16;ZDHHC7;HHAT;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;ZDHHC5
prerank,phosphotyrosine residue binding (GO:0001784),0.4367740900147705,1.0945861781420496,0.35689851767388825,1.0,1.0,4/37,7.45%,SYK;IRS1;PIK3R2;ABL2
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.4488557601080463,1.0933822067756946,0.358974358974359,1.0,1.0,2/28,3.23%,TNFSF9;TMBIM1
prerank,chloride channel regulator activity (GO:0017081),0.5058030530612269,1.0930946703936324,0.3627844712182062,1.0,1.0,7/14,28.25%,SGK3;STX1A;CHRNA7;WNK2;STX7;CFTR;STX8
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5165783739295338,1.0924725865679974,0.36671177266576455,1.0,1.0,4/12,14.87%,AIFM2;DHRS4;NQO2;CRYZ
prerank,sulfate transmembrane transporter activity (GO:0015116),0.4974959239441864,1.0917873593080978,0.3712021136063408,1.0,1.0,4/14,17.09%,SLC26A5;SLC26A11;SLC26A6;SLC26A1
prerank,cysteine-type endopeptidase activity (GO:0004197),0.3972644387276334,1.0887758628255904,0.33714880332986474,1.0,1.0,16/78,15.83%,CAPN5;UCHL1;CAPN2;GPAA1;USP36;USP10;USP29;CAPN1;USP26;USP33;CAPN11;USP48;USP5;PIGK;USP7;PDIA3
prerank,MAP kinase activity (GO:0004707),0.49784798634692995,1.0885551171243346,0.3891891891891892,1.0,1.0,4/14,9.77%,MAPK12;MAPK7;MAPK14;MAPK11
prerank,vinculin binding (GO:0017166),0.535755302364161,1.088101993544855,0.38639455782312926,1.0,1.0,2/11,3.91%,CORO2B;SORBS3
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.3726355960963683,1.0877331612144232,0.178,1.0,1.0,101/597,16.80%,LMX1A;AR;LHX8;ESR1;PAX9;SP9;NFIX;BNC2;IRF4;CREB5;WT1;MEOX2;TBX15;SCRT2;HSF2;SIX4;HOXA2;ELF4;NEUROD2;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ATF5;LMX1B;MEF2D;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZW10;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;NR1D1;NFIB;CREBZF;DPF1;SMAD5;MTF1;HOXA4;GLI2;TBX6;DHX33;ETV3;SOX8;NR6A1;MYBL2;FOXC2;SOX5;ONECUT1;SMAD6;RNF10;BRD7;MCM3;MBNL2;CPSF4;MZF1;ATF7;BCL6;CEBPB;GLI3;XRCC5;BACH2;KDM5B;NCOR1;SIX1;DDX11;HDAC4;RFX5;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;NR2C2;E2F3;CDK5RAP2;GRWD1;CENPC;UBP1;PER1;SNAI2;CHD3;TFAP4
prerank,SUMO transferase activity (GO:0019789),0.4860649001293035,1.0868071113536868,0.38022813688212925,1.0,1.0,8/16,28.12%,RNF212B;CBX4;PIAS3;HDAC4;NSMCE2;MDM2;MUL1;TOPORS
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),0.4713608614244168,1.08604335211276,0.3710292249047014,1.0,1.0,4/18,16.13%,PIK3R2;SOCS2;WDR91;SOCS6
prerank,antiporter activity (GO:0015297),0.4696442918952058,1.0830579121255313,0.38190954773869346,1.0,1.0,5/20,16.61%,SLC35E3;ATP1A3;SLC25A16;SLC35D1;SLC35E1
prerank,DNA polymerase binding (GO:0070182),0.4794891021833359,1.0826003700594624,0.3836150845253576,1.0,1.0,6/18,15.17%,FANCD2;ACD;POLG2;HSP90AA1;SMARCA4;SMG6
prerank,miRNA binding (GO:0035198),0.438184121470617,1.0816035871724086,0.3764988009592326,1.0,1.0,10/30,19.45%,HNRNPA1;RBM4;TRIM71;RC3H1;AGO2;DDX21;PUM1;ZC3H12A;AGO4;AGO3
prerank,WW domain binding (GO:0050699),0.452896388644677,1.0800800561504518,0.3704156479217604,1.0,1.0,8/26,21.96%,SCNN1B;PMEPA1;TCEAL6;KIF20B;NDFIP1;WBP1;TCEAL9;TRAF4
prerank,ubiquitin-dependent protein binding (GO:0140036),0.5230076861667828,1.079990302321696,0.414535666218035,1.0,1.0,5/10,21.16%,DNAJC2;DNAJB2;FAN1;IDE;FAAP20
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.35238901457895944,-1.0799797066014565,0.3282051282051282,0.6668522160320284,1.0,3/21,1.51%,PDE1A;PDE7B;PDE3A
prerank,I-SMAD binding (GO:0070411),0.497428755769042,1.0771121414104845,0.39705882352941174,1.0,1.0,4/13,10.09%,SMAD4;AXIN1;SMAD5;SMAD6
prerank,N-acetyltransferase activity (GO:0008080),0.4690325304921724,1.075185929476263,0.3723270440251572,1.0,1.0,6/19,18.80%,GNPNAT1;ATAT1;KAT2B;NAT8;SAT1;NAA50
prerank,signal sequence binding (GO:0005048),0.43069552540425377,1.0740544760812696,0.38380281690140844,1.0,1.0,18/35,26.59%,KDELR3;KPNA2;KDELR1;CABP1;KDELR2;TNPO2;TIMM22;SEC61A1;PEX5L;IPO5;PEX5;KPNA1;BRAP;RANBP6;AP2M1;TNPO1;KPNA6;KPNB1
prerank,actinin binding (GO:0042805),-0.34495447014745295,-1.0732948857490463,0.3409090909090909,0.6736282301680085,1.0,4/21,4.69%,PDLIM5;SYNPO2;PROM1;CACNA1D
prerank,RNA polymerase II complex binding (GO:0000993),0.42932634276721626,1.0716354461185242,0.3885647607934656,1.0,1.0,16/32,31.70%,SCAF8;RTRAF;NCOA3;AGO2;ELP4;URI1;UVSSA;ERCC5;PCIF1;PAF1;ELOF1;AGO1;WDR43;SCAF1;RPRD1A;WAC
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.5281589868353217,1.0712808967644414,0.4053295932678822,1.0,1.0,5/10,21.16%,DNAJB2;FAN1;PML;IDE;FAAP20
prerank,lysophospholipase activity (GO:0004622),0.46512024143766856,1.0707186973674752,0.41603053435114506,1.0,1.0,1/20,0.62%,MGLL
prerank,potassium ion transmembrane transporter activity (GO:0015079),0.4396799455483885,1.0703558943946472,0.3983548766157462,1.0,1.0,11/31,22.78%,KCNK5;SLC12A8;SLC12A4;PKD2;KCNK9;KCNA2;SLC12A5;HCN1;SLC12A6;KCNF1;ABCC8
prerank,"DNA binding, bending (GO:0008301)",-0.3994193148205426,-1.0696117588167364,0.3423076923076923,0.6729096898473744,1.0,3/14,3.59%,LEF1;HMGB1;FOXC1
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3650729039307902,1.0690670864341985,0.204,1.0,1.0,125/731,16.82%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;CREB3L1;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,cGMP binding (GO:0030553),0.5196262547629368,1.0690236445377728,0.41086350974930363,1.0,1.0,4/11,11.90%,PDE11A;PDE10A;CNGB1;PDE5A
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.34280657531394454,-1.0689950344220618,0.32065217391304346,0.6647723250056471,1.0,3/23,1.51%,PDE1A;PDE7B;PDE3A
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.4910993779074658,1.068738225341464,0.4120734908136483,1.0,1.0,5/14,17.92%,NME2;CMPK2;NME1;AK8;AK9
prerank,TBP-class protein binding (GO:0017025),0.46281730284108913,1.0681292539329883,0.41729323308270677,1.0,1.0,5/21,15.52%,ESR1;BRF2;DR1;GTF2A2;YEATS2
prerank,Toll-like receptor binding (GO:0035325),0.5164695748917965,1.0664726057773202,0.4151967435549525,1.0,1.0,3/11,8.92%,S100A9;S100A8;TIRAP
prerank,calcium activated cation channel activity (GO:0005227),0.4748742169264899,1.0660032400913195,0.39327296248382926,0.9991721272963149,1.0,2/17,5.17%,KCNMA1;TMEM63A
prerank,transforming growth factor beta binding (GO:0050431),0.45770256435557266,1.0634421441398527,0.3924205378973105,1.0,1.0,6/23,11.85%,TGFB3;TGFBR2;ACVR1;ITGAV;TSKU;VASN
prerank,sulfotransferase activity (GO:0008146),0.42315972383026257,1.0631355603839072,0.3953216374269006,1.0,1.0,6/33,9.58%,CHST1;CHST10;GAL3ST3;CHST12;CHST14;HS2ST1
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.36208986898100287,1.0607255963216595,0.236,1.0,1.0,123/732,16.82%,EBF2;PRRX1;AR;ESR1;HOXA3;PAX9;EBF1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;IKZF5;PROX2;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,high voltage-gated calcium channel activity (GO:0008331),-0.41875220154423554,-1.059910128869904,0.39338235294117646,0.6761210404532035,1.0,5/10,25.75%,CACNB2;CACNA1D;CACNB3;CACNA1B;CACNB4
prerank,RNA stem-loop binding (GO:0035613),0.5023009859269965,1.0592680506446068,0.41486486486486485,1.0,1.0,8/12,34.87%,RC3H1;ZC3H12A;EPRS1;RC3H2;LARP6;MYH10;CPEB3;DDX3X
prerank,damaged DNA binding (GO:0003684),0.41011517786911966,1.0573826387070169,0.41261061946902655,1.0,1.0,14/44,22.85%,MPG;ERCC3;ERCC4;RAD1;DDB1;SMC6;FANCG;NBN;ERCC5;POLD1;DCLRE1A;OGG1;SDE2;ERCC1
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.4089130735821185,1.0572728927561759,0.4040632054176072,1.0,1.0,8/42,15.14%,CCNL2;CKS1B;KAT2B;CCNC;CDKN1A;CCND1;CCNH;CCNQ
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.49540513233528727,1.0565022318355395,0.4102209944751381,1.0,1.0,5/14,21.67%,DESI2;OTUD7B;USP7;MINDY3;USP13
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.5240371325544291,1.053985174793303,0.4194008559201141,1.0,1.0,1/10,0.43%,SLCO2A1
prerank,sialyltransferase activity (GO:0008373),-0.3402373032701843,-1.0520922239113346,0.3829787234042553,0.685650266857141,1.0,6/20,9.82%,ST3GAL6;ST8SIA4;ST6GALNAC3;ST6GALNAC5;ST6GAL1;ST8SIA2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.35870496727414064,1.0508481818675315,0.271,1.0,1.0,133/831,16.82%,LMX1A;EBF2;PRRX1;AR;LHX8;ESR1;HOXA3;PAX9;EBF1;TRPS1;SP9;FOXP2;NFIX;IRF4;CREB5;WT1;ZFHX4;MEOX2;TBX15;SCRT2;ZNF367;HSF2;SIX4;HOXA2;ELF4;HIVEP2;NEUROD2;SKIL;KLF3;PBX1;KLF12;FOXP1;BHLHE40;TLX3;GLIS2;RUNX1;TEF;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SKI;PAX1;SOX10;IRX5;RFX1;FOXK2;KLF2;JUND;ZBTB12;NFATC4;MAFF;TCF7L2;NR1D2;NFATC1;RBAK;HOXA5;MEIS2;FOXO1;NR1D1;NFIB;EBF3;ZBTB7C;MUC1;NFIA;ZFHX3;MLXIPL;SMAD5;HDAC6;MYT1;MTF1;HOXA4;GLI2;TBX6;FOXL1;STAT5A;SOX8;ZBTB1;VDR;NR6A1;MYBL2;ZNF260;FOXC2;SOX5;ONECUT1;SATB2;MYPOP;ZNF3;CHD2;MZF1;MITF;PRDM15;ATF7;BCL6;CEBPB;GLI3;BACH2;ZNF691;ZNF112;ATF1;PEG3;IKZF5;PROX2;TWIST1;SIX1;NACC2;HDAC4;RFX5;PLAGL1;ZNF569;KLF4;HOXA7;HOXC4;HOXA9;POU3F2;ZNF692;MLXIP;NFE2L3;NR2C2;E2F3;ZFP28;ZBTB25;ZBTB5;UBP1;PER1;HIVEP3;STAT5B;SNAI2;E4F1;TFAP4;ZEB1
prerank,mRNA 3'-UTR binding (GO:0003730),0.3892042472151385,1.049962315312344,0.41596638655462187,1.0,1.0,21/79,16.97%,RBMS3;ZFP36L1;DAZL;RBM4;TARDBP;RC3H1;CARHSP1;AUH;ZFP36L2;LARP4;CELF2;PUM1;IGF2BP1;LARP1;ZFP36;ZC3H12A;CRYZ;RSL1D1;DDX5;FXR2;CPEB1
prerank,transition metal ion binding (GO:0046914),0.36103743170615,1.0492182880435776,0.33233233233233234,1.0,1.0,100/397,21.58%,TIMP2;LOXL2;SNCB;WT1;SEC24D;B4GALT1;ANG;ANPEP;S100A9;S100A8;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;MGAT1;TK1;RBAK;SEC24A;RASSF1;ABCE1;MDM4;RC3H1;MYT1;MELTF;SLC11A2;LNPEP;ABL2;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;XPNPEP3;USP33;DYRK2;LARGE1;ZNF3;GALNT1;TARS1;WDFY1;RNF7;NUDT16;NQO2;MPPE1;NPEPPS;CZIB;ACO2;KDM5B;MGAT5;MGAT2;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;AOX1;SOD3;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;FBXL5;NEK4;TIMM8B;ZDHHC20;TYR;EPRS1;ARIH2;BLM;MMP16;FDX1;SMPD1;CTCF;TYW5;SCD5;KDM1B;KMT2A;FBXL19;XYLT2;ARIH1;MGAT5B;CCS;TAB2;MBD1;KDM2B;NSD1
prerank,SH3 domain binding (GO:0017124),-0.25732808822722175,-1.0481265914747637,0.38095238095238093,0.6863251825990195,1.0,16/62,14.40%,AFAP1L1;CD2AP;AFAP1;SHANK3;DAB2IP;AFAP1L2;PLSCR1;LANCL1;ZNF106;EVL;KHDRBS1;ABL1;CASP9;ABI3;SGIP1;ABI2
prerank,cholesterol binding (GO:0015485),0.4022237503654987,1.04564301478573,0.42730299667036625,1.0,1.0,9/47,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;SCP2;OSBPL6;VDAC2
prerank,nuclear localization sequence binding (GO:0008139),0.4617218280257176,1.0451163544564674,0.42727272727272725,1.0,1.0,10/18,26.59%,KPNA2;CABP1;TNPO2;IPO5;KPNA1;BRAP;RANBP6;TNPO1;KPNA6;KPNB1
prerank,solute:proton symporter activity (GO:0015295),0.4642842018820371,1.0449470814998556,0.42292490118577075,1.0,1.0,5/16,15.20%,SLC11A2;SLC17A5;SLC2A10;SLC15A4;SLC25A3
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.3625084893914889,1.044184630105,0.378,1.0,1.0,48/254,16.80%,PRRX1;AR;ESR1;IRF4;WT1;MEOX2;HSF2;ELF4;GLIS2;RUNX1;SMAD4;ATF5;SOX10;FOXK2;MAFF;NFATC1;HOXA5;CREB3L1;SMARCD2;MEIS2;FOXO1;NFIB;NFIA;MDM4;MTF1;SMARCD1;MYBL2;FOXC2;ONECUT1;SATB2;MZF1;MITF;PRDM15;ZNF112;ATF1;SIX1;RFX5;PLAGL1;PLAGL2;KLF4;HOXA7;HOXC4;MLXIP;NR2C2;E2F3;UBP1;E4F1;TFAP4
prerank,death receptor activity (GO:0005035),-0.40513187317259025,-1.0440947262712885,0.392226148409894,0.6862408042767095,1.0,5/11,22.92%,TNFRSF19;TNFRSF11A;FAS;TNFRSF10B;TNFRSF25
prerank,iron ion binding (GO:0005506),-0.26776261108603167,-1.0430689648851317,0.40860215053763443,0.6796591734662597,1.0,13/48,13.06%,KDM7A;SNCA;FTH1;TET1;PHYH;EGLN3;FECH;PHF2;NFU1;EGLN1;ETHE1;SCD;ISCU
prerank,aminopeptidase activity (GO:0004177),0.43263476456558125,1.0421447211096484,0.42698019801980197,1.0,1.0,11/26,24.69%,ANPEP;LNPEP;XPNPEP3;NPEPPS;LAP3;MMP16;METAP2;METAP1;METAP1D;JMJD7;MMP15
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.3646352118035453,1.0388630001547976,0.4228456913827655,1.0,1.0,32/173,16.82%,TRPS1;FOXP2;SCRT2;SKIL;KLF12;FOXP1;BHLHE40;ZNF25;SKI;FOXK2;ZBTB12;NFATC4;CREB3L1;NR1D1;ZFHX3;ZBTB1;MYPOP;ZNF3;MZF1;MITF;BCL6;CEBPB;PEG3;IKZF5;NACC2;PLAGL1;ZNF692;ZBTB25;ZBTB5;SNAI2;E4F1;ZEB1
prerank,nucleoside-triphosphatase activity (GO:0017111),0.36087181347008407,1.0376505894948762,0.4114114114114114,1.0,1.0,84/248,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;KLC1;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;VPS4B;ABCG4;RIT2;CLPX;DYNC1I1;TOR1A;KIF2A;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;KIF20B;NKIRAS1;RAB43;PIN1;RHOA;DNA2;RRAGD;GNB1;DDX4;HSP90AA1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;CHD3;RAB35;RAB1B;RAB5B;RAB5C;DYNC2H1;ATP2B1;ATAD1;RRAS2;RAB24;RALA;ABCB10;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;CFTR;DHX29;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,GTPase activity (GO:0003924),0.36309743733196387,1.0375802383272248,0.41566265060240964,1.0,1.0,65/192,28.13%,GNG8;GNAS;DNM1;GNAI3;RAB32;RAB6A;RAB23;GTPBP4;RAB19;RAB6B;RAP1B;RIT2;GNAZ;RHOJ;RHOQ;GSPT2;RAB2A;GFM1;NRAS;KRAS;GTPBP10;NKIRAS1;RAB43;RHOA;RRAGD;GNB1;GEM;RAB27B;GSPT1;RND3;RAB33B;RAC3;RAB35;RAB1B;RAB5B;RAB5C;RRAS2;RAB24;RALA;GNAO1;GPN1;GNB5;SEPTIN9;RABL3;RAB18;ARL8A;AGAP3;GNA14;RAC1;RAB29;ATL1;RHOT2;RAB1A;RHOBTB2;GNA13;RAB3C;RND2;RAP1A;DIRAS2;RHEBL1;RAB8B;TSR1;RAP2B;RAP1GAP;HBS1L
prerank,semaphorin receptor binding (GO:0030215),0.44117376502415817,1.0371426910435124,0.4472049689440994,1.0,1.0,4/23,12.28%,SEMA3C;RIT2;SEMA3A;SEMA3D
prerank,deoxyribonuclease activity (GO:0004536),0.48455707266778986,1.0363944403752163,0.4494818652849741,1.0,1.0,7/14,24.96%,ERCC4;DNASE1L2;NME1;ERCC5;MAP1S;DFFB;DNASE1L1
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),-0.3405753329599211,-1.035862656988455,0.38288288288288286,0.687175570778858,1.0,8/18,20.76%,TNFAIP8;SNCA;XIAP;PRDX3;RPS6KA1;MT3;SERPINB9;BIRC2
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.49533775870312075,1.0348606949619448,0.43658210947930576,1.0,1.0,4/12,18.40%,CISD1;CISD2;AOX1;FDX1
prerank,E-box binding (GO:0070888),0.41520820752848525,1.0345485538576649,0.43548387096774194,1.0,1.0,9/34,16.82%,SCRT2;NEUROD2;BHLHE40;MITF;TWIST1;PER1;SNAI2;TFAP4;ZEB1
prerank,Hsp70 protein binding (GO:0030544),0.4228982852958324,1.0325298852304183,0.4323040380047506,1.0,1.0,12/31,27.95%,DNAJC2;STUB1;DNAJC8;ERN1;PPEF2;DNAJB2;GPR37;DNAJB1;MVD;TSC1;DNAJA1;HDAC8
prerank,beta-tubulin binding (GO:0048487),-0.31634683794016905,-1.0323263137140959,0.41496598639455784,0.6863981652539859,1.0,12/31,16.85%,EML4;GJB6;IFT74;PDCD5;GABARAPL1;GABARAP;SMC3;HTT;TRPV4;PEX14;TAOK1;VAPB
prerank,transforming growth factor beta receptor binding (GO:0005160),0.4477249218587238,1.0320202402260787,0.4491844416562108,1.0,1.0,4/18,10.09%,TGFB3;TGFB2;TGFBR2;SMAD6
prerank,glycerophospholipid flippase activity (GO:0140333),0.49935412451258215,1.0307205651486122,0.423728813559322,1.0,1.0,2/11,7.64%,ATP8B1;ATP11A
prerank,mannose binding (GO:0005537),0.49238298895289034,1.0293172312931327,0.4607977991746905,1.0,1.0,3/12,18.60%,COLEC11;LMAN1;MBL2
prerank,phosphatidylglycerol binding (GO:1901611),0.4845610745609513,1.0291063015867339,0.4482288828337875,1.0,1.0,1/13,0.56%,UCP1
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),0.47078390069992926,1.02731380003341,0.4601542416452442,1.0,1.0,6/16,24.98%,MTMR11;INPP5F;MTMR6;MTMR1;PTEN;MTM1
prerank,SH2 domain binding (GO:0042169),0.4073992681616602,1.023417282524963,0.4552752293577982,1.0,1.0,5/31,12.63%,LAX1;IRS1;SRC;SQSTM1;RUFY1
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3740906631208162,1.0233115515006426,0.4327731092436975,1.0,1.0,16/75,22.83%,EHHADH;DHRS9;UGDH;DHRS4;HSD3B7;HIBADH;PTGR1;KCNAB3;HSD17B8;MDH2;BDH2;GLYR1;LDHA;HSD17B4;HSD17B11;LDHAL6B
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.48138546765946316,1.0219573408796885,0.4596026490066225,1.0,1.0,5/15,15.12%,GPAT4;AGPAT3;LPCAT1;AGPAT5;GPAT3
prerank,phosphatase binding (GO:0019902),0.3648677810163892,1.0218259582141276,0.4587628865979381,1.0,1.0,26/105,17.68%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;RCAN3;CARHSP1;FBXL2;IQGAP1;SIRPA;ANAPC5;MAGI2;JUP;SHOC2;STX17;KIF3A;PPP1R3C;SFI1;CDC27;GTF2F1;TRPC4AP;ANK1;CNST;TRAF3;SH2D4A;ANAPC4
prerank,active ion transmembrane transporter activity (GO:0022853),-0.2866634958793079,-1.0215453998259398,0.36507936507936506,0.7029367533004008,1.0,7/37,6.74%,SLC22A8;SLCO2B1;SLCO1C1;SLC22A6;SLC22A4;COX4I1;ATP13A3
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.37713058511119274,1.0208018876501954,0.4577540106951872,1.0,1.0,21/69,23.21%,CERS6;ZDHHC16;MOGAT1;PLAAT1;ZDHHC7;SCP2;KAT2B;HHAT;MBOAT7;MOGAT2;ZDHHC2;PLA2G4E;ZDHHC21;ZDHHC20;NAA15;MCAT;SOAT1;ZDHHC18;KAT6B;ZDHHC8;ZDHHC5
prerank,cholesterol transfer activity (GO:0120020),0.46019988378382054,1.019921801160877,0.4554054054054054,1.0,1.0,3/16,7.01%,GRAMD1A;OSBPL2;ABCA1
prerank,methyltransferase activity (GO:0008168),0.3930237512809686,1.0193516937641105,0.4557522123893805,1.0,1.0,23/46,34.89%,NTMT1;MEPCE;FTSJ1;COMTD1;COQ3;GAMT;COMT;TRMT11;COQ5;N6AMT1;FTSJ3;EEF1AKMT3;ASMT;NNMT;SUV39H1;PRMT8;LRTOMT;AS3MT;PRMT7;DNMT3B;NSUN3;EEF1AKMT1;BUD23
prerank,telomerase RNA binding (GO:0070034),0.43276764919210364,1.0170344787385848,0.46633416458852867,1.0,1.0,10/22,28.61%,GAR1;SMG7;SMG6;SNRPD3;TENT4B;TEP1;EXOSC10;SMG5;NHP2;HNRNPC
prerank,vascular endothelial growth factor receptor binding (GO:0005172),0.48174639038837275,1.0168185829499374,0.46143250688705234,1.0,1.0,3/12,4.65%,ITGB3;VEGFA;ITGA5
prerank,phosphate ion binding (GO:0042301),0.5006102529395652,1.0159915422502523,0.4715909090909091,1.0,1.0,5/10,25.18%,CHST14;ADSS2;MTHFD2;RELA;RPH3A
prerank,MAP kinase phosphatase activity (GO:0033549),-0.38958320141676167,-1.015351187234441,0.44696969696969696,0.7086106678369106,1.0,3/12,16.45%,DUSP10;DUSP7;DUSP6
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),0.46789190116634966,1.013914897147029,0.4682860998650472,1.0,1.0,9/13,35.14%,FTSJ1;TRMT10B;TRMT1;TRMT11;METTL1;WDR4;THUMPD3;TRMT10C;THUMPD2
prerank,phosphatidylinositol kinase activity (GO:0052742),0.4589903754087036,1.0136975062019722,0.4697368421052632,1.0,1.0,7/15,22.25%,PIK3C2B;PI4K2B;PIK3CA;PI4KB;PI4KA;PIK3CG;PI4K2A
prerank,histone deacetylase binding (GO:0042826),0.36395694782583826,1.011919005558759,0.48175182481751827,1.0,1.0,40/88,30.65%,HDAC9;MEF2D;DACT1;KPNA2;HDAC6;YWHAE;SIRT2;KAT2B;SATB2;HDAC3;GLI3;NCOR2;NCOR1;CCND1;AKAP8;NACC2;HDAC4;HSP90AA1;GMNN;TFAP4;TOP2B;NIPBL;SUDS3;MIER1;KCTD21;AKAP8L;YWHAB;RELA;LCOR;PHF6;SMG5;HES1;HIC1;TP53;MEF2B;BRMS1L;BRMS1;TRAF6;THAP7;RAD9A
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),0.4273661931490783,1.0037386558188468,0.4900990099009901,1.0,1.0,5/21,27.35%,P2RX3;CHRNA7;CHRNA5;GRIK2;P2RX4
prerank,glycine binding (GO:0016594),0.48576120495667474,1.0023833494470353,0.4943661971830986,1.0,1.0,5/11,30.13%,GRIN3A;GLDC;SRR;GLRA3;GLRA2
prerank,zinc ion binding (GO:0008270),0.3463551970836642,1.0016556003915302,0.5075075075075075,1.0,1.0,70/293,21.58%,TIMP2;WT1;SEC24D;ANPEP;S100A9;S100A8;CRIP1;CLIP1;SKI;ADAMTS3;ADAM33;MSRB1;TK1;RBAK;SEC24A;RASSF1;MDM4;RC3H1;MYT1;LNPEP;GLI2;ZFPM2;RNF2;MYCBP2;TIMM9;DPEP1;SEC23A;SIAH1;ECE1;SIRT2;KDM5C;SAMHD1;GDA;USP33;ZNF3;TARS1;WDFY1;NQO2;NPEPPS;CZIB;KDM5B;IKZF5;ZCCHC4;HDAC4;PEX12;KLF4;CHORDC1;PHF5A;SLC30A5;CHD3;GRIN2A;ZEB1;IDE;SEC24B;TIMM8B;ZDHHC20;EPRS1;ARIH2;BLM;MMP16;SMPD1;CTCF;KDM1B;KMT2A;FBXL19;ARIH1;TAB2;MBD1;KDM2B;NSD1
prerank,phosphatidylinositol binding (GO:0035091),0.36114149805903106,1.0006071962063128,0.48693834900731453,1.0,1.0,17/91,14.56%,SESTD1;SCIN;GAP43;GPAA1;FRMPD2;AIDA;PARD3B;PLEKHF1;SNX1;DPEP1;WDFY1;MAPT;PASK;MPPE1;DENND1A;PIGK;BCAS3
prerank,disordered domain specific binding (GO:0097718),0.4327562318875831,0.9982018390628485,0.4849246231155779,1.0,1.0,9/23,24.79%,FYN;NCOA3;CLTC;CALM2;HSP90AA1;FKBP8;NUMA1;DFFB;MDM2
prerank,poly(A) binding (GO:0008143),-0.3307889370017894,-0.9981948640570898,0.45161290322580644,0.7409135191735793,1.0,9/21,19.24%,RBPMS;RBMS2;ZC3H14;PPIE;KHDRBS1;TIA1;HNRNPDL;PABPC4L;EIF4A3
prerank,amyloid-beta binding (GO:0001540),0.36043473370100243,0.9980187530734054,0.4841101694915254,1.0,1.0,19/79,20.22%,EPHB2;APBA3;LRP1;TGFB2;APBA1;ATP1A3;ITGA2;TLR4;GRIA2;TM2D1;HSPG2;FZD4;GRIN2A;CHRNA7;PFDN6;IAPP;GRIA3;ITGAM;BACE1
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",-0.2926145279697394,-0.9978128915278279,0.4233576642335766,0.7326603133581004,1.0,8/34,9.66%,MYO1B;ADAP2;ARAP2;IQGAP2;ARAP3;FCHSD2;HIP1R;ZFYVE1
prerank,cell adhesion mediator activity (GO:0098631),0.4236386709291428,0.997772868083268,0.4987864077669903,1.0,1.0,7/24,13.54%,NPTN;JAM3;CD47;SIRPA;DSCAM;IGSF9;PALLD
prerank,endonuclease activity (GO:0004519),0.3854523718994076,0.9975771457389271,0.48824188129899215,1.0,1.0,13/49,20.44%,ANG;NYNRIN;N4BP2;AGO2;ERN1;ERCC4;RCL1;ZC3H12A;SMG6;ERCC5;AGO3;YBEY;OGG1
prerank,motor activity (GO:0003774),0.369835566726029,0.9971676942708347,0.4860215053763441,1.0,1.0,17/60,21.55%,KLC1;KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;PIN1;KIF3B;DYNC2H1;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,fibroblast growth factor binding (GO:0017134),0.4261631088923509,0.9968042776032017,0.48872180451127817,1.0,1.0,4/21,9.97%,FGFR1;ITGB3;GLG1;ITGAV
prerank,titin binding (GO:0031432),0.46717065323453777,0.9964835322486028,0.4845222072678331,1.0,1.0,3/13,12.63%,ANKRD23;CAMK2D;CALM2
prerank,methyl-CpG binding (GO:0008327),-0.31835444061628637,-0.9962363864431638,0.44502617801047123,0.7275816422956647,1.0,5/22,13.13%,CXXC4;TET1;ZBTB38;CXXC5;LRWD1
prerank,methylation-dependent protein binding (GO:0140034),0.3763853232372227,0.9955632397954232,0.5,1.0,1.0,26/57,30.66%,MORC4;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1;MSH6;ING1;CBX2;ATRX;MBTD1;THAP7;CBX5
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.4803672042866365,0.9939008217141163,0.48132780082987553,1.0,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,adenyl nucleotide binding (GO:0030554),0.4803672042866365,0.9939008217141163,0.48132780082987553,1.0,1.0,5/11,25.45%,GRPEL2;BAG4;BAG3;BAG5;HSPH1
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.37892812379137525,0.9937605933916137,0.4838709677419355,1.0,1.0,10/46,13.40%,B3GALNT1;EXT1;MGAT1;POMGNT2;RFNG;LARGE1;B3GNT8;MGAT5;MGAT2;MGAT4B
prerank,U6 snRNA binding (GO:0017070),0.4593159496650092,0.9930548690351246,0.49115646258503404,1.0,1.0,5/14,21.92%,LSM4;PRPF4;RBM22;LSM7;LARP7
prerank,transition metal ion transmembrane transporter activity (GO:0046915),0.40297100301317557,0.9927318444781642,0.4847775175644028,1.0,1.0,8/30,19.98%,SLC39A13;SLC39A14;SLC11A2;SLC39A7;SLC25A28;TMEM165;SLC30A5;SLC39A3
prerank,protein phosphatase 1 binding (GO:0008157),-0.31865896016149226,-0.9925537757150876,0.4567307692307692,0.7272951788231449,1.0,6/21,12.82%,PPP1R16B;PPP1R3B;SH3RF2;KCNQ1;PPP1R16A;PHACTR4
prerank,potassium:proton antiporter activity (GO:0015386),0.4949019132196172,0.9921970716050263,0.49014084507042255,1.0,1.0,4/10,15.89%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,CCR chemokine receptor binding (GO:0048020),0.40838885398063485,0.991308154720554,0.4987980769230769,1.0,1.0,5/28,20.71%,CCL8;CCL25;CCL13;MSMP;CNIH4
prerank,sterol binding (GO:0032934),0.37539957723184136,0.9909882105194179,0.5043668122270742,0.9991477363126913,1.0,10/56,11.99%,OSBP2;GRAMD1A;OSBPL3;OSBPL2;ABCA1;CD81;INSIG2;SCP2;OSBPL6;VDAC2
prerank,guanyl ribonucleotide binding (GO:0032561),0.34464448968299166,0.990953975735259,0.5195195195195195,0.995718200701376,1.0,66/196,27.93%,GNAI3;RAB32;RAB6A;GTPBP4;RAP1B;PDE11A;ARF4;SCG5;PDE10A;RIT2;DYNC1LI1;CNGB1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;PDE5A;RRAD;TUBD1;RHOA;RRAGD;NME2;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RAB5B;RAB5C;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;RAB18;ARL8A;NOA1;RAB12;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;RAB8B;TSR1;RAP2B
prerank,MHC protein binding (GO:0042287),0.4308752624196536,0.9902780997550035,0.5044472681067345,0.9941915486650049,1.0,7/20,28.85%,KIR3DL2;CD81;COL2A1;ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,translation elongation factor activity (GO:0003746),0.4536976359780926,0.9898470692796848,0.4860927152317881,0.9918406272782873,1.0,4/14,20.40%,GTPBP2;GFM1;EEF1B2;EIF5A2
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),0.36861157828965346,0.9884044917151793,0.5180722891566265,0.9925608284031624,1.0,16/60,16.68%,DDR2;EPHB2;AXL;EGFR;FGFR1;EPHA3;MST1R;RET;EPHB3;MUSK;EPHA10;FLT3;PDGFRA;DDR1;IGF2R;EFEMP1
prerank,mannosyltransferase activity (GO:0000030),-0.3218317492268315,-0.9869848364580793,0.44711538461538464,0.7321600856092855,1.0,7/21,13.39%,TMTC1;TMTC4;TMTC2;ALG12;DPY19L4;PIGB;POMT2
prerank,acetylation-dependent protein binding (GO:0140033),0.43133455741225224,0.985635684872561,0.5050125313283208,0.993652159002982,1.0,10/20,23.83%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,lysine-acetylated histone binding (GO:0070577),0.43133455741225224,0.985635684872561,0.5050125313283208,0.993652159002982,1.0,10/20,23.83%,DPF2;BRD9;ATAD2B;BRD7;SMARCA4;KMT2A;BRD2;CARM1;BAZ2A;TRIM24
prerank,ribosomal small subunit binding (GO:0043024),0.4457746770998618,0.985082979993737,0.5026455026455027,0.9916961287127121,1.0,9/17,26.66%,ABCE1;EIF1;NPM1;LARP1;NME1;MTIF2;EIF4H;ERAL1;DHX29
prerank,phosphatase inhibitor activity (GO:0019212),-0.31744637120958175,-0.9832208927334664,0.48325358851674644,0.7327221716064938,1.0,3/20,4.14%,PTN;LMTK2;BOD1L1
prerank,methylated histone binding (GO:0035064),0.369173350584387,0.9831487685418056,0.5256830601092897,0.9939522184115984,1.0,20/62,24.23%,MORC4;DPF2;CXXC1;SPIN4;TDRD3;PHF1;MSL3;ING4;ZCWPW2;WDR5;MPHOSPH8;CDYL;CHD8;CHD1;GLYR1;SGF29;SPIN1;JMJD7;TRIM24;PYGO1
prerank,sterol transfer activity (GO:0120015),0.4388080376357568,0.981625452499809,0.5127175368139224,0.9949218194451472,1.0,3/17,7.01%,GRAMD1A;OSBPL2;ABCA1
prerank,protein homodimerization activity (GO:0042803),0.3369158543255985,0.9814913779810441,0.574,0.9918849237675431,1.0,139/589,21.08%,MID1;GHR;LRP6;MGLL;CADM3;FOXP2;SRM;ST3GAL2;DPP4;FGFR1;STK25;FAP;TARBP2;ANG;VEGFA;IRAK3;TGFB2;SLIT2;S100A10;SLC51A;BHLHE40;NECTIN3;SLC39A13;SMAD4;EXT1;MID2;AXIN1;ACVR1;TENM3;VPS4B;CAMK2D;ALDH3A2;PRMT2;ABCG4;DGCR8;IDH1;SYNE1;MLXIPL;TMEM266;STUB1;MYO9B;SNX1;TIMM9;PKD2;S100A6;SLK;CHUK;ZBTB1;INPP5F;NR6A1;HPS4;DPY30;ECE1;PON3;NUDT16L1;ODC1;XPNPEP3;ERN1;NPM1;MZF1;SPPL2B;ZHX2;GSTM2;CEBPB;AKT1;NUDT16;KIF20B;IRAK1;NQO2;GLA;JUP;BAK1;FLRT3;GLCE;ADCY8;ALDH1A3;MGAT2;GDNF;ZDHHC2;GTF2A2;TERF1;CRYM;CR2;NACC2;NFS1;PDGFRA;SYNDIG1;CISD2;HSP90AA1;FZD4;PANK1;MTMR1;AOX1;TRIM68;ACOX1;HARS1;NUDT5;PHETA2;PRPS1;PRPS1L1;FXR2;TFAP4;PML;IDE;CANT1;CHRNA7;PADI2;ABCB9;SRGAP2;QTRT1;ERCC5;TYR;EPRS1;SNX6;TPM4;BLM;SUPV3L1;KCNH2;PRDM9;TYW5;AIMP1;PANK3;MKLN1;MCL1;GLDC;ABCD3;GALM;STK26;ACP3;KMT2A;FLNA;PIP4K2B;NECTIN1;ABCB10;ATIC;HSD17B4;PYCARD;BMPR1A;TPST2
prerank,leak channel activity (GO:0022840),0.433891575114953,0.9795504719522138,0.49806451612903224,0.9941069547610026,1.0,3/18,9.45%,KCNK5;KCNK13;KCNK9
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),-0.39645797213360795,-0.9791732179351306,0.486013986013986,0.7258256384961882,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),-0.39645797213360795,-0.9791732179351306,0.486013986013986,0.7258256384961882,1.0,3/10,16.45%,DUSP10;DUSP7;DUSP6
prerank,copper ion binding (GO:0005507),0.38147788302774077,0.9781856278985066,0.5310421286031042,0.9945534946920743,1.0,3/42,2.48%,LOXL2;SNCB;ANG
prerank,protein phosphatase binding (GO:0019903),0.3462783324364003,0.9780133722401058,0.5214285714285715,0.9916464096971359,1.0,29/117,19.47%,EGFR;EIF2AK3;DLG4;PIK3R2;MAPK14;GRIN3A;ATP2B4;FOXO1;FBXL2;IQGAP1;SIRPA;MAPT;ANAPC5;SLC9A1;JUP;SHOC2;STX17;ADCY8;KIF3A;PPP1R3C;CDC27;SMG7;GTF2F1;ANK1;TRAF3;PPP1R9B;ANAPC4;PPP3CB;PPP1R3D
prerank,metalloaminopeptidase activity (GO:0070006),0.4400552789072679,0.9767922692242628,0.531496062992126,0.9916796276379982,1.0,5/16,18.34%,ANPEP;LNPEP;XPNPEP3;NPEPPS;MMP16
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",0.41714477523055926,0.9767488591168179,0.5232273838630807,0.9884114622737759,1.0,6/23,15.34%,SESTD1;CLVS2;WIPI2;PLEKHA4;WDR45B;PLA2G4E
prerank,voltage-gated cation channel activity (GO:0022843),0.3506426248375962,0.9764703875477287,0.5504115226337448,0.9859737424503544,1.0,20/97,19.06%,KCNMA1;KCNV1;CACNA2D2;GRIN3A;KCND1;GRIN2D;PKD2;ITGAV;HCN4;KCNA2;KCNA6;CACNG2;CACHD1;CATSPER3;KCNC2;CACNB1;GRIN2A;NCS1;KCNH2;HCN1
prerank,ubiquitin-protein transferase activity (GO:0004842),0.336768495486265,0.976228969214829,0.588,0.9832838910552063,1.0,119/346,26.48%,SH3RF3;TSPAN17;MIB2;UBE2B;UBE2J2;SMURF2;FBXW8;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RMND5B;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;ANKRD39;UBE2N;UBE2W;FBXO2;FANCL;MAGEL2;SIAH1;FBXO17;MYLIP;CUL3;DTL;UBE2G2;ASB12;HECW2;RNF10;CDC23;TRIM11;IRF2BPL;RNF7;RNF141;UBE2A;CDC34;RSPRY1;LTN1;BSPRY;FBXL3;TRAF3IP2;PEX12;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;TRAF3;RBCK1;HACE1;RNF138;PML;UBE2G1;FBXL5;FBXO11;ANAPC4;VPS11;ARIH2;UBE2R2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;FBXW2;ARIH1;RNF41;CUL5;KCTD10;RC3H2;UBE2Q2;KLHL9;SMURF1;FBXO24;UBE3A;RNF6;SEL1L;UBE2Z;FBXW11;UBR2;DTX2;RNF114;RNF123;TRIM36;RNF13;TRAF5;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;UBA7;FBXO22;RNF20;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;RNF31;MUL1
prerank,receptor tyrosine kinase binding (GO:0030971),0.36797397670496235,0.975125011177021,0.535675082327113,0.9830440365128575,1.0,16/56,23.60%,IRS1;ANGPT4;PIK3R2;SH2B1;GAS6;FLT3LG;NRG3;SQSTM1;CBL;NCK1;DOCK4;PITPNM1;RNF41;GAB2;MAP3K7;CBLB
prerank,single-stranded RNA binding (GO:0003727),0.37201984378911845,0.9744604739753889,0.5158371040723982,0.9815708285193874,1.0,22/43,34.87%,HNRNPA1;AGO2;POLR2D;POLR2G;DDX11;AQR;AGO4;U2AF2;AGO3;PTBP1;EIF4H;EXOSC10;ZFR;AGO1;SNRPC;CNBP;SRA1;FXR1;STRBP;HNRNPU;JMJD6;DDX3X
prerank,potassium channel activity (GO:0005267),0.3524006133908248,0.974200459165552,0.5422314911366006,0.9789356809918621,1.0,11/89,11.21%,KCNK5;KCNT2;KCNMA1;KCNV1;KCND1;PKD2;KCNK13;KCNK9;HCN4;KCNA2;KCNA6
prerank,endoribonuclease activity (GO:0004521),0.39549821177952366,0.9739432048097671,0.5209080047789725,0.9764194542596035,1.0,12/32,28.07%,NYNRIN;AGO2;ERN1;RCL1;ZC3H12A;SMG6;AGO3;YBEY;RNASEK;KHNYN;AGO1;CPSF3
prerank,P-type ion transporter activity (GO:0015662),0.46194096673141893,0.9723914624411002,0.5357142857142857,0.977428196558099,1.0,4/12,18.07%,ATP2B4;ATP6V1E1;ATP2A2;ATP2B1
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),0.4156299890503966,0.9689245366961444,0.5270935960591133,0.9835811279255811,1.0,5/21,25.39%,GRM1;CHRNA7;CHRFAM7A;CHRNA5;GRM5
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),0.4500829169389829,0.9683038238895506,0.5354330708661418,0.9820817977377548,1.0,5/14,24.98%,MTMR11;MTMR6;MTMR1;PTEN;MTM1
prerank,G protein-coupled receptor activity (GO:0004930),0.33552482279674917,0.9671846506464826,0.6106106106106106,0.9820418670794273,1.0,21/239,11.85%,ADGRD1;AVPR1A;VIPR2;LPAR3;PROKR2;MTNR1B;GPR12;F2R;LPAR1;GLP2R;S1PR2;ADGRG2;CRHR1;GPR20;LTB4R2;TM2D1;GPR141;GPR161;GPR45;GPR37L1;TSHR
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",0.3938400472696945,0.9650679374640003,0.5205314009661836,0.9844735336695417,1.0,9/29,20.79%,HEXD;PARG;GBA2;GLA;GAA;PGGHG;IDUA;OVGP1;GANAB
prerank,endopeptidase regulator activity (GO:0061135),-0.261811280971337,-0.9648139609280408,0.5142857142857142,0.7518479304523698,1.0,11/40,14.07%,TFPI;ITIH2;SERPIND1;USP14;RENBP;PSMF1;PSME2;PROS1;PSME1;A2M;CST3
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.3615190776693227,0.9641883651058728,0.5464362850971922,0.9837011991602704,1.0,20/60,21.17%,TIMM50;CDC14B;ILKAP;PPP5C;CTDSP2;PPM1G;PHLPP2;PPEF2;PGAM5;PPP1R3C;CTDP1;PPP3CA;MTMR6;PPP1CC;PDP2;PPP3CB;PPP1R3D;PPM1A;PTEN;PPP6C
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.34122501651514525,-0.9641496378983405,0.4646017699115044,0.745038431873188,1.0,5/14,13.76%,MAL;CASP8AP2;BCL2L13;ATP2A3;NOD1
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4358027434114021,0.9638937909007347,0.533515731874145,0.9811723381008477,1.0,2/15,5.90%,SESTD1;PLEKHF1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.3699015919269282,-0.9618828641365815,0.5227272727272727,0.7415626263148803,1.0,4/12,9.63%,PDE7B;PDE3A;PDE8B;PDE2A
prerank,mitogen-activated protein kinase binding (GO:0051019),0.3902892061790957,0.9616962384829827,0.5155502392344498,0.9838923147697295,1.0,6/29,12.00%,MAPK7;MAPK14;PTPRJ;NFATC1;ATF7;TNIP1
prerank,tau-protein kinase activity (GO:0050321),-0.30502832972541255,-0.9615727937848828,0.4930232558139535,0.734176209589293,1.0,7/20,18.67%,MARK1;DYRK1A;MARK3;TTBK1;CDK5;TAOK1;ROCK1
prerank,mRNA binding (GO:0003729),0.3344614354807364,0.961082566169921,0.6132264529058116,0.9823892364007968,1.0,84/249,26.19%,ADARB1;MRPS11;SRSF6;HDLBP;NYNRIN;RBMS3;ZFP36L1;DAZL;RBM4;CLUH;EIF4A1;SCAF8;SAMD4B;TARDBP;C1QBP;RC3H1;CARHSP1;DHX33;AUH;NSRP1;LARP4;MRPL13;NUP98;CPSF6;AGO2;TDRD7;CELF2;RBFOX2;NUDT16;SLPI;PUM1;IGF2BP1;UNK;EIF3A;LARP1;ZFP36;RPS5;AQR;ZC3H12A;THOC2;CRYZ;ZC3H11A;FYTTD1;RSL1D1;PKM;EIF3D;DDX5;FXR2;CPEB1;YTHDF1;SNIP1;YTHDF2;LUC7L3;EIF2S2;NCBP3;SLBP;SRRM3;LUC7L2;ELAVL2;NOVA1;PTBP1;SF3B1;RC3H2;EIF2A;PTBP2;YTHDF3;RBM5;TPR;EDC3;CSTF2T;EIF4G3;DAZAP1;G3BP1;KHNYN;CALR;LARP6;RBM24;CELF3;RNF20;UPF3B;DCP1A;DCP1B;RBMX;EIF4G1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.44735181663689344,0.9606009916965881,0.5305039787798409,0.9804905567691204,1.0,1/14,0.32%,TIMP2
prerank,tau protein binding (GO:0048156),0.37171460349613555,0.9574206003994766,0.5648679678530425,0.986099556097081,1.0,9/40,14.60%,DCTN1;FYN;BIN1;HDAC6;STUB1;PPP5C;TAOK2;PIN1;HSP90AA1
prerank,DNA-binding transcription factor binding (GO:0140297),0.3329658586518881,0.9569012928559825,0.5993975903614458,0.984393055683184,1.0,31/189,15.37%,PRRX1;AR;TLE6;DGKQ;BHLHE40;CRTC2;NFE2L2;HDAC9;HDAC7;MEF2D;SKI;DACT1;TCF7L2;NFATC1;PIAS3;ZFPM2;TBX6;NOC2L;BEX1;TLE2;NPM1;TCERG1;NCOR1;TWIST1;HDAC4;BBS4;DMAP1;NBN;KLF4;TTC8;DDX20
prerank,RNA methyltransferase activity (GO:0008173),0.42196685238575343,0.9559634145941748,0.5442875481386393,0.9837322721638136,1.0,4/19,12.68%,TYW3;MEPCE;FTSJ1;TGS1
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.2851281704622217,-0.9552834815836835,0.5060240963855421,0.7412388284177084,1.0,9/29,18.14%,PRKAG2;PKIG;PRKAR1B;RPTOR;PRKAR2B;SPRED2;HSPB1;INKA2;CIB1
prerank,protein serine/threonine kinase activity (GO:0004674),0.32748956181085165,0.9550939809861289,0.636,0.9827693413709997,1.0,56/334,14.38%,SYK;PRKCA;EGFR;MAPK12;EIF2AK3;RPS6KA2;CAMKK1;CDKL2;DYRK4;MAPK7;IRAK3;SGK3;SGK2;CDK14;TGFBR2;TAOK3;MAPK14;TRIO;ACVR1;CDK4;RIOK1;MTOR;CLK1;CAMK2D;PRKAB2;MAST4;PRKD2;SLK;CHUK;TESK2;CDK9;CDK20;AKT3;BMP2K;NRBP2;MAPK11;ERN1;DYRK2;SQSTM1;CSNK1G1;IRAK4;AMHR2;CSNK1G3;STK16;AKT1;MAP3K6;IRAK1;PASK;STK39;ULK2;PRKD3;TAOK2;ULK1;HIPK4;STK24;STK3
prerank,aspartic-type peptidase activity (GO:0070001),0.46620308691207524,0.9541342406729302,0.5507868383404864,0.9820898338768432,1.0,4/10,20.22%,PSEN1;NAPSA;CTSD;BACE1
prerank,SUMO binding (GO:0032183),0.446088244255761,0.9540693147916322,0.5421348314606742,0.979140857448349,1.0,7/13,29.74%,CBX4;RNF111;UBA2;PML;SIMC1;HABP4;SERBP1
prerank,RNA 7-methylguanosine cap binding (GO:0000340),-0.35971244007447367,-0.9525654129417778,0.5125448028673835,0.739029048418558,1.0,4/12,8.27%,DCPS;CYFIP2;EIF4E;GEMIN5
prerank,protein kinase binding (GO:0019901),0.3240365014553344,0.9508305819074777,0.692,0.9845027375006852,1.0,95/479,19.07%,NOX4;GHR;AVPR1A;ESR1;LAX1;NELL2;IRS1;DNM1;DCTN1;PRAM1;MAPK7;DACT3;ANK2;CKS1B;IRAK3;CAMK2N1;TNNI3;ADAM9;LLGL1;HDAC9;HDAC7;SKI;PKD1;AXIN1;ACVR1;DACT1;DACT2;MAP2K3;TCF7L2;FAM83G;PTPRJ;PRKAB2;CSK;RBBP6;AP2A2;MAPRE3;TRIP4;BICD1;BANK1;YWHAG;STX1B;CLTC;SLC12A4;PRKD2;PARD6A;SRCIN1;TIRAP;IQGAP1;GSKIP;KAT2B;ITGAV;SIRPA;SQSTM1;NPM1;MAPRE1;IRAK4;ATF7;MAPT;IRAK1;PPEF2;FBXO5;TNIP1;CALM2;ZFP36;SMCR8;TAOK2;CDKN1A;PIN1;CCND1;RHOA;PDE3B;HSP90AA1;TUBA4A;VDAC1;RND3;TRIM68;CDK5RAP2;NSF;RAC3;CAVIN3;KIZ;NBR1;PPP1CC;RNF138;UFL1;RCC2;SNAP91;QARS1;ILK;DOK7;STK38;ATG13;TOP2B;PRKAR2A;IBTK
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.3996430601405663,0.9501116681114264,0.5707376058041113,0.9831636221546143,1.0,8/27,15.89%,SLC4A8;SLC9A9;SLC9A1;SLC23A1;SLC8A2;CNNM4;SLC9A7;SLC9A6
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4200233953890617,0.9491904531006121,0.5448798988621998,0.9824575282408472,1.0,8/17,31.01%,NME2;CMPK2;NME1;AK8;AK9;NME6;AK3;AK5
prerank,N-methyltransferase activity (GO:0008170),0.41373039153939417,0.9482792849855729,0.5510204081632653,0.9816975508380408,1.0,7/20,22.64%,DIMT1;FDXACB1;ZCCHC4;TRMT1;TRMT11;N6AMT1;RNMT
prerank,ephrin receptor activity (GO:0005003),0.42527486395205283,0.9472651236418697,0.562992125984252,0.9781644452308699,1.0,4/17,11.73%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,transmembrane-ephrin receptor activity (GO:0005005),0.42527486395205283,0.9472651236418697,0.562992125984252,0.9781644452308699,1.0,4/17,11.73%,EPHB2;EPHA3;EPHB3;EPHA10
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),0.40937432570460486,0.9448678758347124,0.5600991325898389,0.9812479607379168,1.0,4/20,14.80%,DESI2;COPS5;USP50;USP7
prerank,actin binding (GO:0003779),0.33151763112750515,0.9446751204681806,0.6124497991967871,0.9787468257518994,1.0,49/170,22.60%,DBN1;GSN;KCNMA1;CORO2B;SCIN;MAP1B;ANG;TNNI3;COBL;ABLIM1;MSRB1;FHDC1;PDLIM7;SYNE1;FSCN1;PFN2;ABL2;MYO9B;FXYD5;NCALD;TWF1;SSH1;AVIL;MICAL2;MAPT;PDLIM1;FLNB;ADCY8;MOBP;GIPC1;CAP1;ARPC1A;EPS8L2;CORO7;CXCR4;COTL1;MICAL1;ALDOA;TNNC2;PDLIM2;GC;MAP1A;FMN2;ABITRAM;SSH3;SPTBN4;MAP1S;CCDC88A;MYO1F
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.3781151631317149,-0.9443078985265642,0.48936170212765956,0.7501911165050581,1.0,2/10,7.69%,MECOM;PRDM16
prerank,neurexin family protein binding (GO:0042043),0.4621659186696369,0.9432954942327875,0.566145092460882,0.9794144052641413,1.0,2/10,9.17%,CEL;SYTL5
prerank,pyrophosphatase activity (GO:0016462),0.35325377113099415,0.9389073963720697,0.5698689956331878,0.9873048598319906,1.0,20/50,29.07%,ENTPD2;NUDT1;NUDT7;PLPP5;PLPP1;NUDT16L1;NUDT16;ATCAY;NUDT6;NUDT5;PRUNE2;ENTPD6;CILP;LHPP;DHX29;PPA1;ITPA;ADPRM;PPA2;BNIP2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.4027525608400867,0.9380692194491643,0.5658536585365853,0.9863391814239709,1.0,6/22,16.97%,RBMS3;ZFP36L1;ZFP36L2;ZFP36;ZC3H12A;CPEB1
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.45210116062708905,0.9356259524370983,0.5881561238223418,0.9892641928824968,1.0,2/12,10.59%,B3GALNT1;B3GNT8
prerank,delayed rectifier potassium channel activity (GO:0005251),-0.2646601194157058,-0.9353761644010931,0.5714285714285714,0.7620561717066944,1.0,6/32,10.39%,KCNB1;KCNB2;KCNS3;KCNQ5;KCNA1;KCNQ1
prerank,kinase binding (GO:0019900),0.3181579807761074,0.932554016027605,0.738,0.9937588892978079,1.0,102/434,22.29%,GHR;GSN;ESR1;LAX1;EGFR;DNM1;DCTN1;PRAM1;ANK2;DGKQ;CKS1B;PDE8A;IRAK3;TNS2;CAMK2N1;TNNI3;STX1A;LLGL1;DLG4;HDAC7;ATF5;CD160;ATP1A4;SKI;PKD1;AXIN1;MIDN;MAP2K3;TCF7L2;FAM83G;PTPRJ;TTC28;PRKAB2;RBBP6;DLG2;AP2A2;MAPRE3;CARD16;TRIP4;SRC;BICD1;STX1B;STUB1;CLTC;STRADA;SLC12A4;SRCIN1;IQGAP1;GSKIP;KAT2B;SQSTM1;NPM1;MAPRE1;IRAK4;MAPT;IRAK1;FBXO5;PIK3IP1;CALM2;ZFP36;SMCR8;CDKN1A;CCND1;RHOA;TUBA4A;VDAC1;CHP1;RND3;TRIM68;CDK5RAP2;NSF;PER1;RAC3;KIZ;PPP1CC;RNF138;UFL1;TAX1BP1;RCC2;SNAP91;QARS1;ILK;DOK7;ATG13;IBTK;CIT;TOLLIP;IL31RA;OXSR1;FLNA;TIAM1;LYST;MOB1B;CAB39;CDKN2C;NISCH;BTG1;SIKE1;DCTN2;ATF4;DCX;STK11IP
prerank,MAP kinase kinase activity (GO:0004708),0.42582042741999276,0.9309900617588474,0.5802968960863698,0.994668515163982,1.0,4/15,18.54%,MAPK14;MAP2K3;MAP2K2;MAP2K4
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),-0.35804584690460806,-0.9304505858341809,0.522633744855967,0.7654097512464002,1.0,3/12,7.03%,KDM7A;KDM4A;PHF2
prerank,NADPH binding (GO:0070402),-0.34182233736804035,-0.9297122749244282,0.5061728395061729,0.759050474095327,1.0,9/13,28.61%,HMGCR;QDPR;CBR4;NDOR1;LBR;DECR1;CBR3;GRHPR;KCNAB1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),0.4196112688800938,0.9294151117152629,0.556,0.9953709813354928,1.0,2/15,5.46%,PIK3R2;SOCS2
prerank,ubiquitin binding (GO:0043130),0.3389872439516685,0.9292050787740398,0.630457933972311,0.9929023070837202,1.0,21/73,21.83%,UCHL1;CKS1B;RAD23B;MVB12A;UBE2N;ADRM1;SIRT2;USP33;SQSTM1;DNAJB2;USP5;ILRUN;RBCK1;NBR1;CXCR4;AUP1;UBAP1;TOLLIP;VPS36;USP13;UBXN11
prerank,syntaxin binding (GO:0019905),0.3428028645483074,0.9280343399181458,0.6172707889125799,0.9926624555968763,1.0,25/61,27.18%,SYT2;SYT12;SCFD2;VPS52;VAMP1;ABCA1;SCFD1;SNAP23;NAPA;SNAP25;SNAP47;NSF;NAPG;SNPH;SYT1;VPS11;VAMP2;NAPB;STX16;STXBP5L;BAIAP3;STX7;SYT6;STXBP4;VAMP3
prerank,sodium:proton antiporter activity (GO:0015385),0.45093944604533837,0.9263136872673363,0.5767634854771784,0.9938496074790718,1.0,4/11,15.89%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,nuclear receptor coactivator activity (GO:0030374),0.3490228490394255,0.9262380276627737,0.6021276595744681,0.991105653683327,1.0,17/52,23.80%,ZMIZ1;FGF2;SFR1;NCOA3;WDR77;ATXN7L3;MED24;HELZ2;SLC30A9;DCAF6;MED13;USP22;THRAP3;CARM1;TMF1;NCOA2;NCOA6
prerank,ATP hydrolysis activity (GO:0140603),0.3581335995845148,0.9228777197643433,0.6122222222222222,0.9958053995369793,1.0,12/41,20.66%,VPS4B;ABCG4;CLPX;TOR1A;KIF20B;DNA2;DDX4;HSP90AA1;CHD3;ATP2B1;ATAD1;ABCB10
prerank,solute:anion antiporter activity (GO:0140323),0.42067824239576,0.9225497488878973,0.5656836461126006,0.9936021043485848,1.0,4/14,11.33%,SLC26A5;SLC26A11;SLC4A3;SLC26A6
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.3222787567388849,0.9224450197133187,0.67472306143001,0.9908744495067927,1.0,31/181,15.05%,PRRX1;AR;BHLHE40;NFE2L2;MAPK14;DACT1;TCF7L2;NFATC1;TACC2;PIAS3;NCOA3;TRIP4;ZFPM2;TBX6;MDFIC;BEX1;HDAC3;NPM1;TCERG1;JUP;NCOR2;NCOR1;COMMD6;HDAC4;BBS4;DMAP1;KLF4;CTDP1;BCAS3;TTC8;SMARCA4
prerank,hexosaminidase activity (GO:0015929),-0.35187197338590503,-0.9224409070664359,0.5454545454545454,0.7681553426227486,1.0,2/12,3.15%,CEMIP;CEMIP2
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),0.42507234839836083,0.9215737211200085,0.5811170212765957,0.9900192379884758,1.0,6/15,20.13%,CXXC1;WDR5;PRDM9;KMT2C;SETD1B;KMT2A
prerank,single-stranded DNA binding (GO:0003697),0.3306134317817325,0.9213997902439258,0.6427829698857737,0.9875000071282869,1.0,19/93,18.32%,POLR2H;HNRNPA1;CTC1;RAD51B;RAD23B;IGHMBP2;HMCES;SAMHD1;MCM3;MAPT;ERCC4;POLR2D;POLR2G;SMC6;DDX11;FAM111A;RNF138;ERCC5;BLM
prerank,histone methyltransferase activity (GO:0042054),0.37901569880513597,0.9212588027286056,0.6047835990888383,0.9849436837153314,1.0,15/32,28.91%,PRMT2;NTMT1;SETD7;SETD2;EHMT2;PRDM9;KMT2C;N6AMT1;CARM1;EZH2;SETDB1;KMT5A;MEN1;SUV39H1;PRMT8
prerank,GTP binding (GO:0005525),0.32135469552717855,0.920096694432342,0.6867469879518072,0.9846787841204431,1.0,55/172,27.93%,RAB32;RAB6A;GTPBP4;RAP1B;ARF4;SCG5;RIT2;DYNC1LI1;RHOJ;ARF1;RHOQ;TUBB6;RAB2A;NRAS;KRAS;GTPBP10;NUDT16;RRAD;TUBD1;RHOA;RRAGD;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;GLUD1;RND3;RAC3;RAB35;NME1;RAB1B;RRAS2;PIP4K2B;RALA;RAB10;ADSS2;TUBG2;RABL3;ARL8A;NOA1;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;RND2;RAP1A;DIRAS2;TUBB2A;RHEBL1;TSR1;RAP2B
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.3461376636799438,0.92001593821651,0.6075388026607539,0.9819766414060954,1.0,6/53,5.23%,SLC1A5;SLC1A7;SLC7A6;SLC1A6;SLC47A1;SLC43A2
prerank,rRNA binding (GO:0019843),0.36117040296180075,0.9190887563176675,0.6184649610678532,0.9813051753685447,1.0,10/42,19.51%,MRPS11;ANG;MRPS27;DDX21;SBDS;RPS5;NOP53;RCC1L;RPF2;RPL23
prerank,CARD domain binding (GO:0050700),-0.3213277879251466,-0.9170039541489821,0.6083650190114068,0.772074363679885,1.0,9/14,27.66%,CASP4;MAVS;NOD1;CARD19;IRGM;NOD2;RIPK2;CASP1;CARD14
prerank,protein kinase regulator activity (GO:0019887),0.3268297297383728,0.9154867856011204,0.6466942148760331,0.9868159870984238,1.0,23/95,19.27%,CCNL2;FGF13;TAOK3;PPP1R1B;CXCL10;GPRC5D;STRADA;GSKIP;ELP4;NPM1;KIDINS220;CCNC;SMCR8;CDKN1A;CCND1;CCNH;CCNQ;MADD;NCK1;QARS1;GMFB;PRKAR2A;DUS2
prerank,sodium channel activity (GO:0005272),0.3634629707249028,0.9154712628340935,0.6047565118912798,0.9840118644341521,1.0,12/37,26.21%,SCNN1B;PKD2;HCN4;ASIC2;SCN4B;HCN1;ASIC1;SCN9A;GRIK5;GRIK2;GRIK4;SCN2A
prerank,nucleoside-diphosphatase activity (GO:0017110),0.441213138780727,0.9142679671936199,0.5805142083897158,0.9838751178797435,1.0,4/12,18.58%,ENTPD2;NUDT5;CANT1;ENTPD6
prerank,voltage-gated anion channel activity (GO:0008308),-0.3271142069860903,-0.914056653808234,0.5789473684210527,0.7709404005109679,1.0,6/15,17.09%,VDAC3;ANO1;CLCN2;GPR89B;GPR89A;CLCN1
prerank,voltage-gated potassium channel activity (GO:0005249),0.3322708577007884,0.912134342979428,0.6510416666666666,0.9858157147421044,1.0,11/80,14.62%,KCNT2;KCNMA1;KCNV1;KCNJ2;KCND1;PKD2;HCN4;KCNA2;KCNA6;KCNJ3;KCNC2
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.36800779477128054,-0.9099748010096412,0.5687732342007435,0.7723234191147136,1.0,3/10,12.86%,LACC1;ADARB2;APOBEC1
prerank,cation:chloride symporter activity (GO:0015377),-0.3650780832491387,-0.9099112598942212,0.5910652920962199,0.7649808389347269,1.0,3/10,3.01%,SLC12A7;SLC12A2;SLC6A1
prerank,ubiquitin protein ligase binding (GO:0031625),0.3132329124870551,0.9081418314363627,0.73,0.9919877566173109,1.0,75/253,28.17%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;FOXO1;SCAMP3;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;TRAF5;BAG5;RELA;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,microtubule motor activity (GO:0003777),0.3426550972779842,0.9064965918745584,0.627906976744186,0.9927103310966694,1.0,14/51,21.55%,KIFC2;KIF21B;STARD9;DNAH8;DYNC1I1;KIF2A;KIF20B;KIF3A;KIF21A;KIF3B;CENPE;KIFC3;KIF26B;DYNLRB1
prerank,small GTPase binding (GO:0031267),0.31739216676273674,0.9062428070852799,0.7078313253012049,0.9904104414796935,1.0,40/169,17.80%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;ULK1;TRIOBP;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5
prerank,nuclease activity (GO:0004518),0.34781961507601034,0.90562704874181,0.6329670329670329,0.9890245721799681,1.0,16/52,25.16%,DIS3L2;ANG;RNASE4;N4BP2;SAMHD1;RNASE6;DNA2;ZC3H12A;DNASE1L2;NME1;ERCC5;OGG1;MAP1S;DFFB;DNASE1L1;RNASE1
prerank,N-acyltransferase activity (GO:0016410),0.36190168847312576,0.9052387743516339,0.6100702576112412,0.9871180358195306,1.0,7/32,18.80%,CERS6;PLAAT1;GNPNAT1;NAT8;PLA2G4E;SAT1;NAA50
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3114149577382772,0.90443813735585,0.747,0.9860737746613326,1.0,79/268,28.17%,MID1;EGFR;UCHL1;GLMN;UBE2B;UBE2J2;SKI;SYT11;AXIN1;ITCH;FOXO1;SCAMP3;TRIP4;SMAD5;HDAC6;STUB1;UBE2N;UBE2W;YWHAE;FANCL;CUL3;SMAD6;SQSTM1;UBE2A;UBA52;XRCC5;CDKN1A;FHIT;SMC6;GPR37;TNFRSF1B;TRIOBP;HSP90AA1;USP7;FZD4;BAG4;DIO2;ACTG1;TRAF3;PER1;BLZF1;PML;CXCR4;UBE2G1;AUP1;KCNH2;NEDD8;PRKAR2A;RPL23;ARIH1;CUL5;RALA;JKAMP;ARRB1;USP13;JUN;TRAF4;DERL1;STAT2;TRAF5;BAG5;RELA;STAM;RTN4;ACVR1B;MDM2;CALR;RNF20;FBXW7;UBE2K;RNF31;MUL1;EIF4E2;SMG5;BCL10;DNAJA1;CASP8;LAPTM5;NPLOC4
prerank,calcium channel regulator activity (GO:0005246),0.36116882651184995,0.9024991543506798,0.6349384098544233,0.9875689770686565,1.0,9/37,14.85%,SGK3;TNNI3;SRI;STIMATE;YWHAE;MCUB;RRAD;CALM2;GEM
prerank,UDP-galactosyltransferase activity (GO:0035250),0.44772045902970564,0.902296068481489,0.6168091168091168,0.9852329547089224,1.0,1/10,2.22%,B4GALT1
prerank,GTPase inhibitor activity (GO:0005095),-0.3425906718479407,-0.9021308777987767,0.5814814814814815,0.7736834756243517,1.0,6/13,10.44%,TNK2;IQGAP2;CPEB2;CDC42SE1;ARL2;RHOH
prerank,tRNA binding (GO:0000049),0.3464997112751039,0.9001247409118189,0.6384872080088988,0.9870054524752523,1.0,14/43,21.88%,IGHMBP2;DALRD3;MRPS27;YRDC;SARS2;PSTK;ELP1;TRMT10B;TYW5;AIMP1;PTCD1;XPOT;NEMF;EIF2A
prerank,GTPase binding (GO:0051020),0.3137815028579782,0.899648120886844,0.7382146439317954,0.9853368054733134,1.0,65/194,25.80%,SGSM2;AKAP13;RABGGTA;PLCE1;RABGAP1L;CDC42EP2;RADIL;DOCK7;WASF1;BICD1;ABCA1;FMNL1;MYO5A;MYO9B;MYCBP2;PARD6A;OCRL;HPS4;IQGAP1;GGA1;USP33;DMXL2;ATP6AP1;KIF3A;HPS6;KIF3B;TMEM127;RRAGD;GNB1;ULK1;TRIOBP;HSP90AA1;CCDC186;GGA2;GOLGA4;EVI5;SGSM1;SPTBN1;PEX5L;HACE1;ANKRD27;EVI5L;RCC2;SRGAP2;PEX5;EPRS1;AIMP1;EXOC4;DOCK4;RASA1;FLNA;RNF41;ATG16L1;SIKE1;LZTR1;ANKFY1;ATG14;RAB11FIP3;PDE6D;ALS2;TSC2;RABGGTB;RAB29;CYFIP1;MAPKAP1
prerank,outward rectifier potassium channel activity (GO:0015271),0.4430528674567497,0.8994283861788527,0.6049046321525886,0.983111241733009,1.0,3/11,7.86%,KCNT2;KCND1;PKD2
prerank,intracellular chloride channel activity (GO:0061778),0.4047219155567829,0.8992443779114533,0.6050531914893617,0.9780523404163468,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.4047219155567829,0.8992443779114533,0.6050531914893617,0.9780523404163468,1.0,3/16,17.36%,ANO3;TTYH3;ANO5
prerank,protein phosphatase 2A binding (GO:0051721),-0.27848301435035006,-0.8988425258246495,0.5885167464114832,0.7733003537328119,1.0,5/23,4.14%,CTTNBP2NL;STRN3;DAB2IP;STRN;BOD1L1
prerank,aspartic-type endopeptidase activity (GO:0004190),0.4219752844836703,0.8983848901815339,0.6062246278755075,0.9771645715622045,1.0,4/12,20.22%,PSEN1;SPPL2B;NAPSA;BACE1
prerank,alpha-tubulin binding (GO:0043014),0.3622481317818593,0.8955125552237438,0.6247058823529412,0.98055851594443,1.0,7/31,14.55%,FYN;DLEC1;HDAC6;TBCEL;SETD2;BBS4;INO80
prerank,zinc ion transmembrane transporter activity (GO:0005385),0.3872587605857571,0.89500742292483,0.6055276381909548,0.9789646366740278,1.0,5/20,19.98%,SLC39A13;SLC39A14;SLC39A7;SLC30A5;SLC39A3
prerank,thioesterase binding (GO:0031996),0.4338320321211491,0.8941480674426119,0.6127247579529738,0.9780493676389941,1.0,6/11,30.46%,ARF6;TRAF3;TRAF4;TRAF5;RAC1;TRAF6
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.36680961832921444,0.8921810474794912,0.6359163591635917,0.9792372181063386,1.0,6/28,18.54%,RPS6KA2;MAPK14;MAP2K3;AKT1;MAP2K2;MAP2K4
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.3086435431064291,0.8896717630838559,0.7615230460921844,0.9818367561053032,1.0,79/232,26.48%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;CBX4;RNF121;PIAS3;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;UFL1;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;NSMCE2;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;RNF167;PRPF19;MUL1
prerank,Hsp90 protein binding (GO:0051879),0.3563781962198087,0.8879311139243686,0.6498829039812647,0.9827624032953607,1.0,16/33,30.69%,HDAC6;STUB1;PPP5C;ERN1;MAPT;PPEF2;CHORDC1;AHSA1;USP19;NR3C1;TSC2;UNC45A;TSC1;HDAC8;HSF1;TELO2
prerank,nuclear receptor binding (GO:0016922),0.31596493246958585,0.8869505427721355,0.7054582904222451,0.9821847471952657,1.0,41/111,27.20%,ESR1;FOXP1;TCF7L2;TACC2;PRMT2;NCOA3;TRIP4;GAS2L1;MED24;JUP;NCOR2;MED13;NCOR1;DCAF13;BCAS3;SMARCA4;RNF14;TRIM68;STAT5B;DDX5;PADI2;NRIP1;JMJD1C;NSD1;THRAP3;TMF1;RNF6;BAZ2A;NCOA2;KDM4C;NCOA6;LATS1;LCOR;CALR;ASXL1;KDM3A;BRD8;PRPF6;GRIP1;ARID1A;MMS19
prerank,ephrin receptor binding (GO:0046875),0.3797135573468168,0.8849920660359599,0.6275,0.9836804072283722,1.0,4/21,6.81%,EFNA5;FYN;ANKS1B;SRC
prerank,cytochrome-c oxidase activity (GO:0004129),-0.31399466661120173,-0.8848898090632669,0.6468253968253969,0.7948728564137846,1.0,11/15,43.92%,COX4I1;NDUFA4;COX5A;NDUFA4L2;COX4I2;COX6B1;COX6A1;COX7A1;COX5B;COX6A2;COX8A
prerank,hyaluronic acid binding (GO:0005540),0.4353465969406155,0.8830613051785753,0.6316507503410641,0.9848609774953329,1.0,2/10,6.64%,CD44;C1QBP
prerank,fatty acid synthase activity (GO:0004312),-0.35855115621895006,-0.8825436873570601,0.5980707395498392,0.7923403709533934,1.0,5/10,18.84%,ELOVL7;CBR4;ELOVL1;ELOVL4;OXSM
prerank,phosphatase activity (GO:0016791),0.32357110865655464,0.8824854708354807,0.6811902231668437,0.9833504656581528,1.0,23/73,23.48%,PLPP3;ACP2;PTPRJ;PLPP5;PLPP1;NT5M;BPNT2;OCRL;PPP5C;DUSP11;NUDT16L1;INPP5K;NUDT16;PGAM5;PLPPR3;PHOSPHO2;PPP1CC;PLPP2;ACP3;LPIN3;CILP;ACP6;LHPP
prerank,phosphoric diester hydrolase activity (GO:0008081),0.3519417747377468,0.8821820136718499,0.6462264150943396,0.9813556949030865,1.0,9/35,20.38%,SMPD3;PLCE1;PLCB4;PDE11A;MPPE1;PDIA3;SMPD1;GPLD1;GDPD3
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.3148377110071563,0.8819156499386834,0.6981327800829875,0.9793951950784026,1.0,24/100,19.62%,NCF4;SESTD1;GAP43;MYO10;PLEKHF1;ATG2B;CLVS2;ARHGAP9;IQGAP1;WIPI2;PLEKHA4;WDR45B;PLEKHB2;SNX21;AKT1;MAPT;ATG2A;DENND1A;PLA2G4E;OGT;ARAP1;ANXA8;BBS5;CLVS1
prerank,phosphatidic acid binding (GO:0070300),0.38466592472531436,0.8812688856609946,0.6344221105527639,0.9781522024908139,1.0,2/19,1.06%,SESTD1;SMPD3
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.34907194470640385,0.88087980837597,0.6449359720605355,0.97631768698127,1.0,16/35,29.85%,FOXP1;AGO2;NPM1;UBTF;DR1;SMARCA4;RRN3;BAZ2A;TBP;NR3C1;RELA;KLF10;SNAPC3;AGO1;TP53;FOS
prerank,PDZ domain binding (GO:0030165),0.32375940671665776,0.8718558994434783,0.6786492374727668,0.9915657538847739,1.0,22/61,21.82%,CCDC88C;DLG4;ATP2B4;GNG12;FZD7;PSEN1;SLC26A6;TBC1D10A;KIDINS220;PLEKHA1;CRIPT;FZD4;MAP2K2;ACOX1;NSF;SDC2;ATP2B1;SNTG2;CIT;DOCK4;PTEN;SRR
prerank,transmitter-gated ion channel activity (GO:0022824),0.3545562183160601,0.8715415324371136,0.652989449003517,0.9896223886186661,1.0,13/29,30.13%,GRIN2D;GRIA2;GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GLRA3;GABRA3;GRID2;GABRA1;GLRA2
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.4198334122286258,0.8706333993091716,0.6546463245492372,0.9886868808576322,1.0,4/12,15.89%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,ion channel activity (GO:0005216),0.31805846819160766,0.8702546475732734,0.6923076923076923,0.9867897019616764,1.0,23/80,25.89%,PIEZO2;TRPV3;GRIN3A;TMEM63A;GRIN2D;PKD2;GRIA2;CNGB1;MCUB;TMEM120A;CALHM2;GRID1;GRIN2A;CHRNA7;TMC3;CHRNA5;GRIA3;GRIK5;GRIK2;TRPC1;GRIK4;ANXA6;TRPV2
prerank,acyl-CoA hydrolase activity (GO:0047617),0.3876733072822479,0.8701778991592057,0.6397919375812744,0.9843276337183253,1.0,3/17,14.26%,ACOT6;ACOT9;ACOT1
prerank,transcription cis-regulatory region binding (GO:0000976),0.30002040258993296,0.869160014899613,0.876,0.983737217554026,1.0,61/406,16.80%,LMX1A;AR;LHX8;TRPS1;BNC2;WT1;SCRT2;HSF2;PBX1;FOXP1;GLIS2;RUNX1;SMAD4;NFE2L2;ZNF25;ATF5;LMX1B;MEF2D;SOX10;FOXK2;JUND;TCF7L2;RBAK;CREB3L1;NR1D1;CREBZF;MTF1;FOXC2;AGO2;SOX5;SMAD6;RNF10;SATB2;BRD7;ZNF3;NPM1;MZF1;CEBPB;GLI3;XRCC5;DR1;ATF1;PEG3;NCOR1;IKZF5;TWIST1;SIX1;HDAC4;RFX5;PLAGL1;KLF4;MLXIP;NR2C2;E2F3;CDK5RAP2;ZBTB5;PER1;SNAI2;CHD3;E4F1;TFAP4
prerank,protein kinase activator activity (GO:0030295),0.32268643380768197,0.8654485209645734,0.6984978540772532,0.9883014601784904,1.0,13/60,15.91%,FGF13;ETAA1;GPRC5D;GAS6;STRADA;ABI1;IQGAP1;CALM2;CDKN1A;DBF4;STK3;MAP2K2;MADD
prerank,carboxylic acid binding (GO:0031406),0.3322036713031339,0.8578167458130743,0.7105263157894737,0.9998523529964122,1.0,10/38,22.64%,GCLC;GRIN3A;SESN3;GLUD1;EPDR1;GLDC;CASTOR2;SRR;SESN2;UBR2
prerank,ubiquitin protein ligase activity (GO:0061630),0.2978361339414233,0.8565308083653026,0.8168168168168168,0.9997798657944346,1.0,76/228,26.48%,SH3RF3;SMURF2;NEURL4;SYVN1;TRIM71;ITCH;RFWD3;RNF121;RBBP6;MSL2;COP1;RNF111;RC3H1;PELI3;STUB1;RNF2;MYCBP2;FBXO2;FANCL;SIAH1;FBXO17;MYLIP;CUL3;ASB12;HECW2;RNF10;TRIM11;IRF2BPL;RNF7;LTN1;BSPRY;TRAF3IP2;CBL;UBR4;AMFR;RNF128;UHRF2;RNF216;RNF14;TRIM68;RNF187;HACE1;RNF138;VPS11;ARIH2;RNF19A;RING1;UBE3C;MEX3C;LRSAM1;BRAP;UBE2D3;TRIM35;ARIH1;RNF41;RC3H2;SMURF1;UBE3A;RNF6;UBR2;DTX2;RNF114;RNF13;CBLB;TRIM24;RNF157;MKRN2;TRIM44;MDM2;RNF166;ZNRF2;RNF126;UBE2K;RNF167;PRPF19;MUL1
prerank,hydro-lyase activity (GO:0016836),0.3343352003675535,0.8555783801108446,0.6832018038331454,0.998929174518484,1.0,6/41,15.32%,EHHADH;CYP2S1;AUH;ACO2;CDYL;HACD3
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.29978135933463623,0.8528083930845853,0.8034274193548387,1.0,1.0,36/188,18.75%,AR;BNC2;WT1;PBX1;GLIS2;RUNX1;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;JUND;TCF7L2;CREB3L1;NR1D1;CREBZF;FOXC2;SOX5;SMAD6;RNF10;BRD7;MZF1;CEBPB;XRCC5;NCOR1;SIX1;HDAC4;KLF4;CDK5RAP2;PER1;CHD3;TFAP4;ZBED4;CTCF;KCNH2;PRDM9
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2581727039588818,-0.8513221154308083,0.6815642458100558,0.8483229459412337,1.0,8/27,14.61%,SIAH2;PPARA;UBE3D;RNF144B;DCUN1D4;RNF180;DCUN1D3;SIAH3
prerank,MAP kinase kinase kinase activity (GO:0004709),0.4195749686504887,0.8512917208135387,0.6652719665271967,1.0,1.0,3/11,12.81%,EGFR;MAP3K6;TAOK2
prerank,Tat protein binding (GO:0030957),0.4229576670400717,0.8509253029133876,0.6596045197740112,0.9997360153355698,1.0,4/10,15.05%,MDFIC;NPM1;CTDP1;SMARCA4
prerank,NADP binding (GO:0050661),-0.2478349145951211,-0.849607954885392,0.7445255474452555,0.8439536870368648,1.0,16/32,22.17%,GMDS;DPYD;NOS3;HMGCR;QDPR;CBR4;NOS1;SPR;NDOR1;CRYZL1;DHCR7;LBR;DECR1;CBR3;TM7SF2;HSD11B1
prerank,potassium ion antiporter activity (GO:0022821),-0.30682171105541045,-0.8494117968627437,0.6755555555555556,0.8366410131797509,1.0,2/15,2.49%,SLC24A3;SLC9A2
prerank,ATPase regulator activity (GO:0060590),0.3334663900054761,0.8484062424599799,0.6786922209695603,1.0,1.0,14/38,29.78%,TOR1AIP2;DNAJA2;GRPEL2;DNAJB2;BAG4;AHSA1;DNAJB1;BAG3;BAG5;HSPH1;TSC1;DNAJA1;FNIP1;DNAJC1
prerank,steroid hydroxylase activity (GO:0008395),0.3832751680179979,0.8480778185334819,0.66005291005291,0.999777223722059,1.0,1/16,1.39%,CYP2S1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3589925923512931,0.8478314063040038,0.6868932038834952,0.9977068063717456,1.0,11/24,29.99%,ZDHHC7;ZDHHC2;ZDHHC4;ZDHHC24;ZDHHC21;ZDHHC20;ZDHHC18;ZDHHC8;YKT6;ZDHHC15;GOLGA7B
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.31312758411976954,0.8437731845100537,0.724622030237581,1.0,1.0,14/54,20.08%,HDAC9;HDAC6;SIRT2;HDAC3;GLS2;GLS;NIT2;HDAC4;NGLY1;NTAN1;ASRGL1;SUDS3;NIT1;MIER1
prerank,actin monomer binding (GO:0003785),0.360837630531375,0.8436285122529251,0.6757425742574258,1.0,1.0,4/22,10.26%,COBL;PFN2;ABL2;TWF1
prerank,calcium channel inhibitor activity (GO:0019855),-0.3225368681302313,-0.8413822174844047,0.656934306569343,0.8437543264160994,1.0,1/11,0.06%,ITPR1
prerank,metal ion:proton antiporter activity (GO:0051139),0.3974311547180297,0.8409081475801422,0.7014925373134329,1.0,1.0,4/13,15.89%,SLC9A9;SLC9A1;SLC9A7;SLC9A6
prerank,mRNA methyltransferase activity (GO:0008174),0.40349549922248606,0.84045587097687,0.6828609986504723,1.0,1.0,4/12,22.64%,TRMT61A;CMTR2;PCIF1;RNMT
prerank,lipoprotein particle receptor binding (GO:0070325),0.3510219854182036,0.8402131636897583,0.6943069306930693,0.9987899882675704,1.0,7/27,27.79%,LRP1;CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.33333454093817483,0.8385596428085367,0.6982658959537572,0.9992210315241317,1.0,2/32,5.23%,SLC1A5;SLC43A2
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),0.419690876269477,0.8380206884798187,0.671830985915493,0.9976362631923207,1.0,4/10,21.58%,SETD2;SETD5;PRDM9;NSD1
prerank,peptide N-acetyltransferase activity (GO:0034212),0.41365458838189123,0.8375827792067659,0.6907801418439716,0.9959341662108628,1.0,4/10,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,chloride channel inhibitor activity (GO:0019869),0.41778470944938867,0.8369085737113604,0.6905766526019691,0.994634896477712,1.0,7/10,34.05%,STX1A;WNK2;STX7;CFTR;STX8;VAMP8;WNK3
prerank,peptide hormone receptor binding (GO:0051428),0.4010612332621806,0.8361961785513594,0.6703755215577191,0.9933982719541038,1.0,1/11,7.34%,ADCYAP1
prerank,organic anion transmembrane transporter activity (GO:0008514),0.29326668597101435,0.8356303734103603,0.8113590263691683,0.9918606683356476,1.0,20/134,14.88%,SLCO2A1;SLC1A5;SLC25A21;SLC1A7;SLC26A5;SLC4A8;SLC25A25;SLC4A3;SLC6A8;SLC35B1;SLC26A6;SLC35D1;SLC2A10;SFXN1;SLC7A3;ABCC1;SLC23A1;SLC23A2;SLC15A4;SLC25A17
prerank,cysteine-type peptidase activity (GO:0008234),0.30685976105199697,0.8346020500337087,0.7610993657505285,0.991225373079929,1.0,13/73,15.83%,UCHL1;CAPN2;USP36;USP10;USP29;USP26;USP33;OTUD7B;USP48;USP50;USP5;USP7;PDIA3
prerank,poly(U) RNA binding (GO:0008266),0.365615806196643,0.8342471373701656,0.7066167290886392,0.9893660040088474,1.0,3/20,10.63%,DIS3L2;RBMS3;HNRNPH1
prerank,anion channel activity (GO:0005253),0.3106061109332078,0.8332336020027225,0.745119305856833,0.988589960660249,1.0,11/61,19.27%,ANO3;LRRC8D;CLCN5;GABRR3;VDAC2;CLCC1;GABRG3;TTYH3;VDAC1;ANO5;GABRG2
prerank,magnesium ion binding (GO:0000287),0.29254254924322204,0.8327237058328726,0.8099593495934959,0.9869585459477691,1.0,44/135,28.99%,GCLC;MAPK12;DIS3L2;IRAK3;FOXK2;MVK;IDH1;EYA2;ABL2;UBA2;ERN1;DYRK2;MAP3K6;NUDT16;CERK;FAN1;STK3;GEM;NUDT5;NME1;ADPRH;STK38;RP2;IDH3G;OXSR1;STK26;XYLT2;SRPK1;SRR;PI4K2A;MTHFD2;ADCY2;LATS1;MARK2;XXYLT1;MAST2;PLSCR3;PPA1;MSH6;PSPH;DUT;PGP;HMGCL;PPA2
prerank,thyroid hormone receptor binding (GO:0046966),0.3440110916188715,0.8325212663893843,0.7066356228172294,0.9849137939418229,1.0,10/28,23.80%,PRMT2;NCOA3;GAS2L1;MED24;MED13;NCOR1;JMJD1C;NSD1;THRAP3;NCOA6
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),0.3408780672497922,0.8312943995457598,0.7120481927710843,0.9846370179631578,1.0,11/28,30.04%,GABRG3;GRID1;CHRNA7;CHRNA5;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,3'-5' exonuclease activity (GO:0008408),0.3217258861414112,0.8299215224978609,0.7273755656108597,0.9845843980548528,1.0,6/45,12.48%,REV3L;DIS3L2;ERI3;EXOSC7;RAD1;REXO2
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.39922129601715767,0.8281255348077293,0.7016806722689075,0.9851749390404128,1.0,4/11,23.22%,NAA15;NAA50;NAA20;NAA30
prerank,muscle alpha-actinin binding (GO:0051371),0.3785820053471424,0.8264394392490346,0.7014725568942436,0.985579037153696,1.0,5/15,19.64%,PDLIM7;PKD2;PDLIM1;PALLD;PDLIM2
prerank,metal ion transmembrane transporter activity (GO:0046873),0.3415758335640098,0.8251820123824252,0.7154761904761905,0.9851320809857474,1.0,9/27,18.07%,SLC4A8;ATP2B4;SLC11A2;SLC23A1;SLC8A2;CNNM4;TUSC3;TMEM165;ATP2B1
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.3048407501962001,0.8242316689290813,0.7577045696068013,0.9842459554838585,1.0,19/74,19.35%,PAPSS2;DGKQ;PIK3C2B;MVK;CHKB;GK5;PIK3CA;GALK1;AGK;PGM2L1;PI4KB;PANK1;PI4KA;PKM;IPPK;TRPT1;GNE;PANK3;DCAKD
prerank,protein kinase C activity (GO:0004697),-0.30236487980629745,-0.8240686334128672,0.6983471074380165,0.8681147484925512,1.0,4/14,8.79%,PRKCH;PRKD1;PRKCE;PRKCQ
prerank,MAP-kinase scaffold activity (GO:0005078),0.39512369988622775,0.8221195431848237,0.7052186177715092,0.9852671602157278,1.0,3/11,15.61%,AKAP13;IQGAP1;MAP2K2
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.30607385917551583,-0.821324116001842,0.7044534412955465,0.8651631904162391,1.0,5/12,19.44%,CASP8AP2;BCL2L13;ATP2A3;NOD1;CTSH
prerank,histone acetyltransferase activity (GO:0004402),0.3318771531328958,0.8207714883209174,0.7174677608440797,0.9851028039625683,1.0,12/30,25.21%,NCOA3;MCM3AP;KAT2B;KAT14;SRCAP;USP22;NAA50;ARRB1;KAT6B;BAZ1A;KAT5;KAT7
prerank,gamma-tubulin binding (GO:0043015),0.3555467091794745,0.8177466125275378,0.7266009852216748,0.9875516800460951,1.0,7/21,29.51%,RAB11FIP5;BLOC1S2;CDK5RAP2;TUBGCP5;RAD51D;ARHGEF7;TUBGCP3
prerank,glutamate receptor activity (GO:0008066),0.3572037348286305,0.8148161985328022,0.7206982543640897,0.9900100174785867,1.0,9/19,27.39%,GRIN2D;GRIA2;GRID1;GRM1;GRIK5;GRIK2;GRIK4;GRM5;GRID2
prerank,DNA binding (GO:0003677),0.27782361389726196,0.8131060292401239,0.985,0.9903091235256631,1.0,126/694,18.75%,MPG;FOXP2;IRF4;EGFR;POLR2H;C1D;WT1;MEOX2;HNRNPA1;ANG;HIVEP2;TSHZ2;CTC1;PBX1;KLF12;TRNP1;TIPIN;SMAD4;NFE2L2;ATF5;SOX10;FOXK2;KLF2;RAD51B;MAFF;TCF7L2;COLEC11;HOXA5;RAD23B;MEIS2;FOXO1;JRKL;NFIB;MND1;CREBZF;TARDBP;IGHMBP2;CGAS;MLXIPL;MTF1;AIFM2;GLI2;TBX6;FOXL1;PHF1;MSL3;HMCES;SOX8;SPTY2D1;VDR;NR6A1;FOXC2;SYCP2;DNASE2;CDK9;RYBP;SAMHD1;POLG2;MCM3;ZNF3;CHD2;SMC1A;CSRNP3;BCL6;CEBPB;MAPT;SLPI;ERCC3;ERCC4;RAD1;CCDC25;FAN1;XRCC5;GTF3C2;LIN9;KDM5B;QRICH1;POLR2D;POLR2G;DDB1;TERF1;DNA2;CR2;BRIP1;SMC6;SIX1;DDX11;HDAC4;RFX5;PLAGL1;EZH1;NME2;ZC3H12A;FANCG;PLAGL2;NBN;HOXA7;INO80;POU3F2;FAM111A;DNASE1L2;SMARCA4;CHD8;NUPR1;NR2C2;RPL6;E2F3;HMGB3;CENPC;PSIP1;SNAI2;CHD3;BCLAF3;RNF138;TFAP4;NUFIP1;ILF2;RAD50;ERCC5;RBM6;BLM;POLD1;SUPV3L1;TINF2;CTCF;PRDM9
prerank,phosphatase activator activity (GO:0019211),0.37804254091585465,0.8128956777935091,0.711864406779661,0.9882772733672516,1.0,4/14,17.07%,B3GAT3;CALM2;GTF2F1;PPP2R5B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.34411491054483123,0.812220294593842,0.733502538071066,0.9869363905755512,1.0,2/23,4.67%,PLCE1;PLCB4
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),0.3975167479741743,0.8096892369814255,0.7124277456647399,0.9888654684724795,1.0,2/11,17.91%,CHRNA7;CHRNA5
prerank,cation channel activity (GO:0005261),0.28958308369834557,0.8087106375997014,0.8206967213114754,0.9880799184203337,1.0,11/94,10.51%,KCNK5;PIEZO2;ANXA2;PKD1;TRPV3;TMEM63A;PKD2;MCU;PSEN1;KCNK9;KCNA2
prerank,amino acid binding (GO:0016597),0.3263504910990013,0.8077461252351666,0.7497034400948992,0.9873026988298103,1.0,2/31,5.10%,GCLC;GRIN3A
prerank,kinase activator activity (GO:0019209),-0.23016010938398226,-0.8051396272750688,0.7857142857142857,0.8847817901091993,1.0,4/30,6.55%,PRKAG2;GPRC5C;RPTOR;RGCC
prerank,exoribonuclease activity (GO:0004532),0.3791851881995308,0.8027152444410114,0.7115902964959568,0.9929618630813051,1.0,3/12,14.16%,EXOSC7;ZC3H12A;EXOSC1
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.3440699650104699,0.7990417999271506,0.736318407960199,0.9962838827960907,1.0,6/22,16.13%,ATP6V0A2;ATP6V1E1;ATP2A2;ATP6V0A1;ATP6V1D;ATP6V1B2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3172796954157117,0.7981505557678532,0.767337807606264,0.9954101198991718,1.0,4/38,6.28%,IRS1;AXIN1;SPATA2;SH2B1
prerank,cadherin binding (GO:0045296),0.275606502186189,0.797635547446093,0.941,0.9938243046397978,1.0,82/315,22.81%,DBN1;CDH26;AHNAK;EGFR;ANXA1;PFKP;PKP3;ANXA2;DIAPH3;HDLBP;STX5;MPP7;SPTAN1;ACVR1;PTPRJ;PPL;IDH1;SRC;FSCN1;SNX1;CAST;SLK;ABI1;FXYD5;USO1;YWHAE;SH3GL1;PSEN1;IQGAP1;PDXDC1;CDH22;TWF1;MAPRE1;PAICS;ZC3HAV1;TBC1D10A;PDLIM1;VASN;JUP;FLNB;SFN;LARP1;SCYL1;ATXN2L;CBL;STK24;CTNND2;ARGLU1;EIF3E;TNKS1BP1;GIPC1;EVPL;PI4KA;RSL1D1;RPL6;PKM;SPTBN1;EPS8L2;NCK1;EEF1G;AHSA1;CKAP5;SHTN1;PUF60;STK38;LASP1;ALDOA;UBFD1;LDHA;FLNA;RAB10;ATIC;CCS;DNAJB1;CTNNA3;EIF2A;CTTN;YWHAB;PLEC;SEPTIN9;BAG3;PACSIN2
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.30001416122568814,0.7964096705892912,0.7936681222707423,0.9933106861137297,1.0,20/55,26.25%,ANXA2;PKD1;TRPV3;ATP2B4;PKD2;MCU;PSEN1;ATP2A2;SLC8A2;SEC61A1;TMEM165;CHRNA7;ATP2B1;CUL5;TRPC1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.36456463927332466,0.7955141023048808,0.725,0.9901115376783611,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.36456463927332466,0.7955141023048808,0.725,0.9901115376783611,1.0,6/16,25.52%,ATP6V0A2;ATP6V0A1;ATP6V1D;ATP6V1B2;ATP6V0B;ATP5F1B
prerank,secondary active transmembrane transporter activity (GO:0015291),0.3029645053415635,0.7934229803153506,0.7935135135135135,0.9908994508790511,1.0,10/51,16.78%,SLCO2A1;SLC35E3;MCU;SLC25A16;SLC16A10;SLC4A4;SLC35D1;SLC25A3;SLC35E1;SLC20A1
prerank,nucleosomal DNA binding (GO:0031492),-0.2449488250783146,-0.7929807005240885,0.8043478260869565,0.897225758779431,1.0,5/21,14.06%,H3-3A;CHD4;ACTB;MTA2;SMARCB1
prerank,ATPase activator activity (GO:0001671),0.3475790799659023,0.7924831213862193,0.7469437652811736,0.9899503455752768,1.0,5/20,21.23%,TOR1AIP2;DNAJA2;DNAJB2;AHSA1;DNAJB1
prerank,ion channel inhibitor activity (GO:0008200),0.3173967980009799,0.7919720002658687,0.7678369195922989,0.9884351726942051,1.0,6/35,12.63%,KCNV1;TNNI3;STX1A;CAMK2D;MCUB;CALM2
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.3384181545787633,0.7909910163632742,0.75,0.9877083649931728,1.0,4/22,10.45%,ZRANB1;ZBTB1;OTUD7B;SQSTM1
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.32532108445060204,0.7892601022404195,0.7702227432590856,0.9879425176090774,1.0,6/30,12.21%,CARD16;GAS6;CAST;DPEP1;CSTB;CD27
prerank,lysine N-methyltransferase activity (GO:0016278),0.34020160526923865,0.7880663260783839,0.7407862407862408,0.9874269797491527,1.0,7/20,26.78%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;EEF1AKMT3;KMT5A
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),0.3436609160557562,0.7877185107026232,0.7557544757033248,0.9856599586202393,1.0,9/19,30.04%,GABRG3;GRID1;GABRG2;GRIK5;GRIK2;GRIK4;GABRA3;GRID2;GABRA1
prerank,C2H2 zinc finger domain binding (GO:0070742),0.38266663365596276,0.7869928601135818,0.7642956764295676,0.9844783458714284,1.0,1/11,1.41%,WT1
prerank,protein phosphatase regulator activity (GO:0019888),0.29774199266292145,0.7844692979024899,0.8039647577092511,0.9859412836029692,1.0,14/53,19.23%,PPP1R1B;PPP6R2;RCAN3;B3GAT3;RCAN1;SAG;SHOC2;CALM2;MGAT5;PPP2R1B;PPP2R5B;PPP1R9B;SET;PPP2R2A
prerank,retinoic acid receptor binding (GO:0042974),0.3445240960168756,0.7828201493342923,0.7417302798982188,0.9861144078775124,1.0,7/17,25.84%,PRMT2;VDR;NRIP1;NSD1;NCOA6;ASXL1;RARG
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.38035289248367543,0.7811886538265895,0.7325905292479109,0.9862867505526218,1.0,2/11,20.40%,PADI2;DDAH2
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.37088823889747624,0.780634647846242,0.754054054054054,0.9848305015641979,1.0,3/13,15.00%,FAN1;DNA2;DNASE1L2
prerank,ADP binding (GO:0043531),0.33155690031041946,0.7798911644423617,0.7551515151515151,0.9835843703687961,1.0,4/25,10.24%,GCLC;MYO9B;PPP5C;ERN1
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.3118010364182535,0.7793284755298934,0.7836538461538461,0.9821694120254715,1.0,4/33,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,voltage-gated calcium channel activity (GO:0005245),0.30865178149512285,0.7759358734729359,0.8044237485448196,0.984710491002157,1.0,8/37,18.37%,CACNA2D2;PKD2;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;NCS1
prerank,nucleotidase activity (GO:0008252),0.35109493721100316,0.7728287224592233,0.7410358565737052,0.9869391093431557,1.0,4/15,21.19%,NT5M;BPNT2;ACP3;NT5DC2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.34889961960579985,0.7717101808509711,0.7750952986022872,0.9863046611694833,1.0,4/17,16.57%,BLVRB;TECR;PTGR1;BDH2
prerank,transaminase activity (GO:0008483),0.37481565629955027,0.7707747646078328,0.7303988995873453,0.9854739099946377,1.0,3/11,20.59%,BCAT1;PSAT1;GOT1
prerank,estrogen receptor binding (GO:0030331),0.3075416563742877,0.7701486110998809,0.783175355450237,0.9841446814418645,1.0,10/32,24.40%,ESR1;PRMT2;TRIP4;DCAF13;PADI2;NRIP1;NSD1;NCOA6;LATS1;LCOR
prerank,H4 histone acetyltransferase activity (GO:0010485),0.38060107567306134,0.7687154494310807,0.7674094707520891,0.9839062175623519,1.0,3/10,18.80%,MSL3;USP22;NAA50
prerank,acetylcholine receptor activity (GO:0015464),0.32719327569397644,0.7683401556099675,0.758282208588957,0.9822211415004912,1.0,3/22,17.91%,CHRNA7;CHRFAM7A;CHRNA5
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),0.372034381119892,0.7680277741022757,0.783448275862069,0.9804784221805821,1.0,2/11,14.88%,SLC25A25;SLC25A17
prerank,four-way junction DNA binding (GO:0000400),0.3445178431439554,0.766650560646399,0.7722007722007722,0.9801219054249973,1.0,7/17,27.44%,XRCC3;RAD51B;HMGB3;BLM;RAD51D;MSH6;MEN1
prerank,calcium channel activity (GO:0005262),0.27647294105496717,0.7653510311105055,0.8382663847780126,0.9797410398909041,1.0,23/84,26.25%,CACNA2D2;ANXA2;PKD1;TRPV3;PKD2;MCU;PSEN1;ITGAV;CACNG2;CACHD1;CATSPER3;CACNB1;SEC61A1;CHRNA7;NCS1;CUL5;TRPC1;CACNA2D1;ANXA6;TRPV2;TMCO1;SLC24A4;SLC24A2
prerank,NF-kappaB binding (GO:0051059),0.31393213134149767,0.7647220536616408,0.7703703703703704,0.9784245703251762,1.0,9/24,31.83%,HDAC3;NPM1;COMMD6;ANXA4;CPNE1;RELA;BCL10;BRMS1;CDK5RAP3
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.28835724667284024,0.760259090482703,0.8130530973451328,0.9820092655129448,1.0,15/49,25.51%,ZRANB1;RAD23B;HDAC6;ZBTB1;OTUD7B;SQSTM1;TNIP1;ABRAXAS1;FAAP20;TAB2;TNIP2;UBQLN4;PSMD4;AGAP3;UFD1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),0.37298593465384144,0.7601835164706474,0.7679083094555874,0.9799792198912867,1.0,2/10,8.49%,PIK3C2B;PIK3CA
prerank,neuropeptide binding (GO:0042923),-0.25876986073384495,-0.7599785427030136,0.851063829787234,0.9404152348145723,1.0,10/18,40.46%,SORL1;OPRK1;OPRM1;NMUR2;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.3537946146803205,0.7594618516317818,0.7799442896935933,0.9788185191704182,1.0,3/13,14.59%,SLC7A6;SLC7A3;SLC15A4
prerank,carboxylic ester hydrolase activity (GO:0052689),0.27612828427418745,0.7532654805432009,0.8609958506224067,0.9848695500051442,1.0,11/85,20.38%,MGLL;CEL;PLAAT1;LCAT;PON3;APMAP;DAGLB;PLA2G4E;PTRH2;LIPC;GDPD3
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),0.33416452674038166,0.7531161497939319,0.7880710659898477,0.9829509304256064,1.0,7/18,24.70%,TGFBR2;ACVR1;AMHR2;TGFBR1;ACVR2A;BMPR1A;ACVR1B
prerank,phospholipid transfer activity (GO:0120014),0.3224789593868135,0.7525038343977125,0.782716049382716,0.981582913146325,1.0,6/21,20.35%,TRIAP1;OSBPL2;PRELID3A;GLTP;PITPNM1;PRELID1
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.29452748820976854,-0.7504826998389841,0.7781818181818182,0.9449791695223756,1.0,2/11,10.39%,KCND3;KCNQ1
prerank,RNA cap binding (GO:0000339),0.33839659187899385,0.7480176121100908,0.7824377457404981,0.9850507835383491,1.0,8/16,28.38%,EIF4A1;AGO2;LARP1;EIF3D;NCBP3;CYFIP1;EIF4E2;LSM1
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.255550044403607,0.7464438885348873,0.987,0.9848784475009271,1.0,128/431,28.87%,TNK1;PFKP;RAB32;RAB6A;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;GTPBP4;ACLY;RAP1B;MVK;ABCE1;IGHMBP2;ARF4;SCG5;TBCK;RIT2;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;DYNC1LI1;PPP5C;CLPX;GALK1;AKT3;RHOJ;ARF1;RHOQ;ERN1;TWF1;DYRK2;TUBB6;RAB2A;TARS1;NRAS;KRAS;AKT1;MAP3K6;SARS2;PNPLA8;GTPBP10;NUDT16;RRAD;TUBD1;PXK;RHOA;RRAGD;STK3;HSP90AA1;PEX1;ARF6;TUBB4A;TUBA4A;GEM;RAB27B;CHD8;HSPA14;GLUD1;RND3;PMVK;HARS1;RAC3;PRPS1;PRPS1L1;RAB35;IDE;NME1;ABCF1;ABCB9;RAB1B;BLM;TGFBR1;STK38;PANK3;RRAS2;ABCD3;OXSR1;STK26;PIP4K2B;RALA;RAB10;BMPR1A;SRPK1;SRR;PI4K2A;ADSS2;MYO1F;TUBG2;KCNJ11;RABL3;LATS1;WNK2;ARL8A;NOA1;ACVR1B;MARK2;ANXA6;RAC1;RAB29;ATL1;RHOT2;RHOBTB2;EIF2B2;EIF4G1;MAST2;RND2;MSH6;RAP1A;NDUFA13;DIRAS2;P2RX4;TUBB2A;RHEBL1;PRPS2;TSR1;RAP2B;PRKCI;RPS6KA5;MYH10;PEAK1;BMPR1B;ATP5F1A;PTPA
prerank,poly-pyrimidine tract binding (GO:0008187),0.3153553499576947,0.7432188476769429,0.811965811965812,0.986526171896428,1.0,3/23,10.63%,DIS3L2;RBMS3;HNRNPH1
prerank,hexose transmembrane transporter activity (GO:0015149),0.35577520477276586,0.7430142022501057,0.7856191744340879,0.9846730425866671,1.0,1/12,2.06%,MFSD4A
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.31125874385390556,0.7423767935357893,0.797752808988764,0.9833454171809574,1.0,7/25,21.14%,SESTD1;PLEKHA4;AKT1;PLEKHA1;PLA2G4E;ANXA8;GAB2
prerank,histone acetyltransferase binding (GO:0035035),0.31603273287574196,0.7389037161208832,0.8044831880448319,0.985651417081007,1.0,5/21,15.77%,TRIP4;SIRT2;GLI3;BCAS3;TRIM68
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.29897393677997963,0.7382479911534275,0.8198403648802737,0.9843713555268108,1.0,14/34,28.06%,SETD7;SETD2;ANTKMT;EHMT2;EEF2KMT;PRDM9;N6AMT1;EZH2;SETDB1;CAMKMT;EEF1AKMT3;KMT5A;MEN1;SUV39H1
prerank,glutathione transferase activity (GO:0004364),-0.23883250656071656,-0.737928761768078,0.8148148148148148,0.9542679867522621,1.0,8/23,26.34%,LANCL1;GSTA4;MGST1;GSTA3;MGST3;GSTO1;GSTT2;GSTK1
prerank,protein kinase A catalytic subunit binding (GO:0034236),-0.27079064348105836,-0.737917895024583,0.8125,0.9462579127238544,1.0,4/13,13.37%,PRKAR1B;KCNQ1;RYR2;PRKAR2B
prerank,phosphatidylcholine transporter activity (GO:0008525),0.326482887680684,0.7371703729697723,0.8123359580052494,0.983491853055751,1.0,2/17,7.01%,ATP8B1;ABCA1
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),0.25954409328677436,0.736232908997989,0.9222222222222223,0.9825034240182559,1.0,36/147,20.74%,ARHGEF28;AKAP13;PLCE1;CCDC88C;RASGRF1;PREB;FARP2;RASGEF1A;FARP1;FRMD7;MYCBP2;RGL1;HPS4;ARHGEF10;RGL2;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;EEF1B2;MADD;EPS8L2;SOS1;ANKRD27;RCC1L;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;TIAM1;DENND4B;DENND2A
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),0.30944982551069267,0.7361820093428612,0.8055893074119077,0.9804970296407288,1.0,2/24,5.90%,SESTD1;PLEKHF1
prerank,microtubule minus-end binding (GO:0051011),-0.2729665130469281,-0.7357325367704387,0.8200836820083682,0.9414284954387084,1.0,3/13,9.67%,TUBGCP4;CEP290;MACF1
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),0.3372989393756337,0.7344886367351573,0.788235294117647,0.9804144355459443,1.0,3/14,18.74%,KCNJ2;KCNJ3;KCNH2
prerank,potassium channel regulator activity (GO:0015459),0.2778127260168109,0.7320446793333429,0.8585418933623504,0.9812733293448941,1.0,10/49,20.33%,KCNV1;SGK3;SGK2;YWHAE;AKT1;KCNAB3;CHP1;AKAP9;RASA1;FLNA
prerank,organic cation transmembrane transporter activity (GO:0015101),0.3292485572183347,0.7317957237778903,0.7872892347600519,0.9795572937750772,1.0,4/16,17.47%,SLC18A3;SLC44A1;SLC25A17;SLC44A2
prerank,nuclear export signal receptor activity (GO:0005049),-0.2862381889880794,-0.7304623944484157,0.8113879003558719,0.9402133738830314,1.0,4/11,26.88%,XPO5;NUP214;XPO1;CSE1L
prerank,voltage-gated sodium channel activity (GO:0005248),0.31540608375135093,0.7277190588443105,0.8213399503722084,0.9823135430317896,1.0,11/22,35.53%,PKD2;HCN4;SCN4B;HCN1;SCN9A;SCN2A;CACNA1H;CACNA1I;CACNA1G;SCN8A;SCN1A
prerank,cyclic nucleotide binding (GO:0030551),0.3203322794381617,0.7254044963882562,0.8368617683686177,0.9828664353516283,1.0,5/21,11.90%,PDE11A;PDE10A;CNGB1;PDE4D;PDE5A
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),0.34353096107855596,0.7207017526002115,0.829700272479564,0.9862189175929827,1.0,2/12,14.88%,SLC25A25;SLC25A17
prerank,adenylate cyclase binding (GO:0008179),-0.29003151765100216,-0.7184805614635092,0.822742474916388,0.9472035138709218,1.0,3/10,12.81%,ADCY5;CAP2;AKAP6
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),0.344875491579422,0.7178005930624549,0.8179384203480589,0.987364482236404,1.0,2/12,4.40%,TGFBR2;ACVR1
prerank,pseudouridine synthase activity (GO:0009982),0.3374091999899393,0.7148698836363375,0.8321870701513068,0.9887202330340557,1.0,1/13,4.19%,RPUSD1
prerank,GTPase regulator activity (GO:0030695),0.24714421385557644,0.7137015289917958,0.9699097291875627,0.9879089805523462,1.0,30/212,10.25%,GPSM2;ARHGAP10;SGSM2;ARHGAP44;RABGAP1L;SLIT2;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;PREB;ARHGAP42;ADAP1;ASAP3;TBCK;MYO9B;FLCN;SEC23A;OCRL;ARHGAP9;GPSM1;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;TAGAP;SIRPA;GDI1
prerank,purinergic nucleotide receptor activity (GO:0001614),0.326544546257174,0.7107604847494583,0.8398950131233596,0.9890113122235706,1.0,1/15,4.28%,P2RX3
prerank,GTPase activator activity (GO:0005096),0.24360675920789815,0.7076507874489208,0.984,0.990347119272151,1.0,92/313,24.88%,ARHGEF28;ARHGAP10;SGSM2;ARHGAP44;AKAP13;PLCE1;CCDC88C;RABGAP1L;CDC42EP2;ELMOD1;LLGL1;RAP1GAP2;RASGRF1;PREB;ARHGAP42;ADAP1;FARP2;ASAP3;TBCK;RASGEF1A;FARP1;MYO9B;FRMD7;FLCN;MYCBP2;SEC23A;OCRL;ARHGAP9;RGL1;HPS4;TBC1D2B;ARFGAP3;ARFGAP1;ARHGEF10L;IQGAP1;TBC1D17;ARHGEF10;TAGAP;RGL2;TBC1D10A;PGAM5;NGEF;EGF;SMCR8;DENND1A;RAPGEF1;HACD3;EEF1B2;MADD;EVI5;SGSM1;EPS8L2;SOS1;ANKRD27;EVI5L;TBC1D13;SRGAP2;ARAP1;RCC1L;ADPRH;TBC1D22B;RP2;TBC1D15;MON1A;DENND6A;DNMBP;EIF2B1;ARFGEF1;DOCK4;SERGEF;RASA1;TIAM1;DENND4B;DENND2A;ARHGAP17;ARRB1;RUNDC1;JUN;NF1;GNB5;CCDC88A;TBC1D8B;TBC1D12;VAV2;DOCK11;BCR;ARHGAP20;STXBP5L;ALS2;TSC2;ITSN1;RGS2
prerank,voltage-gated chloride channel activity (GO:0005247),0.35026490960179757,0.7057199595439532,0.8414985590778098,0.9903455714134448,1.0,1/10,5.11%,CLCN5
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.33328672381944224,0.7027616044818726,0.8311345646437994,0.9915191541317296,1.0,2/12,8.96%,CDK4;CDK9
prerank,DNA replication origin binding (GO:0003688),-0.2151532739016166,-0.7006732235446357,0.8901098901098901,0.959704039871325,1.0,2/23,3.07%,ORC5;MCM9
prerank,mRNA 5'-UTR binding (GO:0048027),0.2963831329963238,0.699548285388614,0.8349397590361446,0.9928981964619085,1.0,4/24,15.49%,MRPS11;IGF2BP1;LARP1;RSL1D1
prerank,single-stranded DNA helicase activity (GO:0017116),0.3067724094619827,0.6993152327116391,0.8422425032594524,0.9910754351361087,1.0,3/19,15.70%,HELQ;DNA2;RFC4
prerank,phospholipase C activity (GO:0004629),0.29054555109778885,0.6984735844633763,0.8534798534798534,0.9899004683914832,1.0,2/25,4.67%,PLCE1;PLCB4
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),0.3320047162140773,0.698230178419439,0.8442622950819673,0.9881234173093636,1.0,2/12,8.49%,PIK3C2B;PIK3CA
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.270501570996739,0.6970589811226867,0.8712206047032475,0.9873483049875034,1.0,18/40,35.14%,MEPCE;COMTD1;GAMT;COMT;N6AMT1;ICMT;ASMT;NNMT;SUV39H1;PRMT8;METTL9;THUMPD3;LRTOMT;AS3MT;PRMT7;DNMT3B;FBL;THUMPD2
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.32101806960878965,0.6956196354989803,0.8367911479944675,0.9869686116513966,1.0,6/14,20.32%,EXO5;NDUFS1;ACO2;ETFDH;RSAD1;CIAO3
prerank,metalloexopeptidase activity (GO:0008235),0.2633266436386932,0.6923781227184411,0.8908489525909592,0.9881783188336035,1.0,15/51,25.32%,ANPEP;LNPEP;DPEP1;XPNPEP3;NUDT16;NPEPPS;LAP3;MMP16;METAP2;METAP1;CPZ;METAP1D;MMP15;ZMPSTE24;AGBL1
prerank,proton transmembrane transporter activity (GO:0015078),0.26536574447658967,0.6905555202955148,0.8797250859106529,0.9879280447699547,1.0,7/39,21.20%,CLCN5;SLC11A2;SLC9A1;UQCRQ;ATP6V1B2;UQCRH;UQCR10
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),-0.24560285171288504,-0.6863652494099824,0.8615384615384616,0.9661742033290179,1.0,1/15,2.42%,CCR9
prerank,Wnt-activated receptor activity (GO:0042813),0.3067726394077636,0.6860868239321037,0.8588709677419355,0.990352318418152,1.0,3/15,15.34%,PKD1;FZD7;FZD4
prerank,acetyltransferase activity (GO:0016407),0.27739009709063467,0.6823064388132161,0.8820093457943925,0.992147425661947,1.0,9/31,22.22%,GNPNAT1;LCAT;KAT2B;NAT8;SAT1;NAA15;NAA50;ACAT1;KAT6B
prerank,exonuclease activity (GO:0004527),0.2644185509674,0.6808360258843099,0.9076923076923077,0.9915598101843155,1.0,8/46,17.41%,REV3L;EXOSC7;RAD1;FAN1;REXO2;ZC3H12A;EXOSC1;RAD50
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.28820067132221,0.6806281455173069,0.8788249694002448,0.989784247034632,1.0,7/24,20.20%,NME2;PMVK;CMPK2;NME1;AK8;AK9;IP6K1
prerank,adenyl ribonucleotide binding (GO:0032559),0.23403664833579382,0.6787011726886186,0.986986986986987,0.9897167786525017,1.0,59/291,21.09%,GCLC;TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;PDE10A;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PDE4D;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;GLUD1;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;HCN1;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,ATP binding (GO:0005524),0.2333250188425309,0.677578437041601,0.983983983983984,0.9887968532890201,1.0,54/266,21.09%,TNK1;PFKP;IRAK3;ATP1A3;ATP1A1;P2RX3;ACVR1;ACLY;MVK;ABCE1;IGHMBP2;TBCK;ABCA1;ABCB8;MYO9B;UBA2;N4BP2;HSPA13;PPP5C;CLPX;GALK1;AKT3;ERN1;TWF1;DYRK2;TARS1;AKT1;MAP3K6;SARS2;PNPLA8;PXK;STK3;HSP90AA1;PEX1;CHD8;HSPA14;PMVK;HARS1;PRPS1;PRPS1L1;IDE;NME1;ABCF1;ABCB9;BLM;TGFBR1;STK38;PANK3;ABCD3;OXSR1;STK26;PIP4K2B;BMPR1A;SRPK1
prerank,adenylyltransferase activity (GO:0070566),0.290550010753416,0.6768575030869267,0.8884758364312267,0.9875425488584767,1.0,5/21,18.37%,TENT4A;SELENOO;PAPOLB;TENT2;TENT4B
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.2682644741482083,0.6737735019020563,0.8826291079812206,0.9885646587549778,1.0,9/33,20.30%,UBA2;SIAH1;TCERG1;RNF14;AUP1;ARIH2;RNF19A;TOLLIP;ARIH1
prerank,G protein-coupled photoreceptor activity (GO:0008020),-0.2567312845548675,-0.6734442141680081,0.8592057761732852,0.970419596265858,1.0,11/12,50.40%,ELOVL4;GPR88;GPR52;RRH;OPN1MW3;OPN1MW;RHO;OPN5;OPN1SW;GNAT2;OPN4
prerank,channel activity (GO:0015267),0.26266425898739926,0.6724028357249011,0.9084895259095921,0.9878345673655488,1.0,5/41,17.16%,TRPV3;TMEM266;MCUB;TMEM120A;CHRNA7
prerank,inward rectifier potassium channel activity (GO:0005242),0.2853702126934287,0.6721740588447468,0.8827160493827161,0.9860894869435626,1.0,5/24,23.16%,KCNJ2;KCNJ3;KCNH2;ABCC8;KCNJ11
prerank,phospholipase A2 activity (GO:0004623),0.28359535346996256,0.6713191310780462,0.8822115384615384,0.9849362720138932,1.0,3/26,15.34%,PLAAT1;PNPLA8;PLA2G4E
prerank,chloride channel activity (GO:0005254),0.2483246876593052,0.6681687884751497,0.9222462203023758,0.9858892889337356,1.0,8/59,19.27%,ANO3;CLCN5;GABRR3;CLCC1;GABRG3;TTYH3;ANO5;GABRG2
prerank,kinase activity (GO:0016301),0.2378127153527719,0.6676906615680336,0.953464322647363,0.9843914299807992,1.0,26/109,21.28%,PAPSS2;DGKQ;PIK3C2B;MTOR;MVK;CHKB;GK5;PIK3CA;AGK;AKT1;PGM2L1;IRAK1;STK39;PSTK;CERK;PRKD3;PI4KB;PANK1;PI4KA;PMVK;IPPK;PANK3;DCAKD;IP6K1;TRRAP;PIK3CG
prerank,retinoid X receptor binding (GO:0046965),0.32142126775441715,0.6660707689095985,0.8620689655172413,0.9839132161443562,1.0,5/11,25.84%,VDR;NRIP1;NSD1;NCOA6;RARG
prerank,FMN binding (GO:0010181),-0.26216479953148186,-0.6634209191986754,0.8775510204081632,0.9718567743063076,1.0,4/11,18.50%,NOS3;NOS1;NDOR1;PPCDC
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),-0.17080593004528133,-0.6616536084446515,1.0,0.966048058322878,1.0,23/57,26.29%,COX4I1;NDUFA9;NDUFA5;NDUFB4;CYB561A3;UQCR11;NDUFA4;NDUFB10;NDUFB8;NDUFS4;NDUFC1;UQCRFS1;NDUFA10;CYBRD1;NDUFA6;NDUFS2;COX5A;NDUFS8;NDUFA12;NDUFA8;NDUFS6;NDUFS7;NDUFA4L2
prerank,DNA secondary structure binding (GO:0000217),0.26729456727446466,0.6615569744337546,0.8868360277136259,0.986120067018602,1.0,12/31,28.97%,XRCC3;RAD51B;MAPT;HMGB3;ERCC5;BLM;KMT2A;CLSPN;RAD51D;MSH6;MEN1;LIN54
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2644659275795722,0.661535054912151,0.9057471264367816,0.9842058055743026,1.0,8/35,20.77%,TYW3;FTSJ1;DTWD1;PTRH2;TRPT1;QTRT1;DUS2;QRSL1
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),0.3132576651929588,0.6610162320748781,0.8699186991869918,0.9827364547044761,1.0,5/13,21.28%,PIK3C2B;PIK3CA;PIP4K2C;PIP4K2B;PIK3CG
prerank,histone-lysine N-methyltransferase activity (GO:0018024),0.2584860854736554,0.6596367053443302,0.9169398907103825,0.9819709612881626,1.0,19/44,29.32%,CXXC1;SETD7;WDR5;SETD2;EHMT2;SETD5;PRDM9;KMT2C;SETD1B;KMT2A;N6AMT1;NSD1;EZH2;SETDB1;SETDB2;KMT5A;MEN1;SUV39H1;SETD1A
prerank,diacylglycerol kinase activity (GO:0004143),0.3164568226166522,0.6594474085073456,0.8658536585365854,0.9802122625652803,1.0,2/11,9.22%,DGKQ;AGK
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.32880733244116306,0.6590521455427794,0.8804945054945055,0.9786404834210924,1.0,5/10,33.39%,POLD1;DCLRE1A;MGME1;EXO1;TATDN1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),0.30453706578497136,0.658873248870088,0.8766404199475065,0.976900817502949,1.0,8/13,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;GABRA1;GLRA2;GABRA5;GLRA1
prerank,death receptor binding (GO:0005123),0.29885452146990693,0.6551948389373009,0.8823529411764706,0.9782764843720344,1.0,3/15,15.91%,TMBIM1;EDA;MADD
prerank,NAD binding (GO:0051287),0.2713991962756285,0.6542029101661919,0.8978622327790974,0.9773270388627663,1.0,9/26,21.43%,SIRT2;ZC3HAV1;CRYZ;HSD17B8;GLUD1;NUDT6;BDH2;CTBP1;UXS1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.25717736109542616,0.647966247483572,0.902122641509434,0.9804168979103127,1.0,4/34,12.48%,DIS3L2;ERI3;EXOSC7;REXO2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.26983981096499626,0.6465095346092243,0.8998822143698468,0.9796851708545663,1.0,10/27,27.37%,POLR2D;POLR2G;POLR3H;TENT2;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.2694264275932277,0.6389834161581168,0.9179548156956004,0.9837224543801699,1.0,15/27,35.70%,POLR2D;POLR2G;POLR3H;POLR1D;POLR1C;POLR3A;POLR1B;POLR2C;MED21;PRIM1;POLR2I;CRCP;POLR2E;POLR2B;POLR2J
prerank,phosphoric ester hydrolase activity (GO:0042578),0.24073957746475189,0.6338853198422053,0.9490586932447398,0.9856860651410365,1.0,13/49,23.48%,ACP2;PTPRJ;PPP5C;DUSP11;SAMHD1;PGAM5;PHOSPHO2;PPP1CC;SMPD1;ACP3;GDPD3;ACP6;LHPP
prerank,sequence-specific mRNA binding (GO:1990825),-0.24841523881252744,-0.6259534079092504,0.9222614840989399,0.9855309482964972,1.0,10/10,75.18%,SSB;SHFL;TYMS;LIN28A;FMR1;DHX9;ETF1;DHFR;RBM24;LARP6
prerank,carbohydrate kinase activity (GO:0019200),0.30310615278873354,0.6185074767305364,0.8901098901098901,0.995076245325873,1.0,3/11,18.68%,NAGK;GALK1;GNE
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.288126359378521,0.6169389307061312,0.9035667107001321,0.9941865280248897,1.0,6/14,29.84%,BLVRB;CRYM;PYCR1;DHFR;NOXRED1;PYCR3
prerank,alpha-actinin binding (GO:0051393),0.2618620535064029,0.6162398827600392,0.9158415841584159,0.9927909577469236,1.0,4/24,13.54%,PDLIM7;PKD2;PDLIM1;PALLD
prerank,tRNA methyltransferase activity (GO:0008175),0.2770385788514005,0.6149720280313181,0.9114583333333334,0.9917401816808891,1.0,2/16,8.42%,TYW3;FTSJ1
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.30515330094088544,0.6139687919925114,0.9022662889518414,0.9905473848065092,1.0,5/10,31.20%,GLCE;GNE;GALM;DSEL;GALE
prerank,5'-nucleotidase activity (GO:0008253),0.2851292173918709,0.6128636089727272,0.9079837618403248,0.989467484763664,1.0,3/13,21.19%,NT5M;ACP3;NT5DC2
prerank,voltage-gated ion channel activity (GO:0005244),0.28401574780514693,0.6120875594362772,0.9019867549668874,0.9880932894808033,1.0,4/14,19.06%,PKD2;VDAC2;VDAC1;HCN1
prerank,heparan sulfate sulfotransferase activity (GO:0034483),0.2763113907896822,0.6115616532731619,0.9132124352331606,0.986554903543293,1.0,4/15,17.64%,HS2ST1;HS3ST6;HS3ST5;NDST2
prerank,NAD+ binding (GO:0070403),0.2869449019706367,0.6104191632592438,0.9126344086021505,0.9854923648730458,1.0,4/12,21.43%,SIRT2;ZC3HAV1;GLUD1;UXS1
prerank,histone demethylase activity (GO:0032452),0.2565627130961464,0.609128105532195,0.9252669039145908,0.9844486632304469,1.0,11/27,28.65%,KDM3B;KDM5C;KDM5B;JMJD1C;FBXL19;KDM2B;KDM4C;KDM3A;JARID2;KDM4B;KDM2A
prerank,endodeoxyribonuclease activity (GO:0004520),0.263553510986522,0.6066393538802198,0.9152970922882427,0.9841510918385291,1.0,5/20,22.85%,ERCC4;DNA2;RAD50;ERCC5;ERCC1
prerank,cation transmembrane transporter activity (GO:0008324),0.22666322162575103,0.6035802842414453,0.9652173913043478,0.9842352048547852,1.0,11/48,25.71%,SLC1A5;SFXN1;SLC7A3;SLC15A4;SLC38A1;SLC25A15;SLC8B1;SLC38A9;SLC25A2;SLC36A4;SFXN2
prerank,pyridoxal phosphate binding (GO:0030170),0.25921047059867514,0.5994352651849395,0.9214195183776933,0.985041833988385,1.0,8/20,30.21%,ACCS;PSAT1;PYGB;GLDC;SRR;CTH;PNPO;PLPBP
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.23179992603619923,-0.5931439993214079,0.947565543071161,0.9979900504528509,1.0,6/12,26.73%,GABRG1;GABRB3;GABRA4;GABRE;GABRB2;GABRA2
prerank,neuropeptide receptor binding (GO:0071855),0.266118400401783,0.5728574451232282,0.9429708222811671,0.9982449659811234,1.0,14/14,73.41%,NMU;SHANK1;AGRP;NTS;PPY;APELA;UCN3;QRFP;GHRH;NPPA;UCN2;GAL;APLN;NPY
prerank,ankyrin binding (GO:0030506),0.25695675779829885,0.5688728226166917,0.9546027742749055,0.9984070270388647,1.0,6/19,25.91%,SPTBN1;KCTD6;PLEC;SPTBN4;KCNJ11;NRCAM
prerank,5'-3' exonuclease activity (GO:0008409),0.26329685309327044,0.5653688814855437,0.9434724091520862,0.9981632466356618,1.0,6/14,32.81%,FAN1;DCLRE1A;TRIR;CPSF3;EXO1;XRN2
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.24052657151107745,0.5639165789579508,0.9486858573216521,0.9969942673500378,1.0,6/22,27.79%,CLTC;HSPG2;SYT1;AP2M1;HSP90B1;DNAJA1
prerank,symporter activity (GO:0015293),0.27847927488036717,0.5620487612337601,0.9372384937238494,0.996023271925426,1.0,1/10,11.12%,SLC4A4
prerank,GABA receptor binding (GO:0050811),0.27431263093498287,0.5610418860405512,0.9536516853932584,0.994663827031727,1.0,1/11,6.69%,TRAK2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),0.2706906556024609,0.5523446451568697,0.9511173184357542,0.9967257318436151,1.0,1/11,8.04%,HMCES
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.2728355571616593,0.5513647738992935,0.9487534626038782,0.9953136883623684,1.0,4/11,26.34%,STUB1;AMFR;UBE2K;PRPF19
prerank,protein phosphatase activator activity (GO:0072542),0.25480672588452524,0.5390581932284939,0.9551451187335093,0.9983351543782839,1.0,3/13,17.07%,B3GAT3;CALM2;PPP2R5B
prerank,GABA-A receptor activity (GO:0004890),0.23817828630287757,0.537024710243266,0.9725130890052356,0.9972294339403873,1.0,3/18,19.27%,GABRR3;GABRG3;GABRG2
prerank,G protein-coupled amine receptor activity (GO:0008227),-0.1655797173873491,-0.5356531406924635,0.9813953488372092,0.9983200713752058,1.0,12/22,38.93%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,serotonin receptor activity (GO:0099589),-0.1655797173873491,-0.5356531406924635,0.9813953488372092,0.9983200713752058,1.0,12/22,38.93%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,G protein-coupled serotonin receptor activity (GO:0004993),-0.1655797173873491,-0.5356531406924635,0.9813953488372092,0.9983200713752058,1.0,12/22,38.93%,HTR4;HTR7;HRH1;HTR1B;HRH2;CHRM1;HTR6;HTR5A;HTR1A;HRH3;CHRM5;HTR1D
prerank,kinesin binding (GO:0019894),0.22407786901911816,0.5354747250149503,0.9810201660735468,0.9959760050718455,1.0,11/27,31.69%,TOR1A;ARHGEF10;ATCAY;CROCC;RAB29;KIFAP3;SPAG9;MAPK8IP3;PLEKHM2;KLC2;KIF1B
prerank,tumor necrosis factor receptor binding (GO:0005164),0.24741809154571315,0.5204722902684059,0.9696551724137931,0.9989489982736929,1.0,4/12,23.69%,TRAF3;TRAF4;TRAF5;TRAP1
prerank,extracellular ligand-gated ion channel activity (GO:0005230),0.2539681737239823,0.5191063162165643,0.9672364672364673,0.9975493977486825,1.0,5/10,33.00%,GABRG3;GABRG2;GABRA3;GABRA1;GABRA5
prerank,ligand-gated anion channel activity (GO:0099095),0.23067009580194725,0.5184254016697907,0.9741602067183462,0.995917721237228,1.0,9/17,34.85%,GABRG3;GABRG2;GLRA3;GABRA3;CFTR;GABRA1;GLRA2;GABRA5;GLRA1
prerank,histone methyltransferase binding (GO:1990226),0.24754135569968463,0.5173174039517059,0.961218836565097,0.9944067777453517,1.0,5/11,34.41%,PHF1;LCOR;NOP56;WIZ;HSP90AB1
prerank,Notch binding (GO:0005112),0.22018034075717244,0.5162773079387035,0.9789864029666254,0.9929102801665604,1.0,5/22,23.82%,CUL3;JAG1;NCOR2;KCTD10;CCN3
prerank,vitamin D receptor binding (GO:0042809),0.24065568714888497,0.5144871558552744,0.9720101781170484,0.9916551071554259,1.0,3/14,21.59%,MED24;MED13;THRAP3
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.19866902684258883,0.4969136576810109,0.9872093023255814,0.9927124617318368,1.0,9/34,27.23%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.19866902684258883,0.4969136576810109,0.9872093023255814,0.9927124617318368,1.0,9/34,27.23%,NDUFS5;NDUFS1;NDUFB7;NDUFV2;NDUFA2;NDUFB2;NDUFB3;NDUFB9;NDUFA13
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",-0.1707163935455516,-0.48853596097579016,0.9953488372093023,1.0,1.0,16/16,82.95%,CD38;TDG;NEIL1;NEIL3;NTHL1;NEIL2;BST1;DNPH1;RPS3;OARD1;MACROD1;ADPRS;SMUG1;MACROD2;ADPRH;SARM1
prerank,endopeptidase activator activity (GO:0061133),0.24023656486219944,0.4852479654223733,0.9722991689750693,0.9932951525678728,1.0,1/10,8.49%,ADRM1
prerank,neuropeptide receptor activity (GO:0008188),-0.13730049013447282,-0.473219273847257,1.0,0.9958509534828054,1.0,29/29,86.30%,TACR1;TACR3;OPRM1;GALR1;NPY5R;NMUR2;GRPR;KISS1R;SSTR2;NPY1R;GPR143;NPY2R;SSTR1;NMUR1;NTSR1;NPFFR1;GAL;HCRTR2;TACR2;MCHR1;SSTR4;SSTR5;GALR3;GALR2;SORCS2;NPSR1;SORCS3;SORCS1;GPR37
prerank,GABA receptor activity (GO:0016917),0.19618240379657828,0.46155047346854405,0.992462311557789,0.9956038004522103,1.0,3/21,19.27%,GABRR3;GABRG3;GABRG2
prerank,MHC class I protein binding (GO:0042288),0.21246712792590172,0.4546951646245901,0.9947575360419397,0.9948084451455224,1.0,4/13,28.85%,ABCB9;DERL1;ATP5F1B;ATP5F1A
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),0.1867780010045202,0.4010996142078075,0.996042216358839,0.9980995987059593,1.0,15/15,81.34%,PLA2G4E;PLA2G12A;PLA2G4D;PLA2G1B;PLA2G2F;PLA2G2E;PLA2G10;PLA2G2D;PLA2G2C;PLA2G3;PLA2G5;PLA2G4B;PLA2G4A;PLA2G4F;PLA2G4C
